CINXE.COM

<!DOCTYPE html><html lang="en"><head><title>Ethics and Compliance</title><meta http-equiv="X-UA-Compatible" content="IE=edge"/><meta charSet="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1.0,shrink-to-fit=no"/><meta name="apple-mobile-web-app-capable" content="yes"/><link rel="apple-touch-icon" sizes="180x180" href="/Themes/Corporate/ui/images/apple-touch-icon.png"/><link rel="icon" type="image/png" href="/Themes/Corporate/ui/images/favicon-32x32.png" sizes="32x32"/><link rel="icon" type="image/png" href="/Themes/Corporate/ui/images/favicon-16x16.png" sizes="16x16"/><link rel="manifest" href="/manifest.json"/><link rel="mask-icon" href="/Themes/Corporate/ui/images/safari-pinned-tab.svg" color="#666666"/><link rel="shortcut icon" href="/Themes/Corporate/ui/images/favicon.ico"/><meta name="apple-mobile-web-app-title" content="Takeda"/><meta name="application-name" content="Takeda"/><meta name="msapplication-config" content="/Themes/Corporate/ui/images/browserconfig.xml"/><meta name="theme-color" content="#ffffff"/><meta name="description" content="Takeda believes that, in addition to complying with all applicable laws and regulations, it is essential for all Takeda employees to conduct business in line with the highest ethical and moral standards."/><meta name="robots" content="index,follow"/><meta property="og:title" content="Ethics and Compliance"/><meta property="og:description" content="Takeda believes that, in addition to complying with all applicable laws and regulations, it is essential for all Takeda employees to conduct business in line with the highest ethical and moral standards."/><meta property="og:image" content="https://www.takeda.com/4ac76f/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/ethics--compliance_mobile_banner.jpg"/><meta property="og:url" content="https://www.takeda.com/corporate-responsibility/ethics-and-compliance/"/><meta name="twitter:card" content="summary"/><meta name="twitter:title" content="Ethics and Compliance"/><meta name="twitter:description" content="Takeda believes that, in addition to complying with all applicable laws and regulations, it is essential for all Takeda employees to conduct business in line with the highest ethical and moral standards."/><meta name="twitter:image" content="https://www.takeda.com/4ac76f/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/ethics--compliance_mobile_banner.jpg"/><meta name="twitter:url" content="https://www.takeda.com/corporate-responsibility/ethics-and-compliance/"/><meta name="twitter:widgets:csp" content="on"/><link rel="canonical" href="https://www.takeda.com/en-us/corporate-responsibility/ethics-and-compliance/"/><link rel="alternate" href="https://www.takeda.com/en-us/corporate-responsibility/ethics-and-compliance/" hrefLang="x-default"/><link rel="preload" as="image" imageSrcSet="https://assets-dam.takeda.com/image/upload/c_lfill,w_640/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/ethics--compliance_banner 640w, https://assets-dam.takeda.com/image/upload/c_lfill,w_750/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/ethics--compliance_banner 750w, https://assets-dam.takeda.com/image/upload/c_lfill,w_828/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/ethics--compliance_banner 828w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1080/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/ethics--compliance_banner 1080w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1200/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/ethics--compliance_banner 1200w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/ethics--compliance_banner 1920w, https://assets-dam.takeda.com/image/upload/c_lfill,w_2048/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/ethics--compliance_banner 2048w, https://assets-dam.takeda.com/image/upload/c_lfill,w_3840/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/ethics--compliance_banner 3840w" imageSizes="100vw"/><meta name="next-head-count" content="32"/><link rel="preload" href="/_next/static/media/3f90e6c778c79bff-s.p.woff2" as="font" type="font/woff2" crossorigin="anonymous" data-next-font="size-adjust"/><link rel="preload" href="/_next/static/media/83651bee47cf14da-s.p.woff2" as="font" type="font/woff2" crossorigin="anonymous" data-next-font="size-adjust"/><link rel="preload" href="/_next/static/media/6fed4e5749a3ea15-s.p.woff2" as="font" type="font/woff2" crossorigin="anonymous" data-next-font="size-adjust"/><link rel="preload" href="/_next/static/media/062522b8b7c3ad6a-s.p.woff2" as="font" type="font/woff2" crossorigin="anonymous" data-next-font="size-adjust"/><link rel="preload" href="/_next/static/media/e6f5886ae1242622-s.p.woff2" as="font" type="font/woff2" crossorigin="anonymous" data-next-font="size-adjust"/><link rel="preload" href="/_next/static/media/19e37deead9b3ec2-s.p.woff2" as="font" type="font/woff2" crossorigin="anonymous" data-next-font="size-adjust"/><link rel="preload" href="/_next/static/media/9beef36ab83de3f0-s.p.woff2" as="font" type="font/woff2" crossorigin="anonymous" data-next-font="size-adjust"/><link rel="preload" href="/_next/static/media/faac4ac11aa3d97b-s.p.woff2" as="font" type="font/woff2" crossorigin="anonymous" data-next-font="size-adjust"/><link rel="preload" href="/_next/static/media/3d9ea938b6afa941-s.p.woff2" as="font" type="font/woff2" crossorigin="anonymous" data-next-font="size-adjust"/><script id="disable-nextjs-error-overlay-with-stackbit" data-nscript="beforeInteractive"> window.addEventListener('error', event => { if (undefined) { event.stopImmediatePropagation() } }) window.addEventListener('unhandledrejection', event => { if (undefined) { event.stopImmediatePropagation() } }) </script><link rel="preload" href="/_next/static/css/c21d984c4894eaaa.css" as="style"/><link rel="stylesheet" href="/_next/static/css/c21d984c4894eaaa.css" data-n-g=""/><link rel="preload" href="/_next/static/css/81d3d7d68e7efd5a.css" as="style"/><link rel="stylesheet" href="/_next/static/css/81d3d7d68e7efd5a.css" data-n-p=""/><noscript data-n-css=""></noscript><script defer="" nomodule="" src="/_next/static/chunks/polyfills-c67a75d1b6f99dc8.js"></script><script src="data:text/javascript,%20%20var%20_mtm%20%3D%20window._mtm%20%3D%20window._mtm%20%7C%7C%20%5B%5D%3B%0A%20%20_mtm.push%28%7B%27mtm.startTime%27%3A%20%28new%20Date%28%29.getTime%28%29%29%2C%20%27event%27%3A%20%27mtm.Start%27%7D%29%3B%0A%20%20%28function%28%29%20%7B%0A%20%20%20%20var%20d%3Ddocument%2C%20g%3Dd.createElement%28%27script%27%29%2C%20s%3Dd.getElementsByTagName%28%27script%27%29%5B0%5D%3B%0A%20%20%20%20g.async%3Dtrue%3B%20g.src%3D%27https%3A%2F%2Fcdn.matomo.cloud%2Ftakeda.matomo.cloud%2Fcontainer_rTZNKGIx.js%27%3B%20s.parentNode.insertBefore%28g%2Cs%29%3B%0A%20%20%7D%29%28%29%3B" id="matomo-script" _key="b71b3c2c6d22" referrerPolicy="" _type="scriptTag" data-nscript="beforeInteractive"></script><script src="/Themes/Corporate/ui/js/retail-investors-init.js" defer="" data-nscript="beforeInteractive"></script><script src="/Scripts/ipaddress_setting.js" defer="" data-nscript="beforeInteractive"></script><script src="/Themes/Corporate/ui/js/jquery-2.1.1.min.js" defer="" data-nscript="beforeInteractive"></script><script src="/Themes/Corporate/ui/js/jquery.validate-min.js" defer="" data-nscript="beforeInteractive"></script><script src="/Themes/Corporate/ui/js/vendors/jquery-ui/jquery-ui.min.js" defer="" data-nscript="beforeInteractive"></script><script src="/Scripts/bootstrap.min.js" defer="" data-nscript="beforeInteractive"></script><script src="/Themes/Corporate/ui/js/namespace.js" defer="" data-nscript="beforeInteractive"></script><script defer="" src="/_next/static/chunks/777.210bdb8857240742.js"></script><script defer="" src="/_next/static/chunks/3743.819dc6e920559143.js"></script><script defer="" src="/_next/static/chunks/6189.1c040f63925a969f.js"></script><script defer="" src="/_next/static/chunks/2062.6c841c37f71856ad.js"></script><script defer="" src="/_next/static/chunks/2516.c5e071a2082997f6.js"></script><script defer="" src="/_next/static/chunks/6089.1bed5173ad55d881.js"></script><script defer="" src="/_next/static/chunks/7597.f5d2dccbacb957c7.js"></script><script defer="" src="/_next/static/chunks/2691.2a80ce57c2a66f5c.js"></script><script defer="" src="/_next/static/chunks/8042.ebd8eed067575d15.js"></script><script defer="" src="/_next/static/chunks/9391.0c91cf4d2d6ebf31.js"></script><script defer="" src="/_next/static/chunks/1878.1183db2177e24ebc.js"></script><script src="/_next/static/chunks/webpack-a5bd792fa538bb36.js" defer=""></script><script src="/_next/static/chunks/framework-a09d748f2d67c977.js" defer=""></script><script src="/_next/static/chunks/main-b714e4244f8b51ae.js" defer=""></script><script src="/_next/static/chunks/pages/_app-8db6d054dbe14197.js" defer=""></script><script src="/_next/static/chunks/579-cc324184d2b9723f.js" defer=""></script><script src="/_next/static/chunks/1343-42765608927613e4.js" defer=""></script><script src="/_next/static/chunks/pages/%5B%5B...slug%5D%5D-35174e984ca0a2a2.js" defer=""></script><script src="/_next/static/B-wrCqxaVyylFXttWiqv_/_buildManifest.js" defer=""></script><script src="/_next/static/B-wrCqxaVyylFXttWiqv_/_ssgManifest.js" defer=""></script><style id="__jsx-4272609781">body{font-family:'__Open_Sans_cdfc58',sans-serif}</style></head><body itemscope="" itemType="http://schema.org/WebPage"><noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-5XBTH5B" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript><div id="__next"><script id="OptanonWrapper" type="text/javascript">function OptanonWrapper() {}</script><div id="AccessibilitySection"><span><span class="Accessibility_hide-on-mobile accessibility-Text"><a href="#" class="UsableNetAssistive accessbility-Desktop-link">Enable Accessibility</a></span><span class="Accessibility_hide-on-desktop"><a href="#" class="UsableNetAssistive accessbility-mobile-link">Enable Accessibility</a></span></span><input type="hidden" id="disableAccessbility" value=""/></div><header class="main__header"><div class="main__header__top inner" itemscope="" itemType="http://schema.org/Organization"><a href="/en-us/" class="main__header__logo" accessKey="1" rel="noreferrer" data-watermark="watermark"><img src="https://assets-dam.takeda.com/image/upload/v1/legacy-dotcom/globalassets/corporate/takeda_logo" alt="HOME" class="main__header__logo__image" itemProp="logo"/><div class="main__header__tagline __className_141369"><span>Better Health,</span> <span class="main__header__tagline--break">Brighter Future</span></div></a><div class="main__header__nav"><nav class="nav-service" itemscope="" itemType="http://schema.org/SiteNavigationElement"><a href="/en-us/newsroom/news-releases/" data-is-active="false" aria-current="false" class="nav-service__url" itemProp="url" rel="noreferrer" data-watermark="watermark"> <span itemProp="name" class="nav-service__url--item">Newsroom</span></a><a href="/en-us/careers/?epslanguage=en-US" data-is-active="false" aria-current="false" class="nav-service__url" itemProp="url" rel="noreferrer" data-watermark="watermark"> <span itemProp="name" class="nav-service__url--item">Careers</span></a><a href="/investors/" data-is-active="false" aria-current="false" class="nav-service__url" itemProp="url" rel="noreferrer" data-watermark="watermark"> <span itemProp="name" class="nav-service__url--item">Investors</span></a><a href="/en-us/who-we-are/contact-us" data-is-active="false" aria-current="false" class="nav-service__url" itemProp="url" rel="noreferrer" data-watermark="watermark"> <span itemProp="name" class="nav-service__url--item">Contact Us</span></a><div class=""><a href="/worldwide/" class="countryselector__url"><img src="https://assets-dam.takeda.com/image/upload/v1/legacy-dotcom/siteassets/en-us/us" class="country__flag" alt=""/> <span>United States</span></a></div></nav></div></div><div id="wrapper-menu" class="menu__inner menu--dir-right"><input type="checkbox" class="state menu__toggle--mobile" aria-hidden="true" id="tgl-mobile"/><label for="tgl-mobile" class="menu__overlay--mobile"></label><label for="tgl-mobile" class="menu__toggle--mobile--wrapper"><span class="menu__toggle--mobile__icon"></span></label><div class="menu__wrapper"><nav class="menu" itemscope="" itemType="http://schema.org/SiteNavigationElement"><a href="/en-us/" class="main__header__logo" itemProp="url" rel="noreferrer" data-watermark="watermark"><img class="main__header__logo__image" sizes="100vw" alt="" loading="lazy" src="https://assets-dam.takeda.com/image/upload/v1/legacy-dotcom/globalassets/corporate/takeda_logo"/></a><input id="item-0" name="mega" type="radio" class="state" aria-hidden="true"/><label for="item-0" class="menu__label " itemProp="name"><span class="menu__label__text">Who We Are</span></label><div class="menu__panel"><div class="menu__panel__inner"><div class="menu__sub"><a href="/en-us/who-we-are/" itemProp="url" rel="noreferrer" data-watermark="watermark"><strong class="menu__sub__heading">About Takeda</strong><span class="menu__panel__landing__caption"><div>How can we do more for our patients?<br>Everything at Takeda starts with this question.</div></span><span itemProp="name" class="menu__panel__link">Learn more</span></a></div><div class="menu__sub__expanded"><div class="menu__panel__inner__content"><strong class="menu__sub__heading"><a href="/en-us/who-we-are/company-information/" rel="noreferrer" data-watermark="watermark">Company Information</a></strong><a href="/en-us/who-we-are/company-information/company-facts/" class="menu__panel__submenu__link" itemProp="url" rel="noreferrer" data-watermark="watermark"><span itemProp="name">Takeda in the U.S.</span></a><a href="/en-us/who-we-are/company-information/worldwide-offices/" class="menu__panel__submenu__link" itemProp="url" rel="noreferrer" data-watermark="watermark"><span itemProp="name">Worldwide Offices</span></a><a href="/en-us/shortcut_content_136879/" class="menu__panel__submenu__link" itemProp="url" rel="noreferrer" data-watermark="watermark"><span itemProp="name">Executive Leadership</span></a></div><div class="menu__panel__inner__content"><strong class="menu__sub__heading"><a href="/en-us/who-we-are/corporate-philosophy/" rel="noreferrer" data-watermark="watermark">Corporate Philosophy</a></strong></div><div class="menu__panel__inner__content"><strong class="menu__sub__heading"><a href="/en-us/who-we-are/takeda-pricing-philosophy/" rel="noreferrer" data-watermark="watermark">Takeda Pricing Philosophy</a></strong></div><div class="menu__panel__inner__content"><strong class="menu__sub__heading"><a href="/en-us/who-we-are/contact-us/" rel="noreferrer" data-watermark="watermark">Contact Us</a></strong></div></div><div class="menu__sub menu__panel__feature"><div class="grid-1-4 w-full"><section class="spot-block visual headingColor-color1 linkStyling-normal linkCasing-normal" itemscope="" itemType="http://schema.org/CreativeWork"><div class="spot-block__flex"><div class="spot-block__text-wrapper"><h2 class="spot-block__heading custom--head" itemProp="headline"></h2><div class="spot-block__text" itemProp="description"><div></div></div></div></div></section></div></div></div><button id="btnClose-0" type="button"><span class="close-menu"> </span></button></div><input id="item-1" name="mega" type="radio" class="state" aria-hidden="true"/><label for="item-1" class="menu__label " itemProp="name"><span class="menu__label__text">What We Do</span></label><div class="menu__panel"><div class="menu__panel__inner"><div class="menu__sub"><a href="/en-us/what-we-do/" itemProp="url" rel="noreferrer" data-watermark="watermark"><strong class="menu__sub__heading">Our Business</strong><span class="menu__panel__landing__caption"><div>Takeda continues its transformation into an agile and innovative global pharmaceutical leader, serving the needs of patients and physicians worldwide.</div></span><span itemProp="name" class="menu__panel__link">Learn more</span></a></div><div class="menu__sub__expanded"><div class="menu__panel__inner__content"><strong class="menu__sub__heading"><a href="/en-us/what-we-do/areas-of-focus/" rel="noreferrer" data-watermark="watermark">Areas of Focus</a></strong></div><div class="menu__panel__inner__content"><strong class="menu__sub__heading"><a href="/en-us/what-we-do/patient-services/" rel="noreferrer" data-watermark="watermark">Patient Services & Assistance</a></strong></div><div class="menu__panel__inner__content"><strong class="menu__sub__heading"><a href="/en-us/what-we-do/product-portfolio/" rel="noreferrer" data-watermark="watermark">U.S. Product List</a></strong></div><div class="menu__panel__inner__content"><strong class="menu__sub__heading"><a href="/en-us/what-we-do/independent-medical-education-grants/" rel="noreferrer" data-watermark="watermark">Independent Medical Education Grants</a></strong></div></div><div class="menu__sub menu__panel__feature"></div></div><button id="btnClose-1" type="button"><span class="close-menu"> </span></button></div><input id="item-2" name="mega" type="radio" class="state" aria-hidden="true"/><label for="item-2" class="menu__label " itemProp="name"><span class="menu__label__text">Our Stories</span></label><div class="menu__panel"><div class="menu__panel__inner"><div class="menu__sub"><a href="/en-us/our-stories/" itemProp="url" rel="noreferrer" data-watermark="watermark"><strong class="menu__sub__heading">Our Stories</strong><span class="menu__panel__landing__caption"><div>A selection of stories related to Innovation, Caring and Heritage</div></span><span itemProp="name" class="menu__panel__link">Learn more</span></a></div><div class="menu__sub__expanded"></div><div class="menu__sub menu__panel__feature"></div></div><button id="btnClose-2" type="button"><span class="close-menu"> </span></button></div><input id="item-3" name="mega" type="radio" class="state" aria-hidden="true"/><label for="item-3" class="menu__label selected" itemProp="name"><span class="menu__label__text">Corporate Responsibility</span></label><div class="menu__panel"><div class="menu__panel__inner"><div class="menu__sub"><a href="/en-us/corporate-responsibility/" itemProp="url" rel="noreferrer" data-watermark="watermark"><strong class="menu__sub__heading">Purpose-led Sustainability</strong><span class="menu__panel__landing__caption"><div>Sustainability underpins all we do at Takeda to help solve key societal challenges and create value for society.</div></span><span itemProp="name" class="menu__panel__link">Learn more</span></a></div><div class="menu__sub__expanded"><div class="menu__panel__inner__content"><strong class="menu__sub__heading"><a href="/en-us/corporate-responsibility/patients/" rel="noreferrer" data-watermark="watermark">Patients</a></strong><a href="/en-us/shortcut_content_251810/" class="menu__panel__submenu__link" itemProp="url" rel="noreferrer" data-watermark="watermark"><span itemProp="name">Patient Services and Assistance</span></a><a href="/en-us/shortcut_content_251811/" class="menu__panel__submenu__link" itemProp="url" rel="noreferrer" data-watermark="watermark"><span itemProp="name">Diversity, Equity & Inclusion in R&D</span></a></div><div class="menu__panel__inner__content"><strong class="menu__sub__heading"><a href="/en-us/corporate-responsibility/people/" rel="noreferrer" data-watermark="watermark">People</a></strong><a href="/en-us/shortcut_content_251812/" class="menu__panel__submenu__link" itemProp="url" rel="noreferrer" data-watermark="watermark"><span itemProp="name">Diversity, Equity & Inclusion</span></a><a href="/en-us/shortcut_content_251813/" class="menu__panel__submenu__link" itemProp="url" rel="noreferrer" data-watermark="watermark"><span itemProp="name">Commitment to Community</span></a><a href="/en-us/corporate-responsibility/people/#Philantropic-Giving" class="menu__panel__submenu__link" itemProp="url" rel="noreferrer" data-watermark="watermark"><span itemProp="name">Philanthropic Giving</span></a><a href="/en-us/shortcut_content_251814/" class="menu__panel__submenu__link" itemProp="url" rel="noreferrer" data-watermark="watermark"><span itemProp="name">Careers</span></a></div><div class="menu__panel__inner__content"><strong class="menu__sub__heading"><a href="/en-us/corporate-responsibility/planet/" rel="noreferrer" data-watermark="watermark">Planet</a></strong></div><div class="menu__panel__inner__content"><strong class="menu__sub__heading"><a href="/en-us/corporate-responsibility/ethics-and-compliance/" rel="noreferrer" data-watermark="watermark">Ethics and Compliance</a></strong><a href="/en-us/corporate-responsibility/ethics-and-compliance/cpsia/" class="menu__panel__submenu__link" itemProp="url" rel="noreferrer" data-watermark="watermark"><span itemProp="name">Statements & Disclosures</span></a></div></div><div class="menu__sub menu__panel__feature"></div></div><button id="btnClose-3" type="button"><span class="close-menu"> </span></button></div><nav class="styles_navMobile__dVKw_" itemscope="" itemType="http://schema.org/SiteNavigationElement"><a href="/en-us/newsroom/news-releases/" data-is-active="false" aria-current="false" class="nav-service__url" itemProp="url" data-sb-field-path=".topToolbarLinksCollection.0" rel="noreferrer" data-watermark="watermark"> <span itemProp="name" class="nav-service__url--item" data-sb-field-path=".title .text">Newsroom</span></a><a href="/en-us/careers/?epslanguage=en-US" data-is-active="false" aria-current="false" class="nav-service__url" itemProp="url" data-sb-field-path=".topToolbarLinksCollection.1" rel="noreferrer" data-watermark="watermark"> <span itemProp="name" class="nav-service__url--item" data-sb-field-path=".title .text">Careers</span></a><a href="/investors/" data-is-active="false" aria-current="false" class="nav-service__url" itemProp="url" data-sb-field-path=".topToolbarLinksCollection.2" rel="noreferrer" data-watermark="watermark"> <span itemProp="name" class="nav-service__url--item" data-sb-field-path=".title .text">Investors</span></a><a href="/en-us/who-we-are/contact-us" data-is-active="false" aria-current="false" class="nav-service__url" itemProp="url" data-sb-field-path=".topToolbarLinksCollection.3" rel="noreferrer" data-watermark="watermark"> <span itemProp="name" class="nav-service__url--item" data-sb-field-path=".title .text">Contact Us</span></a><div class=""><a href="/worldwide/" class="countryselector__url"><img src="https://assets-dam.takeda.com/image/upload/v1/legacy-dotcom/siteassets/en-us/us" class="country__flag" alt=""/> <span>United States</span></a></div></nav><input id="tgl-overlay" name="mega" type="radio" class="state menu__toggle" aria-hidden="true" checked=""/><label for="tgl-overlay" class="menu__overlay"></label><form itemscope="" itemType="http://schema.org/WebSite" class="search whitespace-nowrap"><div itemProp="potentialAction" itemscope="" itemType="http://schema.org/SearchAction" class="search__fieldset"><meta itemProp="target"/><label for="search-submit"><button type="submit" id="search-submit" class="search__submit" title="Search"><svg class="search__submit__image"><use xlink:href="/Themes/Shared/ui/svg/takeda.svg#icon-search"></use></svg></button> </label><label><input id="query" name="query" type="text" placeholder="Search" class="search__input" itemProp="query-input" autoComplete="off" value=""/></label></div></form></nav></div></div><input type="checkbox" class="state" aria-hidden="true" id="tgl-search"/><label for="tgl-search" class="search__toggle"><svg class="search__toggle__icon"><use xlink:href="/Themes/Shared/ui/svg/takeda.svg#icon-search"></use></svg></label><div class="search__mobile"><form><label><label><input id="search-input-mobile" name="query" type="text" placeholder="Search" class="search__input" itemProp="query-input" autoComplete="off" value=""/></label></label></form></div></header><main class=""><nav class="breadcrumb-social__wrapper inner"><div class="breadcrumbs" itemProp="breadcrumb" itemscope="" itemType="http://schema.org/BreadcrumbList"><span itemProp="itemListElement" itemscope="" itemType="http://schema.org/ListItem"><meta itemProp="position" content="3"/><a class="item" href="/en-us/" itemscope="" itemType="http://schema.org/Thing" itemProp="item"><span itemProp="name">HOME</span></a></span> <span itemProp="itemListElement" itemscope="" itemType="http://schema.org/ListItem"><meta itemProp="position" content="2"/><a class="item" href="/en-us/corporate-responsibility/" itemscope="" itemType="http://schema.org/Thing" itemProp="item"><span itemProp="name">Corporate Responsibility</span></a></span> <span itemProp="itemListElement" itemscope="" itemType="http://schema.org/ListItem"><meta itemProp="position" content="1"/><span class="active" itemscope="" itemType="http://schema.org/Thing" itemProp="item"><span itemProp="name">Ethics and Compliance</span><meta itemProp="url" content="/en-us/corporate-responsibility/ethics-and-compliance/"/></span></span> </div><nav class="social-sharing" itemscope="" itemType="http://schema.org/SiteNavigationElement"><span class="social-sharing__text">Share:</span><span class="social-sharing__icons"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fbit.ly%2F3Ht7l58" title="facebook" target="_blank" rel="noreferrer"><span class="icon" data-action="facebook"><meta itemProp="name" content="facebook"/><svg class="circle-icon"><use href="/Resources/ui/svg/takeda.svg#icon-facebook"></use></svg></span></a> <a href="https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Fbit.ly%2F3Ht7l58&title=Ethics%20and%20Compliance&summary=&source=" title="linkedin" target="_blank" rel="noreferrer"><span class="icon" data-action="linkedin"><meta itemProp="name" content="linkedin"/><svg class="circle-icon"><use href="/Resources/ui/svg/takeda.svg#icon-linkedin"></use></svg></span></a> <a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fbit.ly%2F3Ht7l58&text=Ethics%20and%20Compliance" title="twitter" target="_blank" rel="noreferrer"><span class="icon" data-action="twitter"><meta itemProp="name" content="twitter"/><svg class="circle-icon"><use href="/Resources/ui/svg/takeda.svg#icon-twitter"></use></svg></span></a> <a href="/cdn-cgi/l/email-protection#6c531f190e06090f185125495e5c1b03190008495e5c00050709495e5c1803495e5c1f040d1e09495e5c1804051f495e5c1b051804495e5c150319424a0d011c570e030815512b1e09091805020b1f495e2f495c2d495c2d25495e5c0a03190208495e5c1804051f495e5c050218091e091f1805020b495e5c0d0208495e5c25495e5c1b03190008495e5c00050709495e5c1803495e5c1f040d1e09495e5c0518495e5c1b051804495e5c15031942495c2d495c2d4c291804050f1f495e5c0d0208495e5c2f03011c00050d020f094c0418181c1f495f2d495e2a495e2a0e0518420015495e2a5f24185b005954" title="email" target="_blank" rel="noreferrer"><span class="icon" data-action="email"><meta itemProp="name" content="email"/><svg class="circle-icon"><use href="/Resources/ui/svg/takeda.svg#icon-email"></use></svg></span></a></span></nav></nav><section class="hero mb-1"><div class="epi-wrapper"><div class="grid-1-1"><div class="hero-spot hero-spot--right"><div id="hero-spot-133ad5a6-3db2-463f-b497-b6b4fc5d989b" class="hero-spot--background bg-center"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" sizes="100vw" srcSet="https://assets-dam.takeda.com/image/upload/c_lfill,w_640/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/ethics--compliance_banner 640w, https://assets-dam.takeda.com/image/upload/c_lfill,w_750/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/ethics--compliance_banner 750w, https://assets-dam.takeda.com/image/upload/c_lfill,w_828/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/ethics--compliance_banner 828w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1080/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/ethics--compliance_banner 1080w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1200/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/ethics--compliance_banner 1200w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/ethics--compliance_banner 1920w, https://assets-dam.takeda.com/image/upload/c_lfill,w_2048/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/ethics--compliance_banner 2048w, https://assets-dam.takeda.com/image/upload/c_lfill,w_3840/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/ethics--compliance_banner 3840w" src="https://assets-dam.takeda.com/image/upload/c_lfill,w_3840/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/ethics--compliance_banner" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:cover;background-size:cover;background-position:0% 0%;filter:blur(20px);background-image:url("data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAACBAMAAACTT1DjAAAALVBMVEW6x8xkW1qjo6cQIDq0srRzZV9lQzB8Zl5xnK2unphnip5NQEOnub+6iXFWWGvGeRJ9AAAAFElEQVQI12PoChPXYWAw3iun6QAAEGQCmxwXDl0AAAAASUVORK5CYII=")"/><noscript><img alt="" loading="eager" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:cover" sizes="100vw" srcSet="https://assets-dam.takeda.com/image/upload/c_lfill,w_640/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/ethics--compliance_banner 640w, https://assets-dam.takeda.com/image/upload/c_lfill,w_750/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/ethics--compliance_banner 750w, https://assets-dam.takeda.com/image/upload/c_lfill,w_828/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/ethics--compliance_banner 828w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1080/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/ethics--compliance_banner 1080w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1200/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/ethics--compliance_banner 1200w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/ethics--compliance_banner 1920w, https://assets-dam.takeda.com/image/upload/c_lfill,w_2048/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/ethics--compliance_banner 2048w, https://assets-dam.takeda.com/image/upload/c_lfill,w_3840/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/ethics--compliance_banner 3840w" src="https://assets-dam.takeda.com/image/upload/c_lfill,w_3840/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/ethics--compliance_banner"/></noscript></span></div><div class="hero-spot__content hero-spot__content--right"><div class="hero-spot__content__text"><div>Living our values every day</div></div></div></div></div></div></section><section class="main inner"><div class="epi-wrapper"><div class="grid-1-1"><div><div class="richtext"><h2>Our Culture of Ethics and Compliance</h2> <p>Takeda is a global, values-based, R&D-driven biopharmaceutical leader committed to discovering and delivering life-transforming treatments, and committed to patients, our people and the planet. We’re guided by our values of Takeda-ism, which incorporate Integrity, Fairness, Honesty and Perseverance, with Integrity at the core. They’re brought to life through actions based on Patient-Trust-Reputation-Business.</p> <p>A culture of ethics and compliance is born out of this foundation and shapes the decisions we make and the actions that we take as Takeda employees. Please view the <a rel="noopener" target="_blank" href="https://www.takeda.com/who-we-are/global-ethics-compliance/" title="Takeda Global Code of Conduct">Takeda Global Code of Conduct</a> for more information.</p> <p>To report a suspected violation, please call <span class="red-text">1-888-TAKEDA-0 (1-888-825-3320)</span> or make an online report via <a rel="noopener" target="_blank" href="https://secure.ethicspoint.com/domain/media/en/gui/28267/index.html" title="EthicsPoint">EthicsPoint</a>.</p></div></div></div><div class="grid-1-1"><section class="accordion"><input type="checkbox" id="accordion-item-1dbcf3b1-6fa4-42f8-8238-3ac6ebb3cea8" class="accordion--toggle"/><label for="accordion-item-1dbcf3b1-6fa4-42f8-8238-3ac6ebb3cea8" class="accordion__title"><span class="accordion__title__wrapper"><span class="accordion__title--heading">Consumer Product Safety Improvement Act (CPSIA)</span><span class="accordion__title--subheading"></span></span></label><div class="accordion__content__wrapper"><div class="accordion__content"><div class="accordion__content__text"><p>Pursuant to the Consumer Product Safety Improvement Act (CPSIA), manufacturers of imported or domestically manufactured (U.S.A.) prescription drug products that are subject to a consumer product safety rule, ban, standard or regulation enforced by the U.S. Consumer Product Safety Commission (CPSC) are required to provide General Certificates of Conformity (GCC).</p> <p> </p> <p>Takeda manufactures prescription drug products that are governed under the CPSC regulations. The Takeda GCC certifies that the product (the child-resistant package) complies with the Poison Prevention Packaging Act (PPPA) requirements for special packaging under 16 CFR § 1700.</p> <p> </p> <p>The GCCs are maintained to reflect additions of new products and existing product changes. Please see <a rel="noopener" target="_blank" href="https://www.cpsc.gov/" title="cpsc.gov">CPSC regulations</a> for further information and see product-specific GCC listings below.</p> <p> </p> <table border="0" style="width: 864px; height: 456px;" class="takeda__table--striped"> <tbody> <tr> <td style="width: 210px;"><strong>Name</strong></td> <td style="width: 240px;"><strong>Dosage</strong></td> <td style="width: 100px;"><strong>Type</strong></td> <td><strong>Prescribing Information</strong></td> </tr> <tr> <td style="width: 210px;"><strong><a href="https://assets-dam.takeda.com/raw/upload/v1662724750/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/cpsia/TGCC_Actos_Pioglitzone_30ct_btl_15mg_30mg_45mg.pdf">ACTOS (pioglitazone)</a></strong></td> <td style="width: 240px;"> <p>30ct bottle, 15mg tablet<br>30ct bottle, 30mg tablet<br>30ct bottle, 45mg tablet</p> </td> <td style="width: 100px;">Tablet</td> <td><a rel="noopener" target="_blank" href="http://general.takedapharm.com/content/file/pi.pdf?filetypecode=actospi"><strong>Click here for Prescribing Information including boxed warning and medication guide</strong></a></td> </tr> <tr> <td style="width: 210px;"><strong><a href="https://assets-dam.takeda.com/raw/upload/v1662724751/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/cpsia/TGCC_ActoPlus_MET_60ct_btl_15mg-500mg_15mg-850mg.pdf">ACTO<em>plus</em> met (pioglitazone and metformin HCI)</a></strong></td> <td style="width: 240px;"> <p>60ct bottle, 15mg/500mg tablet<br>60ct bottle, 15mg/850mg tablet</p> </td> <td style="width: 100px;">Tablet</td> <td><a rel="noopener" target="_blank" href="http://general.takedapharm.com/content/file/pi.pdf?filetypecode=actoplusmetpi"><strong>Click here for Prescribing Information including boxed warning and medication guide</strong></a></td> </tr> <tr> <td style="width: 210px;"> <p><a href="https://assets-dam.takeda.com/raw/upload/v1662724752/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/cpsia/TGCC_ActoPlus_MET_XR_30ct_btl_15mg-1000mg_30mg-1000mg.pdf">ACTO<em>plus</em> met XR (pioglitazone and metformin HCI) (extended release)</a><br><small>(Discontinued)</small></p> </td> <td style="width: 240px;"> <p>30ct bottle, 15mg/1000mg tablet<br>30ct bottle, 30mg/1000mg tablet</p> </td> <td style="width: 100px;">Tablet</td> <td><a rel="noopener" target="_blank" href="http://general.takedapharm.com/content/file/pi.pdf?filetypecode=ACTOPLUSMETXRPI"><strong>Click here for Prescribing Information including boxed warning and medication guide</strong></a></td> </tr> <tr> <td style="width: 210px;"><strong><a href="https://assets-dam.takeda.com/raw/upload/v1662724753/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/cpsia/TGCC_Colcrys_30ct_btl_0.6mg.pdf">COLCRYS (colchicine)</a></strong></td> <td style="width: 240px;"> <p>30ct bottle, 0.6mg tablet<br>100ct bottle, 0.6mg tablet</p> </td> <td style="width: 100px;">Tablet</td> <td><strong><a rel="noopener" target="_blank" href="http://general.takedapharm.com/content/file.aspx?filetypecode=COLCRYSPI">Click here for Prescribing Information including medication guide</a></strong></td> </tr> <tr> <td style="width: 210px;"><strong><a href="https://assets-dam.takeda.com/raw/upload/v1662724754/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/cpsia/TGCC_Dexilant_5ct_btl_60mg_30ct_btl_30mg_60mg_90ct_btl_30mg_60mg.pdf">DEXILANT (dexlansoprazole)</a></strong></td> <td style="width: 240px;"> <p>5ct bottle, 30mg capsule<br>5ct bottle, 60mg capsule<br>30ct bottle, 30mg capsule<br>30ct bottle, 60mg capsule<br>90ct bottle, 60mg capsule</p> </td> <td style="width: 100px;">Capsule</td> <td> <p><a rel="noopener" target="_blank" href="http://general.takedapharm.com/content/file/pi.pdf?filetypecode=DEXILANTPI"><strong><br></strong><strong>Click here for Prescribing Information including medication guide</strong></a></p> </td> </tr> <tr> <td style="width: 210px;"><strong><a href="https://assets-dam.takeda.com/raw/upload/v1662724755/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/cpsia/TGCC_DuetAct_30ct_btl_30mg-2mg_30mg-4mg.pdf"><em>Due</em>tact (pioglitazone and glimepiride)</a></strong></td> <td style="width: 240px;"> <p>30ct bottle, 30mg/2mg tablet<br>30ct bottle, 30mg/4mg tablet</p> </td> <td style="width: 100px;">Tablet</td> <td><a rel="noopener" target="_blank" href="http://general.takedapharm.com/content/file/pi.pdf?filetypecode=duetactpi"><strong>Click here for Prescribing Information including boxed warning and medication guide</strong></a></td> </tr> <tr> <td style="width: 210px;"><strong><a href="https://assets-dam.takeda.com/raw/upload/v1662724756/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/cpsia/TGCC_Kazano_60ct_bottle_12.5mg-500mg.pdf">KAZANO (alogliptin and metformin HCI)</a></strong></td> <td style="width: 240px;"> <p>60ct bottle, 12.5mg/500mg tablet<br>60ct bottle, 12.5mg/1000mg tablet</p> </td> <td style="width: 100px;">Tablet<br><br></td> <td><a rel="noopener" target="_blank" href="http://general.takedapharm.com/content/file/pi.pdf?FileTypeCode=KAZANOPI"><strong>Click here for Prescribing Information including boxed warning and medication guide</strong></a></td> </tr> <tr> <td style="width: 210px;"><strong><a href="https://assets-dam.takeda.com/raw/upload/v1662724757/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/cpsia/TGCC_Nesina_30ct_btl_6.25mg_12.5mg _25mg.pdf">NESINA (alogliptin)</a></strong></td> <td style="width: 240px;"> <p>30ct bottle, 12.5mg tablet<br>30ct bottle, 25mg tablet<br>30ct bottle, 6.25mg tablet</p> </td> <td style="width: 100px;">Tablet</td> <td><a rel="noopener" target="_blank" href="http://general.takedapharm.com/content/file/pi.pdf?FileTypeCode=NESINAPI"><strong>Click here for Prescribing Information including medication guide</strong></a></td> </tr> <tr> <td style="width: 210px;"><strong><a href="https://assets-dam.takeda.com/raw/upload/v1662724758/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/cpsia/TGCC_Oseni_30ct_btl_12.5mg-15mg_12.5mg-30mg_12.5mg-45mg_25mg-15mg_25mg-30mg_25mg-45mg.pdf">OSENI (alogliptin and pioglitazone)</a></strong></td> <td style="width: 240px;"> <p>30ct bottle, 12.5mg/15mg tablet<br>30ct bottle, 12.5mg/30mg tablet<br>30ct bottle, 12.5mg/45mg tablet<br>30ct bottle, 25mg/15mg tablet<br>30ct bottle, 25mg/30mg tablet<br>30ct bottle, 25mg/45mg tablet</p> </td> <td style="width: 100px;">Tablet</td> <td><a rel="noopener" target="_blank" href="http://general.takedapharm.com/content/file/pi.pdf?filetypecode=OSENIPI"><strong>Click here for Prescribing Information including boxed warning and medication guide</strong></a></td> </tr> <tr> <td style="width: 210px;"><strong><a href="https://assets-dam.takeda.com/raw/upload/v1662724759/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/cpsia/TGCC_Prevacid_15mg_30ct_30mg_100ct.pdf">PREVACID (lansoprazole)</a></strong></td> <td style="width: 240px;"> <p>30ct bottle, 15mg capsule <br>100ct bottle, 30mg capsule</p> </td> <td style="width: 100px;">Capsule</td> <td><a rel="noopener" target="_blank" href="http://general.takedapharm.com/content/file/pi.pdf?filetypecode=PREVACIDPI"><strong>Click here for Prescribing Information including medication guide</strong></a></td> </tr> <tr> <td style="width: 210px;"><strong><a href="https://assets-dam.takeda.com/raw/upload/v1662724760/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/cpsia/TGCC_Rozerm_30ct_btl_8mg_100ct_btl_8mg.pdf">ROZEREM (ramelteon)</a></strong></td> <td style="width: 240px;"> <p>30ct bottle, 8mg tablet<br>100ct bottle, 8mg tablet</p> </td> <td style="width: 100px;">Tablet</td> <td><a rel="noopener" target="_blank" href="http://general.takedapharm.com/content/file/pi.pdf?filetypecode=rozerempi"><strong>Click here for Prescribing Information including medication guide</strong></a></td> </tr> <tr> <td style="width: 210px;"><strong><a href="https://assets-dam.takeda.com/raw/upload/v1662724760/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/cpsia/TGCC_Trintellix_7ct_btl_5mg_10mg_30ct_btl_5mg_20mg.pdf">TRINTELLIX (vortioxetine)</a></strong></td> <td style="width: 240px;"> <p>7ct bottle, 5mg tablet<br>7ct bottle, 10mg tablet<br>30ct bottle, 5mg tablet<br>30ct bottle, 10mg tablet<br>30ct bottle, 20mg tablet</p> </td> <td style="width: 100px;">Tablet</td> <td><a rel="noopener" target="_blank" href="http://general.takedapharm.com/content/file/pi.pdf?filetypecode=TRINTELLIXPI"><strong>Click here for Prescribing Information including boxed warning and medication guide</strong></a></td> </tr> <tr> <td style="width: 210px;"><strong><a href="https://assets-dam.takeda.com/raw/upload/v1662724761/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/cpsia/TGCC_Uloric_7ct_btl_40mg_80mg_30ct_btl_40mg_80mg.pdf">ULORIC (febuxostat)</a></strong></td> <td style="width: 240px;"> <p>7ct bottle, 40mg tablet<br>7ct bottle, 80mg tablet<br>30ct bottle, 40mg tablet<br>30ct bottle, 80mg tablet</p> </td> <td style="width: 100px;">Tablet</td> <td><strong><a rel="noopener" target="_blank" href="http://general.takedapharm.com/content/file/pi.pdf?filetypecode=ULORICPI">Click here for Prescribing Information including boxed warning and medication guide</a></strong></td> </tr> </tbody> </table> <p> </p> <p>ACTOS®, ACTOPLUS MET® and DUETACT® are registered trademarks of Takeda Pharmaceutical Company Limited.</p> <p> </p> <p>COLCRYS® is a registered trademark of Takeda Pharmaceuticals U.S.A., Inc.</p> <p> </p> <p>DEXILANT® and the DEXILANT Logo® are registered trademarks of Takeda Pharmaceuticals U.S.A., Inc.</p> <p> </p> <p>KAZANO® is a registered trademark of Takeda Pharmaceutical Company Limited.</p> <p> </p> <p>NESINA® is a registered trademark of Takeda Pharmaceutical Company Limited.</p> <p> </p> <p>OSENI® is a registered trademark of Takeda Pharmaceutical Company Limited.</p> <p> </p> <p>PREVACID® is a registered trademark of Takeda Pharmaceuticals U. S. A., Inc.  </p> <p> </p> <p>ROZEREM® is a registered trademark of Takeda Pharmaceutical Company Limited.</p> <p> </p> <p>TRINTELLIX® is a registered trademark of H. Lundbeck A/S and used under license by Takeda Pharmaceuticals America, Inc.</p> <p> </p> <p>ULORIC® is a registered trademark of Teijin Kabushiki Kaisha (Teijin Limited), used under license.</p> <hr></div></div></div><input type="checkbox" id="accordion-item-eb3ed475-4845-4ba0-a192-8e97cdbd2b4d" class="accordion--toggle"/><label for="accordion-item-eb3ed475-4845-4ba0-a192-8e97cdbd2b4d" class="accordion__title"><span class="accordion__title__wrapper"><span class="accordion__title--heading">Federal Disclosures</span><span class="accordion__title--subheading"></span></span></label><div class="accordion__content__wrapper"><div class="accordion__content"><div class="accordion__content__text"><h3>Ethical Participation in Federal Health Care Programs</h3> <p>Takeda is committed to being a lawful, compliant, and ethical participant in the federal health care programs. Many federal and state laws, regulations, and other legal requirements, including the federal False Claims Act, have been created to prevent and help detect fraud, waste, and abuse in federal health care programs.</p> <p> </p> <p>Takeda complies with any such applicable requirements in full, and has developed various policies and procedures for detecting and preventing fraud, waste and abuse. Takeda maintains a Corporate Ethics & Compliance program, which includes a Code of Conduct, policies and procedures for detecting and preventing fraud, waste and abuse, a monitoring program and a Compliance Hotline/Helpline. Please contact Ethics & Compliance for more information at <a href="/cdn-cgi/l/email-protection#8adfd9c8dfc9e5e7fae6e3ebe4e9efcafeebe1efeeeba4e9e5e7"><span class="__cf_email__" data-cfemail="1540465740567a7865797c747b76705561747e7071743b767a78">[email protected]</span></a>.</p> <p> </p> <hr></div></div></div><input type="checkbox" id="accordion-item-631fae80-618f-46b3-84c4-97dd949b6596" class="accordion--toggle"/><label for="accordion-item-631fae80-618f-46b3-84c4-97dd949b6596" class="accordion__title"><span class="accordion__title__wrapper"><span class="accordion__title--heading">Lobbying & Political Contributions</span><span class="accordion__title--subheading"></span></span></label><div class="accordion__content__wrapper"><div class="accordion__content"><div class="accordion__content__text"><p>Takeda is a global, values-based, R&D-driven biopharmaceutical leader with a large U.S. presence. We connect to our 240-year-old history and Japanese heritage through everything we do. Our unwavering commitment to putting patients first guides our scientific discovery and helps us as we strive to address unmet medical needs. As Takeda’s U.S. operations are integral to our global business, it’s important for Takeda to have appropriate engagement opportunities with U.S. policymakers and policy influencers.</p> <p> </p> <p>The U.S. government accounts for nearly half of all U.S. health care spending, and its policies, legislation, and regulations impact the entire health care system. In order to ensure that Takeda’s point of view is considered by policymakers in critical debates affecting our products and therapeutic areas, we must provide a regular stream of information over time to educate elected officials on both sides of the aisle.</p> <p> </p> <h2>Lobbying Activities</h2> <p>Elected officials have an impact on public policy issues affecting Takeda and the patients we serve. We believe that public policy engagement is an important and appropriate role for companies when conducted in a legal and transparent manner. In the U.S., there are important federal and state lobbying registration and disclosure laws with which Takeda complies.</p> <p> </p> <p>Where required, Takeda reports lobbying activity at state and federal levels. Takeda files quarterly lobbying reports that capture federal lobbying activity in the Congress and with any federal agencies. Takeda’s reports can be found by searching the <a rel="noopener" target="_blank" href="https://lobbyingdisclosure.house.gov/" title="lobbyingdisclosure.house.gov">Congressional lobby disclosure website</a>.</p> <p> </p> <h2>Trade Associations</h2> <p>Takeda is a member of several industry and trade groups that represent both the pharmaceutical industry and the business community at large in an effort to bring about consensus on broad policy issues that can impact Takeda’s business objectives and ability to serve patients. Takeda’s participation as a member of these various industry and trade groups comes with the understanding that we may not always agree with the positions of the larger organization and/or other members, and that we are committed to voicing our concerns as appropriate through our colleagues who serve on the boards and committees of these groups. We disclose our <a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1722434769/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/US_Trade_Associations_over_25k.pdf">current memberships in the U.S.</a> where annual dues are more than $25,000.</p> <p> </p> <h2>Political Contributions</h2> <p>In the U.S., Takeda is committed to supporting candidates of any party using fair and objective criteria in the selection of candidates − including those who support public policies that contribute to the health needs of our patients, pharmaceutical innovation, and the interests of our company. This support comes from two different sources: Takeda’s Political Action Committee (TakPAC) and from corporate funds where legally allowed.</p> <p> </p> <p>TakPAC is a separate, segregated fund registered with the Federal Election Commission and connected to Takeda Pharmaceuticals America, Inc. as a Lobbyist/Registrant PAC. The purpose of TakPAC is to provide monetary contributions and other support to candidates for federal, state, and local offices. Employee participation in TakPAC is completely voluntary, all contribution guidelines are only suggestions, and employees are free to contribute more or less than the guidelines or nothing at all. Takeda will neither favor nor disadvantage any employee by reason of the amount of his or her contribution or decision not to contribute. Employees may refuse to contribute without reprisal.</p> <p> </p> <p>TakPAC activity reports are filed monthly with additional reporting requirements during an election year. TakPAC’s reports are available on the <span style="text-decoration: underline;"><a href="https://www.fec.gov">Federal Election Commission’s website</a></span>, and a list of all PAC contributions is included in the TakPAC Annual Report:</p> <ul> <li><strong><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1722434945/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/TAKEDA_2023_Annual_Report_TakPAC.pdf"><span style="position: relative;" class="chevron-after"><span style="text-decoration: underline;">2023 TakPAC ANNUAL REPORT</span></span></a></strong></li> <li><strong><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1691773715/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/2022_Annual_Report_TakPAC.pdf"><span style="position: relative;" class="chevron-after"><span style="text-decoration: underline;">2022 TakPAC ANNUAL REPORT</span></span></a></strong></li> <li><strong><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/raw/upload/v1675187316/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/2021-takpac-annual-report.pdf"><span style="position: relative;" class="chevron-after"><span style="text-decoration: underline;">2021 TakPAC ANNUAL REPORT</span></span></a></strong></li> <li><strong><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/raw/upload/v1675187316/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/2020-takpac-annual-report.pdf"><span style="position: relative;" class="chevron-after"><span style="text-decoration: underline;">2020 TakPAC ANNUAL REPORT</span></span></a></strong></li> <li><span style="text-decoration: underline;"><strong><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/raw/upload/v1662724969/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/takeda_2019-annual-report_public.pdf"><span style="position: relative;" class="chevron-after">2019 TakPAC ANNUAL REPORT</span></a></strong></span></li> </ul> <p> </p> <p>In some states, corporations are allowed to give directly to candidates in accordance with state campaign finance law. Takeda chooses to make contributions in some of these states, and discloses these contributions annually:</p> <ul> <li><span style="text-decoration: underline;"><strong><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1722435027/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/2023_State_Corporate_Political_Contributions.pdf"><span style="position: relative;" class="chevron-after">TAKEDA’S 2023 CORPORATE CONTRIBUTIONS</span></a></strong></span></li> <li><span style="text-decoration: underline;"><strong><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1691773708/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/2022_USPA_Corporate_Contributions.pdf"><span style="position: relative;" class="chevron-after">TAKEDA’S 2022 CORPORATE CONTRIBUTIONS</span></a></strong></span></li> <li><span style="text-decoration: underline;"><strong><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/raw/upload/v1675187316/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/2021-corporate-contributions.pdf"><span style="position: relative;" class="chevron-after">TAKEDA’S 2021 CORPORATE CONTRIBUTIONS</span></a></strong></span></li> <li><span style="text-decoration: underline;"><strong><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/raw/upload/v1675187315/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/2020-corporate-contributions.pdf"><span style="position: relative;" class="chevron-after">TAKEDA’S 2020 CORPORATE CONTRIBUTIONS</span></a></strong></span></li> <li><span style="text-decoration: underline;"><strong><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/raw/upload/v1662724972/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/2019-takeda-us-corporate-contributions.pdf"><span style="position: relative;" class="chevron-after">TAKEDA’S 2019 CORPORATE CONTRIBUTIONS</span></a></strong></span></li> </ul> <p> </p> <hr></div></div></div><input type="checkbox" id="accordion-item-d1c4ddfb-edfb-4fab-bb9b-8e753c1c0ff4" class="accordion--toggle"/><label for="accordion-item-d1c4ddfb-edfb-4fab-bb9b-8e753c1c0ff4" class="accordion__title"><span class="accordion__title__wrapper"><span class="accordion__title--heading">Open Payments Act Disclosures</span><span class="accordion__title--subheading"></span></span></label><div class="accordion__content__wrapper"><div class="accordion__content"><div class="accordion__content__text"><h3>Open Payments Act</h3> <p>Takeda is committed to improving health for people worldwide through innovation in medicine. We recognize the important contributions of valuable insight, expertise, and feedback that health care professionals ("HCPs") provide to us in support of this mission.</p> <p> </p> <p>Section 6002 of the Patient Protection and Affordable Care Act, commonly known as the Open Payments Act or the Sunshine Act, requires pharmaceutical manufacturers, including Takeda, to track “transfers of value” provided to actively-licensed U.S. HCPs and Teaching Hospitals (collectively described as “Covered Recipients”) and to submit an annual report detailing such transactions to the Center for Medicare and Medicaid Services by March 31st each year for the prior calendar year.</p> <p> </p> <h4>Report Information</h4> <p>It is helpful to understand that there are two reporting submission templates provided by the Centers for Medicare and Medicaid Services (CMS) for reporting transfers of value under the Open Payments Act: General Payments and Research Payments. Takeda will report transfers of value in these areas based on the type of interaction conducted with Covered Recipients and the statutory definitions. Transfers of value to Covered Recipients that do not meet the Open Payments Act definition of Research will be submitted on the General Payments template with a corresponding payment nature per the statutory requirements.</p> <p> </p> <p>For 2021 spend, Takeda is required to report transfers of value to Covered Recipients provided by, or on behalf of, Takeda, including fees/reimbursable expenses that are individually greater than $11.05 or cumulatively greater than $110.40.</p> <p> </p> <p>It is important to note that Research payments will appear as aligned both with the entity receiving the payment and the principal investigator(s) for the clinical trial.</p> <p> </p> <p>Some additional examples of reportable transfers of value are listed below:</p> <ul> <li><strong>Professional Services:</strong> Including payments for advisory boards, consulting services, or promotional speaking</li> <li><strong>Educational Materials:</strong> Including certain reference materials such as journal articles and textbooks</li> <li><strong>Business Meals:</strong> Including Takeda-provided or reimbursed meals in conjunction with professional services or recruiting</li> <li><strong>Business Travel:</strong> Including Takeda provided or reimbursed amounts for transportation (e.g., airfare, hotel, taxi)</li> </ul> <p> </p> <h4>Collaboration</h4> <p>Takeda values working with Covered Recipients and we believe such collaboration is critical to deliver better health and a brighter future to patients we serve.</p> <p> </p> <h4>Additional Information about Open Payments</h4> <p>To learn more about the Open Payments Act, please visit the CMS <a rel="noopener" target="_blank" href="https://www.cms.gov" title="www.cms.gov">website</a>.</p> <h4> </h4> <h4>Questions</h4> <p>If you have any questions concerning this matter, please do not hesitate to contact us at <a href="/cdn-cgi/l/email-protection#b4e7c1dac7dcdddad1f5d7c0e5c1d1c7c0dddbdac7f4c0d5dfd1d0d59ad7dbd9"><span class="__cf_email__" data-cfemail="f2a1879c819a9b9c97b39186a3879781869b9d9c81b2869399979693dc919d9f">[email protected]</span></a>.</p></div></div></div><input type="checkbox" id="accordion-item-9ef0e50b-c2bd-4ef1-be7e-2142419d9e87" class="accordion--toggle"/><label for="accordion-item-9ef0e50b-c2bd-4ef1-be7e-2142419d9e87" class="accordion__title"><span class="accordion__title__wrapper"><span class="accordion__title--heading">California State Commercial Disclosure</span><span class="accordion__title--subheading"></span></span></label><div class="accordion__content__wrapper"><div class="accordion__content"><div class="accordion__content__text"><h3 id="statecompliance">State Compliance</h3> <p>Compliance with state law requirements is an important feature of Takeda’s Ethics & Compliance Program. Click the links below for information relating to our state compliance efforts.</p> <p>You can view our California Annual Comprehensive Compliance Program Declaration by clicking the button below.</p> <p style="padding-top:20px;"><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/state/ca/State_of_California.pdf"><button style="font-size: 18px; color: white; background-color: #34373f; padding: 15px 32px;"><span style="position: relative;" class="chevron-after">GO NOW</span></button></a></p></div></div></div><input type="checkbox" id="accordion-item-5cdc7eac-4eff-40dd-9e95-430cd6cea462" class="accordion--toggle"/><label for="accordion-item-5cdc7eac-4eff-40dd-9e95-430cd6cea462" class="accordion__title"><span class="accordion__title__wrapper"><span class="accordion__title--heading">Colorado Prescriber Price Disclosure Forms</span><span class="accordion__title--subheading"></span></span></label><div class="accordion__content__wrapper"><div class="accordion__content"><div class="accordion__content__text"><div style="column-count: 4;"> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299129/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Adderall_XR.pdf" title="CO - Adderall XR">Adderall XR</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299130/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Advate.pdf" title="CO Advate">Advate</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299131/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Adynovate.pdf" title="CO - Adynovate">Adynovate</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299132/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Adzynma.pdf" title="CO - Adzynma">Adzynma</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299133/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Agrylin.pdf" title="CO - Agrylin">Agrylin</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730921472/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Alunbrig.pdf" title="CO - Alunbrig">Alunbrig</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299134/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Amitiza.pdf" title="CO - Amitiza">Amitiza</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/state/CO_Aralast_NP_Product_Form.pdf" title="CO - Aralast NP">Aralast NP</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299136/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Carbatrol.pdf" title="CO - Carbatrol">Carbatrol</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299137/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Ceprotin.pdf" title="CO - Ceprotin">Ceprotin</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299139/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Cinryze.pdf" title="CO - Cinryze">Cinryze</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299140/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Colcrys.pdf" title="CO - Colcrys">COLCRYS</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299141/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Cuvitru.pdf" title="CO - Cuvitru">Cuvitru</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299142/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Dexilant.pdf" title="CO - Dexilant">DEXILANT</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299143/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Elaprase.pdf" title="CO - Elaprase">Elaprase</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299144/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Entyvio.pdf" title="CO - Entyvio">Entyvio</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299146/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Eohilia.pdf" title="CO - Eohilia">Eohilia</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299147/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Feiba.pdf" title="CO - Feiba">Feiba</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299148/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Firazyr.pdf" title="CO - Firazyr">Firazyr</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299150/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Flexbumin_25.pdf" title="CO - Flexbumin 25%">Flexbumin 25%</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299152/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Fosrenol_-_CO.pdf" title="CO - Flexbumin 5%">Flexbumin 5%</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299152/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Fosrenol.pdf" title="CO - Fosrenol">Fosrenol</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730912005/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Fruzaqla.pdf" title="CO - Fruzaqla">Fruzaqla</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299153/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Gammagard_Liquid.pdf" title="CO - Gammagard">Gammagard</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299154/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Gammagard_SD.pdf" title="CO - Gammagard SD">Gammagard SD</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299155/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Gattex.pdf" title="CO - Gattex">Gattex</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299157/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Glassia.pdf" title="CO - Glassia">Glassia</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299159/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Hemofil_M.pdf" title="CO - Hemofil">Hemofil</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299160/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Hyqvia.pdf" title="CO - Hyqvia">Hyqvia</a></p> <p><a href="https://assets-dam.takeda.com/image/upload/v1730921518/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Iclusig.pdf" title="CO - Inclusig">Iclusig</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299161/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Intuniv.pdf" title="CO - Intuniv">Intuniv</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299163/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Kalbitor.pdf" title="CO - Kalbitor">Kalbitor</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299165/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Kazano.pdf" title="CO - Kazano">Kazano</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299166/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Lialda.pdf" title="CO - Lialda">Lialda</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299167/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Livtencity.pdf" title="CO - Livtencity">Livtencity</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299168/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Motegrity.pdf" title="CO - Motegrity">Motegrity</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299170/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Mydayis.pdf" title="CO - Mydayis">Mydayis</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/raw/upload/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/state/CO_Natpara_Product_Form.pdf" title="CO - Natpara">Natpara</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299171/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Nesina.pdf" title="CO - Nesina">Nesina</a></p> <p><a href="https://assets-dam.takeda.com/image/upload/v1730921518/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Ninlaro.pdf" title="CO - Ninlaro">Ninlaro</a></p> <p><a href="https://assets-dam.takeda.com/image/upload/v1730299173/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Obizur.pdf" title="CO - Obizur">Obizur</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299174/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Oseni.pdf" title="CO - Oseni">Oseni</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299175/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Pentasa.pdf" title="CO - Pentasa">Pentasa</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299177/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Recombinate.pdf" title="CO - Recombinate">Recombinate</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299179/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Rixubis.pdf" title="CO - Rixubis">Rixubis</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299180/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Rozerem.pdf" title="CO - Rozerem">Rozerem</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299182/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Takhzyro.pdf" title="CO- Takhzyro">Takhzyro</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299183/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Trintellix.pdf" title="CO - Trintellix">Trintellix</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299186/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Uloric.pdf" title="uloric">Uloric</a></p> <p><a href="https://assets-dam.takeda.com/image/upload/v1730921519/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Velcade.pdf" title="Velcade Colorado price form">Velcade</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299187/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Vonvendi.pdf" title="CO - Vonvendi">Vonvendi</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299189/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/VPRIV.pdf" title="CO - VPRIV">VPRIV</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730299191/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Vyvanse.pdf" title="CO - Vyvanse">Vyvanse</a></p> </div> <hr></div></div></div><input type="checkbox" id="accordion-item-853a7fc6-4f2d-4cae-99e2-9ef67e4264f0" class="accordion--toggle"/><label for="accordion-item-853a7fc6-4f2d-4cae-99e2-9ef67e4264f0" class="accordion__title"><span class="accordion__title__wrapper"><span class="accordion__title--heading">Connecticut Prescriber Price Disclosure Forms</span><span class="accordion__title--subheading"></span></span></label><div class="accordion__content__wrapper"><div class="accordion__content"><div class="accordion__content__text"><div style="column-count: 4;"> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730307438/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Advate.pdf" title="CT Advate">Advate</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730307440/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Adynovate.pdf" title="CT - Adynovate price form">Adynovate</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730307444/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Adzynma.pdf" title="CT - Adzynma price form">Adzynma</a></p> <p><a href="https://assets-dam.takeda.com/image/upload/v1730921680/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Alunbrig.pdf" title="CT - Alunbrig pricing form">Alunbrig</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730307447/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Aralast.pdf" title="CT - Aralast NP price form">Aralast NP</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730307451/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Ceprotin.pdf" title="CT - Cinryze price form">Ceprotin</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730307454/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Cinryze.pdf" title="CT - Cinryze price form">Cinryze</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730307458/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Cuvitru.pdf" title="CT - Cuvitru price form">Cuvitru</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730307463/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Elaprase.pdf" title="CT - Elaprase price form">Elaprase</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730307467/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Entyvio.pdf" title="CT - Entyvio price form">Entyvio</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730307472/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Eohilia.pdf" title="CT - Eohilia price form">Eohilia</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730307476/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Feiba.pdf" title="CT - Feiba price form">Feiba</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730307480/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Firazyr.pdf" title="CT - Firazyr price form">Firazyr</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730307488/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Flexbumin_25.pdf" title="CT - Flexbumin 25% price form">Flexbumin 25%</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730307484/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Flexbumin_5.pdf" title="CT - Flexbumin 5% price form">Flexbumin 5%</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730911971/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Fruzuqla.pdf" title="CT - Fruzaqla price form">Fruzaqla</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730307492/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Gammagard.pdf" title="CT - Gammagard Liquid price form">Gammagard Liquid</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730307496/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Gammagard_SD.pdf" title="CT - Gammagard SD price form">Gammagard SD</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730307501/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Gattex.pdf" title="CT - Gattex price form">Gattex</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730307506/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Glassia.pdf" title="CT - Glassia price form">Glassia</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730307510/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Hemofil_M.pdf" title="CT - Hemofil M price form">Hemofil M</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730307514/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Hyqvia.pdf" title="CT - Hyqvia price form">Hyqvia</a></p> <p><a href="https://assets-dam.takeda.com/image/upload/v1730922767/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Iclusig.pdf" title="CT - Inclusig price form">Iclusig</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730307519/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Kalbitor.pdf" title="CT - Kalbitor price form">Kalbitor</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730307524/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Livtencity.pdf" title="CT - Livtencity price form">Livtencity</a></p> <p><a href="https://assets-dam.takeda.com/image/upload/v1730921678/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Ninlaro.pdf" title="CT - Ninlaro price form">Ninlaro</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730307528/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Obizur.pdf" title="CT - Obizur">Obizur</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730307533/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Recombinate.pdf" title="CT - Recombinate">Recombinate</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730307537/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Rixubis.pdf" title="CT - Rixubis price form">Rixubis</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730307542/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Takhzyro.pdf" title="CT- Takhzyro price form">Takhzyro</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730307547/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Trintellix.pdf" title="CT - Trintellix price form">Trintellix</a></p> <p><a href="https://assets-dam.takeda.com/image/upload/v1730921679/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Velcade.pdf" title="CT - Velcade price form">Velcade</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730307552/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Vonvendi.pdf" title="CT - Vonvendi price form">Vonvendi</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730307557/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/VPRIV.pdf" title="CT - VPRIV price form">VPRIV</a></p> <p><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730307561/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Vyvanse.pdf" title="CT - Vyvanse price form">Vyvanse</a></p> </div> <hr></div></div></div><input type="checkbox" id="accordion-item-4ec5b489-7042-4384-a3ff-408fdffd2cb0" class="accordion--toggle"/><label for="accordion-item-4ec5b489-7042-4384-a3ff-408fdffd2cb0" class="accordion__title"><span class="accordion__title__wrapper"><span class="accordion__title--heading">Vermont Prescriber Price Disclosure Forms</span><span class="accordion__title--subheading"></span></span></label><div class="accordion__content__wrapper"><div class="accordion__content"><div class="accordion__content__text"><div style="column-count: 4;"> <p>ADDERALL XR<br><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730320779/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Adderall_XR_SF.pdf" title="Adderall XR Vermont Prescribers short form">Short Form</a> | <a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730321118/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Adderall_LF.pdf" title="Adderall XR Vermont Prescribers long form">Long Form</a></p> <p>AGRYLIN<br><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730320781/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Agrylin_SF.pdf" title="Agrylin Vermont Prescribers short form">Short Form</a> | <a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730321116/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Agrylin_LF.pdf" title="Agrylin Vermont prescribers long form">Long Form</a></p> <p>ALUNBRIG<br><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730922980/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Alunbrig_SF.pdf" title="Alunbrig Vermont Prescribers short form">Short Form</a> | <a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730922979/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Alunbrig_LF.pdf" title="Alunbrig Vermont Prescribers long form">Long Form</a></p> <p>AMITIZA<br><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/state/VT_Amitiza_SF.pdf" title="VT Amitiza short form">Short Form</a> | <a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/state/VT_Amitiza_LF.pdf" title="VT Amitiza long form">Long Form</a></p> <p>COLCRYS<br><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/state/VT_Colcrys_SF.pdf" title="VT Colcrys short form">Short Form</a> | <a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/state/VT_Colcrys_LF.pdf" title="VT Colcrys long form">Long Form</a></p> <p>CARBATROL<br><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730320786/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Carbatrol_SF.pdf" title="Carbatrol Vermont prescribers short form">Short Form</a> | <a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730321122/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Carbatrol_LF.pdf" title="Carbatrol Vermont prescribers long form">Long Form</a></p> <p>DEXILANT<br><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730320790/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Dexilant_SF.pdf" title="VT DEXILANT short form">Short Form</a> | <a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730321128/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Dexilant_LF.pdf" title="VT DEXILANT long form">Long Form</a></p> <p>FOSRENOL<br><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730320793/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Fosrenol_SF.pdf" title="FOSRENOL Vermont Prescribers short form">Short Form</a> | <a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730321133/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Fosrenol_LF.pdf" title="FOSRENOL Vermont Prescribers long form">Long Form</a></p> <p>FRUZAQLA<br><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730911894/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Fruzaqla_SF.pdf" title="Fruzaqla Vermont Prescribers short form">Short Form</a> | <a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730911895/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Fruzaqla_LF.pdf" title="Fruzaqla Vermont Prescribers long form">Long Form</a></p> <p>ICLUSIG<br><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730922974/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Iclusig_SF.pdf" title="Iclusig Vermont Prescribers short form">Short Form</a> | <a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730922980/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Iclusig_LF.pdf" title="Iclusig Vermont Prescribers long form">Long Form</a></p> <p>INTUNIV<br><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730320797/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Intuniv_SF.pdf" title="Intuniv Vermont prescribers short form">Short Form</a> | <a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730321138/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Intuniv_LF.pdf" title="Intuniv Vermont prescribers long form">Long Form</a></p> <p>Kazano<br><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/state/VT_Kazano_SF.pdf" title="VT Kazano short form">Short Form</a> | <a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/state/VT_Kazano_LF.pdf" title="VT Kazano long form">Long Form</a></p> <p>LIALDA<br><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730320800/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Lialda_SF.pdf" title="Lialda Vermont prescribers short form">Short Form</a> | <a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730321269/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Lialda_LF.pdf" title="Lialda Vermont prescribers long form">Long Form</a></p> <p>LIVTENCITY<br><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730320805/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Livtencity_SF.pdf" title="Livtencity Vermont short form">Short Form</a> | <a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730321142/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Livtencity_LF.pdf" title="Livtencity Vermont long form">Long Form</a></p> <p>MOTEGRITY<br><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730320808/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Motegrity_SF.pdf" title="Motegrity-Vermont Prescribers short form">Short Form</a> | <a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730321147/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Motegrity_LF.pdf" title="Motegrity-Vermont Prescribers long form">Long Form</a></p> <p>Mydayis<br><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730320813/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Mydayis_SF.pdf" title="Mydayis Vermont prescribers short form">Short Form</a> | <a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730320813/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Mydayis_SF.pdf" title="Mydayis Vermont prescribers long form">Long Form</a></p> <p>NESINA<br><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/state/VT_Nesina_SF.pdf" title="VT Nesina short form">Short Form</a> | <a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/state/VT_Nesina_LF.pdf" title="VT Nesina long form">Long Form</a></p> <p>NINLARO<br><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730922975/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Ninlaro_SF.pdf" title="Ninlaro Vermont Prescribers short form">Short Form</a> | <a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730922981/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Ninlaro_LF.pdf" title="Ninlaro Vermont Prescribers long form">Long Form</a></p> <p>Oseni<br><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/state/VT_Oseni_SF.pdf" title="VT Oseni short form">Short Form</a> | <a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/state/VT_Oseni_LF.pdf" title="VT Oseni long form">Long Form</a></p> <p>PENTASA<br><a href="https://assets-dam.takeda.com/image/upload/v1730320816/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Pentasa_SF.pdf" title="Pentasa Vermont prescribers short form">Short Form</a> | <a href="https://assets-dam.takeda.com/image/upload/v1730321158/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Pentasa_LF.pdf" title="Pentasa Vermont prescribers long form">Long Form</a></p> <p>ROZEREM<br><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730320822/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Rozerem_SF.pdf" title="VT Rozerem short form">Short Form</a> | <a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730321163/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Rozerem_LF.pdf" title="VT Rozerem long form">Long Form</a></p> <p>TRINTELLIX<br><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730320826/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Trintellix_SF.pdf" title="VT Trintellix short form">Short Form</a> | <a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730321168/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Trintellix_LF.pdf" title="VT Trintellix long form">Long Form</a></p> <p>ULORIC<br><a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730320831/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Uloric_SF.pdf" title="VT Uloric short form">Short Form</a> | <a rel="noopener" target="_blank" href="https://assets-dam.takeda.com/image/upload/v1730321173/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Uloric_LF.pdf" title="VT Uloric long form">Long Form</a></p> <p>VYVANSE<br><a href="https://assets-dam.takeda.com/image/upload/v1730320835/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Vyvanse_SF.pdf" title="Vyvanse Vermont prescribers short form">Short Form</a> | <a href="https://assets-dam.takeda.com/image/upload/v1730321179/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Vyvanse_LF.pdf" title="Vyvanse Vermont prescribers long form">Long Form</a></p> </div></div></div></div></section></div><div class="grid-1-1"><hr/></div><div class="grid-1-3"><section class="spot-block visual headingColor-color1 linkStyling-bold linkCasing-uppercase" itemscope="" itemType="http://schema.org/CreativeWork"><a class="spot-block__wrapper-link" href="/en-us/corporate-responsibility/patients/" rel="noreferrer"><div class="spot-block__flex"><div class="spot-block__image"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:cover;background-size:cover;background-position:0% 0%;filter:blur(20px);background-image:url("data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAGCAMAAADNLv/0AAAATlBMVEXl1tTSurnn3NfIqaPezMi9p6bq4uDt7Ozr5eXz8fHf0c+KeXN2ZWKXgnlRQUIrISdgUFPs6OHhw763nZyciYm3mZmll46yiIVYQD85Mi17LYQSAAAAPElEQVQIHQ3BhwGAMAwDMKeZdLPh/0dBwvILQGeFByAE7gNuG9+a+BnwSHRmkzbhIaSapHWslvejlKu+HzwKAhwvlKCkAAAAAElFTkSuQmCC")"/><noscript><img alt="" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:cover" sizes="(max-width: 768px) 100vw, 33vw" srcSet="https://assets-dam.takeda.com/image/upload/c_lfill,w_256/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/people/patient_callout-2 256w, https://assets-dam.takeda.com/image/upload/c_lfill,w_384/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/people/patient_callout-2 384w, https://assets-dam.takeda.com/image/upload/c_lfill,w_640/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/people/patient_callout-2 640w, https://assets-dam.takeda.com/image/upload/c_lfill,w_750/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/people/patient_callout-2 750w, https://assets-dam.takeda.com/image/upload/c_lfill,w_828/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/people/patient_callout-2 828w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1080/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/people/patient_callout-2 1080w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1200/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/people/patient_callout-2 1200w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/people/patient_callout-2 1920w, https://assets-dam.takeda.com/image/upload/c_lfill,w_2048/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/people/patient_callout-2 2048w, https://assets-dam.takeda.com/image/upload/c_lfill,w_3840/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/people/patient_callout-2 3840w" src="https://assets-dam.takeda.com/image/upload/c_lfill,w_3840/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/people/patient_callout-2"/></noscript></span></div><div class="spot-block__text-wrapper"><h2 class="spot-block__heading custom--head" itemProp="headline"></h2><div class="spot-block__text" itemProp="description"><div></div><div class="spot-block__link custom--link">PATIENTS</div></div></div></div></a></section></div><div class="grid-1-3"><section class="spot-block visual headingColor-color1 linkStyling-bold linkCasing-uppercase" itemscope="" itemType="http://schema.org/CreativeWork"><a class="spot-block__wrapper-link" href="/en-us/corporate-responsibility/people/" rel="noreferrer"><div class="spot-block__flex"><div class="spot-block__image"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:cover;background-size:cover;background-position:0% 0%;filter:blur(20px);background-image:url("data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAGCAMAAADNLv/0AAAAY1BMVEWsramqtLeopZ6vqaN5h5CzvsGysq+lt782HhkrFhCvxs8uKza3yc9ERlRDIyaowMuGlJ+RgHLMu655g4p3a2YjHCOrn5dmXF+niXt7aVxHOz+QlZmJWkacsrxJSFOifWp5Uj5TB6A3AAAAQUlEQVQI1wXBhQHAIBAEsMN53OpC95+yCTgYM4/sgyC0Ui6X+RGgEYK77mGBtTKT+/la8HpIWaJPFq2JfYt+SfQDWdAC+Sn3zbAAAAAASUVORK5CYII=")"/><noscript><img alt="" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:cover" sizes="(max-width: 768px) 100vw, 33vw" srcSet="https://assets-dam.takeda.com/image/upload/c_lfill,w_256/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/patients/people_callout 256w, https://assets-dam.takeda.com/image/upload/c_lfill,w_384/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/patients/people_callout 384w, https://assets-dam.takeda.com/image/upload/c_lfill,w_640/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/patients/people_callout 640w, https://assets-dam.takeda.com/image/upload/c_lfill,w_750/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/patients/people_callout 750w, https://assets-dam.takeda.com/image/upload/c_lfill,w_828/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/patients/people_callout 828w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1080/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/patients/people_callout 1080w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1200/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/patients/people_callout 1200w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/patients/people_callout 1920w, https://assets-dam.takeda.com/image/upload/c_lfill,w_2048/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/patients/people_callout 2048w, https://assets-dam.takeda.com/image/upload/c_lfill,w_3840/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/patients/people_callout 3840w" src="https://assets-dam.takeda.com/image/upload/c_lfill,w_3840/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/patients/people_callout"/></noscript></span></div><div class="spot-block__text-wrapper"><h2 class="spot-block__heading custom--head" itemProp="headline"></h2><div class="spot-block__text" itemProp="description"><div></div><div class="spot-block__link custom--link">People</div></div></div></div></a></section></div><div class="grid-1-3"><section class="spot-block visual headingColor-color1 linkStyling-bold linkCasing-uppercase" itemscope="" itemType="http://schema.org/CreativeWork"><a class="spot-block__wrapper-link" href="/en-us/corporate-responsibility/planet/" rel="noreferrer"><div class="spot-block__flex"><div class="spot-block__image"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:cover;background-size:cover;background-position:0% 0%;filter:blur(20px);background-image:url("data:image/webp;base64,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")"/><noscript><img alt="" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:cover" sizes="(max-width: 768px) 100vw, 33vw" srcSet="https://assets-dam.takeda.com/image/upload/c_lfill,w_256/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/planet-thumb 256w, https://assets-dam.takeda.com/image/upload/c_lfill,w_384/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/planet-thumb 384w, https://assets-dam.takeda.com/image/upload/c_lfill,w_640/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/planet-thumb 640w, https://assets-dam.takeda.com/image/upload/c_lfill,w_750/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/planet-thumb 750w, https://assets-dam.takeda.com/image/upload/c_lfill,w_828/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/planet-thumb 828w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1080/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/planet-thumb 1080w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1200/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/planet-thumb 1200w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/planet-thumb 1920w, https://assets-dam.takeda.com/image/upload/c_lfill,w_2048/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/planet-thumb 2048w, https://assets-dam.takeda.com/image/upload/c_lfill,w_3840/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/planet-thumb 3840w" src="https://assets-dam.takeda.com/image/upload/c_lfill,w_3840/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/planet-thumb"/></noscript></span></div><div class="spot-block__text-wrapper"><h2 class="spot-block__heading custom--head" itemProp="headline"></h2><div class="spot-block__text" itemProp="description"><div></div><div class="spot-block__link custom--link">Planet</div></div></div></div></a></section></div></div></section></main><nav class="totop__wrapper" itemscope="" itemType="http://schema.org/SiteNavigationElement"><div class="totop__inner"><div class="totop" itemProp="name">TOP</div></div></nav><footer class="footer"><div class="footer__content"><div class="footer__nav" itemscope="" itemType="http://schema.org/SiteNavigationElement"><a href="/en-us/terms-of-use/?epslanguage=en-US" class="footer__url" itemProp="url" rel="noreferrer" data-watermark="watermark"><span itemProp="name">Terms of Use</span></a><a href="/link/f14a80e4a53c4fdbaf012a2e57198ee9.aspx?epslanguage=en" class="footer__url" itemProp="url" target="_blank" data-action="External" data-category="External" rel="noreferrer" data-watermark="watermark"><span itemProp="name">Privacy Notice</span></a><a href="/en-us/who-we-are/contact-us/" class="footer__url" itemProp="url" rel="noreferrer" data-watermark="watermark"><span itemProp="name">CONTACT US</span></a><a href="/en-us/patents/" class="footer__url" itemProp="url" rel="noreferrer" data-watermark="watermark"><span itemProp="name">PATENTS</span></a><a href="/accessibility-statement/?lang=en" class="footer__url" itemProp="url" rel="noreferrer" data-watermark="watermark"><span itemProp="name">Accessibility Statement</span></a><a href="/cookie-policy/" class="footer__url" itemProp="url" rel="noreferrer" data-watermark="watermark"><span itemProp="name">Cookie Policy</span></a><div class="footer__copyright--desktop"><div>Copyright 2024 Takeda Pharmaceutical Company Limited. All rights reserved.<br><br><a href="https://www.top-employers.com/en/globalcompanyprofiles/takeda-global/">Certified Top Employer</a></div></div></div><div class="footer__social-wrap"><div class="footer__social"><div class="footer__social__text">Connect with us:</div> <div class="footer__social__links"><a href="https://www.linkedin.com/company/takeda-pharmaceuticals/" title="linkedin" target="_blank" rel="noreferrer"><span class="icon" data-action="linkedin"><meta itemProp="name" content="linkedin"/><svg class="footer__social__icon icon--social"><use href="/Resources/ui/svg/takeda.svg#icon-linkedin"></use></svg></span></a> <a href="https://twitter.com/TakedaPharma" title="twitter" target="_blank" rel="noreferrer"><span class="icon" data-action="twitter"><meta itemProp="name" content="twitter"/><svg class="footer__social__icon icon--social"><use href="/Resources/ui/svg/takeda.svg#icon-twitter"></use></svg></span></a> </div></div><div class="footer__worlwide"><div class=""><a href="/worldwide/" class="countryselector__url"><img src="https://assets-dam.takeda.com/image/upload/v1/legacy-dotcom/siteassets/en-us/us" class="country__flag" alt=""/> <span>United States</span></a></div><div class=""><div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script> var x = document.querySelectorAll(".secondary > label"); if (x.length>1) { for (i =1; i < x.length; i++) { x[i].style.display = "none"; } } </script></div></div><div class=""><div><div class="richtext"><div> </div></div></div></div><div class=""><div><script> var accessibilityMobileLink = document.getElementsByClassName('accessbility-mobile-link') [0]; if ( accessibilityMobileLink) { accessibilityMobileLink.style.backgroundColor = "white"; } </script></div></div></div></div></div></footer><div><div class="footer__copyright--mobile"><div>Copyright 2024 Takeda Pharmaceutical Company Limited. All rights reserved.<br><br><a href="https://www.top-employers.com/en/globalcompanyprofiles/takeda-global/">Certified Top Employer</a></div></div></div><div class="footer__settings"><div class=""><div><div><div class="modal fade js-internalLinkDisclaimerPopUp block-externaldisclaimer"><input type="hidden" id="linkType" value="INTERNAL"/><div class="modal-dialog"><div class="modal-content"><div class="modal-header"><button type="button" class="close" data-dismiss="modal" aria-label="Close"><span aria-hidden="true">×</span></button><div></div></div><div class="modal-body"><button type="button" class="btn ok js-disclaimerPopUpOKButton">OK</button><button type="button" class="btn cancel" data-dismiss="modal">CANCEL</button></div></div></div></div></div></div></div><div class=""><div><div class="richtext"></div></div></div><div class=""><div><style> @media (max-width: 769px){ .highlightcard-font-18 { font-size: 21px !important; } } </style></div></div></div><div id="ir-subscription-wrapper" class="modal fade" tabindex="-1" role="dialog" aria-hidden="true"><div class="modal-dialog modal-lg modal-dialog-centered"><div class="modal-content"></div><a class="close-modal" data-dismiss="modal" aria-label="Close">Close</a></div></div><link rel="stylesheet" href="/Themes/Corporate/ui/css/vendors/jquery-ui/jquery-ui.min.css" class="jsx-4272609781"/></div><script id="__NEXT_DATA__" type="application/json">{"props":{"pageProps":{"homepage":{"shortUrl":"https://takeda.info/3d4yD3n","optimizelyId":"888","mainContentArea":[{"linkStyling":"normal","link":"/en-us/what-we-do/areas-of-focus/rare-diseases/reduce-time-to-diagnosis-improve-access-to-care/","linkText":"LEARN MORE","backgroundColor":"","image":{"excludeFromSearch":false,"_type":"imageFile","_key":"ab036a3f-dfff-4eee-9b07-d507d0f639f4","url":{"type":"upload","created_by":{"type":"user","id":"ec6a5b13a6920997f0770195fabdbb"},"uploaded_by":{"id":"ec6a5b13a6920997f0770195fabdbb","type":"user"},"access_control":[],"version":1708973943,"public_id":"legacy-dotcom/siteassets/system/what-we-do/areas-of-focus/rare-diseases/reduce-time-to-diagnosis-improve-access-to-care/TAK2333_Takeda_RDBU_Policy_Paper_Asset_4","duration":null,"url":"http://assets-dam.takeda.com/image/upload/v1708973943/legacy-dotcom/siteassets/system/what-we-do/areas-of-focus/rare-diseases/reduce-time-to-diagnosis-improve-access-to-care/TAK2333_Takeda_RDBU_Policy_Paper_Asset_4.png","secure_url":"https://assets-dam.takeda.com/image/upload/v1708973943/legacy-dotcom/siteassets/system/what-we-do/areas-of-focus/rare-diseases/reduce-time-to-diagnosis-improve-access-to-care/TAK2333_Takeda_RDBU_Policy_Paper_Asset_4.png","resource_type":"image","access_mode":"public","metadata":{"epzciwdjuelllku8ngpo":["0001"]},"bytes":4106765,"created_at":"2024-02-26T18:59:03Z","folder_id":"c190ebfaf3894651e47c265f9f99158f0a","format":"png","width":1920,"id":"6cd95a487ca1f8a496a53805e081df2b","height":1080,"_type":"cloudinary.asset","tags":[]}},"linkCasing":"normal","layout":"topimage","contentAsString":"Reduce time to diagnosis, improve access to care","_type":"spotBlock","_key":"70db4e5d-79f9-466e-9a84-12adc1a35083","displayOption":"onethird","customCssClass":"","headingColor":"color1"},{"displayOption":"onethird","backgroundColor":"","headingColor":"color1","linkStyling":"normal","link":"/en-us/our-stories/Addressing-health-inequities-Community-efforts-and-root-causes","contentAsString":"Addressing health inequities: Community efforts and root causes\n\n\n","_type":"spotBlock","_key":"769c4e93-b0e5-4257-9209-efd0e751124e","linkCasing":"normal","image":{"url":{"metadata":{"epzciwdjuelllku8ngpo":["0001"]},"id":"72c221e3e4cc2b37d10a86f8e7743c22","_type":"cloudinary.asset","access_mode":"public","type":"upload","created_by":{"id":"ec6a5b13a6920997f0770195fabdbb","type":"user"},"width":1200,"created_at":"2023-11-15T20:52:41Z","height":500,"tags":[],"format":"jpg","secure_url":"https://assets-dam.takeda.com/image/upload/v1700081561/legacy-dotcom/siteassets/en-us/home/our-stories/capacity_community.jpg","version":1700081561,"duration":null,"bytes":488605,"folder_id":"c190ebfdeb09157f0578fdd41c45db25ea","url":"http://assets-dam.takeda.com/image/upload/v1700081561/legacy-dotcom/siteassets/en-us/home/our-stories/capacity_community.jpg","access_control":[],"resource_type":"image","public_id":"legacy-dotcom/siteassets/en-us/home/our-stories/capacity_community","uploaded_by":{"id":"ec6a5b13a6920997f0770195fabdbb","type":"user"}},"excludeFromSearch":false,"_type":"imageFile","_key":"adc83ae6-c506-45c5-b548-c289e7272bad"},"layout":"topimage","linkText":"LEARN MORE","customCssClass":""},{"tab1Title":"RECENT NEWS","_type":"tabContainerBlock","tab2Title":"","tab1Heading":"","displayOption":"onethird","tab2Heading":"","tab3Title":"","tab2BackgroundColor":"color4","tab1Content":[{"dateFormat":"","_type":"filteredListSpotBlock","linkCasing":"","noContentMessage":"","_key":"7ecad1d9-6403-4610-9b95-0a9ae5f11c2b","root":{"_weak":true,"_ref":"dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_en-US","_type":"reference"},"allTopicsLabel":"","hideTopicsFilter":false,"linkText":"","layout":"simple","categoryMatchMode":1,"itemsToTake":1,"headingColor":"","pageTypeIds":"68","sortOrder":1,"hideLoadMoreButton":true,"backgroundColor":"Color4","linkStyling":"normal","displayOption":"full","dontRenderItemLinks":false,"loadMoreButtonText":"GO TO THE US NEWSROOM"},{"displayOption":"full","customCssClass":"","layout":"","backgroundColor":"Transparent","contentAsString":"\u003cp\u003e\u003ca href=\"/en-us/newsroom/\"\u003eGO TO THE US NEWSROOM\u003cstrong\u003e\u003cspan class=\"red-text\"\u003e\u0026gt;\u003c/span\u003e\u003c/strong\u003e\u003c/a\u003e\u003c/p\u003e","_type":"richTextBlock","_key":"17c44d27-fe6e-4cd4-b026-888b7a0b3422"}],"tab1BackgroundColor":"color4","tab3Heading":"","customCssClass":"","_key":"5120feb5-0a59-4405-bbfa-f4ea2d3fa682","tab3BackgroundColor":"color4"}],"childSortOrder":"index","friendlyUrl":{"current":"/en-us/","_type":"slug","_key":"f5ee80b5-8975-4ad2-a947-f5b20b70a799"},"_id":"719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-US","_createdAt":"2017-06-15T06:45:00Z","hideInThisSection":false,"startPublish":"2018-03-28T20:24:33+00:00","linkType":"normal","trackingRoot":false,"showNewInLanguages":"","parentWasSkipped":false,"visibleInMenu":true,"hideBreadCrumb":true,"hideFooter":false,"title":"HOME","_base":{"_weak":true,"_ref":"719d1b8a-9834-4b1f-8b58-1c0063ac3094","_type":"reference"},"settingsPage":{"_weak":true,"_ref":"f6caa076-f145-407f-b409-1b3e38b0e08a","_type":"reference"},"mainHeroArea":[{"spotContentAsString":"\u003cp\u003eLearn about our work in the Caring for Tomorrow: 2023 U.S. Community Impact Report\u003c/p\u003e\n\n","_type":"heroBannerBlock","callToActionLinkText":"LEARN MORE","callToActionLinkUrl":"https://assets-dam.takeda.com/image/upload/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/people/Takeda_CSR_Report_2023.pdf","spotContentAlignment":0,"_key":"fea4e3af-d942-4098-a95d-bcf7dded1130","customCssClass":"","displayOption":"threequarter","backgroundImageUrl":{"excludeFromSearch":false,"_type":"imageFile","_key":"3655cecc-0b3c-4056-9db0-da2b8b3703ab","url":{"access_control":[],"uploaded_by":{"id":"ec6a5b13a6920997f0770195fabdbb","type":"user"},"width":5472,"height":3080,"folder_id":"c190ebf456892b37de388e1a90748dab51","type":"upload","_type":"cloudinary.asset","public_id":"legacy-dotcom/siteassets/en-us/home/Community_Servings_Banner_Image","bytes":1651931,"secure_url":"https://assets-dam.takeda.com/image/upload/v1712164722/legacy-dotcom/siteassets/en-us/home/Community_Servings_Banner_Image.jpg","tags":[],"created_by":{"id":"ec6a5b13a6920997f0770195fabdbb","type":"user"},"metadata":{"epzciwdjuelllku8ngpo":["0001"]},"format":"jpg","resource_type":"image","created_at":"2024-04-03T17:17:57Z","access_mode":"public","duration":null,"id":"4fa4c8a281ba6b9a1ac9de35b86825db","version":1712164722,"url":"http://assets-dam.takeda.com/image/upload/v1712164722/legacy-dotcom/siteassets/en-us/home/Community_Servings_Banner_Image.jpg","folder":"legacy-dotcom/siteassets/en-us/home"}},"backgroundImageAlignment":0,"backgroundMobileImageUrl":{"excludeFromSearch":false,"_type":"imageFile","_key":"3f106459-6fcf-42da-907d-ea79d245a665","url":{"resource_type":"image","tags":[],"id":"db3125c38314652d5971e0129bf83730","height":3648,"public_id":"legacy-dotcom/siteassets/en-us/home/Community_Servings_original","url":"http://assets-dam.takeda.com/image/upload/v1712164274/legacy-dotcom/siteassets/en-us/home/Community_Servings_original.jpg","folder_id":"c190ebf456892b37de388e1a90748dab51","created_by":{"type":"user","id":"ec6a5b13a6920997f0770195fabdbb"},"format":"jpg","uploaded_by":{"id":"ec6a5b13a6920997f0770195fabdbb","type":"user"},"access_mode":"public","version":1712164274,"metadata":{"epzciwdjuelllku8ngpo":["0001"]},"access_control":[],"bytes":12208259,"duration":null,"created_at":"2024-04-03T17:11:14Z","folder":"legacy-dotcom/siteassets/en-us/home","type":"upload","secure_url":"https://assets-dam.takeda.com/image/upload/v1712164274/legacy-dotcom/siteassets/en-us/home/Community_Servings_original.jpg","width":5472,"_type":"cloudinary.asset"}}},{"customCssClass":"","backgroundImageUrl":{"excludeFromSearch":false,"_type":"imageFile","_key":"f67e56c2-b56e-41d1-970d-8248f2df94aa","url":{"public_id":"legacy-dotcom/siteassets/en-us/home/map_us_panel","secure_url":"https://assets-dam.takeda.com/image/upload/v1671244096/legacy-dotcom/siteassets/en-us/home/map_us_panel.jpg","_key":"56eb113b-6598-4365-8b17-778ef48799e0","type":"upload","version":1671244096,"_version":1,"height":396,"url":"http://assets-dam.takeda.com/image/upload/v1671244096/legacy-dotcom/siteassets/en-us/home/map_us_panel.jpg","bytes":11997,"_type":"cloudinary.asset","width":702,"resource_type":"image","created_at":"2022-09-09T10:42:23Z","format":"jpg"}},"bodyTextAsString":"\u003ch4 style=\"text-align: center;\"\u003eTakeda\u003cbr /\u003ein the U.S.\u003c/h4\u003e\n\u003cp\u003e\u003cbr /\u003e\u003cbr /\u003e\u003cbr /\u003e\u003cbr /\u003e\u003c/p\u003e\n\u003cp style=\"text-align: center;\"\u003e\u003cspan\u003eFor our global site or other location:\u003c/span\u003e\u003c/p\u003e","_type":"contentBannerBlock","_key":"2cb3d1d7-5a44-4954-9f39-b4b37fcb7bd1","bannerContent":[{"_type":"countrySelectorLinkBlock","link":"/worldwide/","linkText":"SELECT A COUNTRY OR REGION SITE","_key":"85eafd2d-c0d0-4603-b422-54f3340f5ddb"}],"displayOption":"quarter"}],"theme":"corporate","_type":"sectionPage","contentFolderWasParent":true,"excludeFromSearch":false,"hideHeader":false,"parent":{"_type":"reference","_weak":true,"_ref":"e2cbba90-4d9e-4b44-80ef-114f703b6375"},"urlSegment":"/en-us/","releaseDate":"2018-03-28T20:24:33+00:00","_updatedAt":"2024-04-09T14:03:44Z","hideSocialSharingButtons":true,"customCssClass":"","partialPageCallToActionText":"Learn more","_rev":"5ertRheBuhYWXTyG8vG8Nt","partialPageHeading":"","_langRefs":null,"sortIndex":100,"canonicalUrl":"https://www.takeda.com/","language":"en-US","seo":{"indexing":0,"_key":"20b155b1-4c46-430e-b07e-0e614c43ee13","openGraphImage":"","openGraphTitle":"Takeda - Better Health, Brighter Future","openGraphDescription":"Takeda is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Takeda focuses its R\u0026D efforts on oncology, gastroenterology and central nervous system therapeutic areas plus vaccines. Takeda conducts R\u0026D both internally and with partners to stay at the leading edge of innovation. New innovative products, especially in oncology and gastroenterology, as well as our presence in Emerging Markets, fuel the growth of Takeda. More than 30,000 Takeda employees are committed to improving quality of life for patients, working with our partners in health care in more than 70 countries. ","descriptionString":"Takeda is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Takeda focuses its R\u0026D efforts on oncology, gastroenterology and central nervous system therapeutic areas plus vaccines. Takeda conducts R\u0026D both internally and with partners to stay at the leading edge of innovation. New innovative products, especially in oncology and gastroenterology, as well as our presence in Emerging Markets, fuel the growth of Takeda. More than 30,000 Takeda employees are committed to improving quality of life for patients, working with our partners in health care in more than 70 countries. ","title":"Takeda - Better Health, Brighter Future","targetGroup":0,"_type":"seoBlock"},"shortcut":{"_type":"shortcut","shortcutType":"Normal","_key":"37149fed-9441-4ec3-b8ca-a080cfa36c38"},"partialPageThumbnailAlt":""},"siteSettings":{"contentSettings":[{"ourStoriesSectionHeadingAsString":"\u003cdiv\u003eOur Stories\u003c/div\u003e","searchResultPageLink":{"_type":"sectionPage","hideFooter":false,"hideBreadCrumb":false,"_base":{"_weak":true,"_ref":"bf101a93-b8c5-4d6b-8d64-1f83b3f88593","_type":"reference"},"showNewInLanguages":"","title":"Search","parentWasSkipped":false,"customCssClass":"","excludeFromSearch":true,"_id":"bf101a93-b8c5-4d6b-8d64-1f83b3f88593__i18n_en-US","hideInThisSection":false,"linkType":"normal","hideHeader":false,"trackingRoot":false,"startPublish":"2018-03-28T20:37:28+00:00","seo":{"_key":"6d748663-dd22-414f-a4a7-9b9c5d98c5b8","openGraphImage":"","targetGroup":0,"indexing":0,"_type":"seoBlock"},"_createdAt":"2017-07-26T13:41:01Z","optimizelyId":"902","partialPageThumbnailAlt":"","partialPageCallToActionText":"Learn more","_updatedAt":"2018-03-28T20:37:28Z","childSortOrder":"createdDescending","shortcut":{"shortcutType":"Normal","_key":"c53df22d-61e6-4319-8233-6c4c6703310b","_type":"shortcut"},"parent":{"_weak":true,"_ref":"719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-US","_type":"reference"},"visibleInMenu":false,"language":"en-US","urlSegment":"/en-us/search/","sortIndex":600,"partialPageHeading":"","mainContentArea":[{"searchExcludeContentMedia":false,"mostRecentLabel":"","allTopicsLabel":"","searchExcludePdFs":false,"chronologyFilter":"","numberOfResultsLabel":"Results","isNewsroom":false,"searchExcludeVideos":false,"hideTopicsFilter":true,"showingResultLabel":"Showing Results for","numberOfResultsPerPage":10,"searchDefaultTerm":"","descriptionExcerptLength":200,"displayOption":"full","searchFieldPlaceholder":"Search Website","allTypesLabel":"","searchRootPageLink":{"_type":"reference","_weak":true,"_ref":"719d1b8a-9834-4b1f-8b58-1c0063ac3094"},"dateFormat":"","hideNewsListHeader":false,"allYearsLabel":"","searchRootMediaLink":{"_weak":true,"_ref":"2527e3ad-d821-479b-85ff-c5cad7c30295","_type":"reference"},"childrenPagesOnNoQuery":false,"searchExcludeImages":true,"layout":"simplewithexcerpt","_type":"searchResultBlock","searchButtonLabel":"Enter","searchResultSortOrder":4,"numberOfPages":5,"heading":"Search Results","hideChronologyFilter":true,"showingSynonymsLabel":"Search Instead for","noResultTextAsString":"\u003cdiv\u003eNo Results\u003c/div\u003e","hideTypesFilter":true,"_key":"f137505c-1bf5-44f4-afc8-e45efbee2099"}],"_langRefs":null,"theme":"","contentFolderWasParent":false,"hideSocialSharingButtons":false,"_rev":"aUNQU13w4ufRVSXZ64AdEf","canonicalUrl":"https://www.takeda.com/search/","friendlyUrl":{"current":"/en-us/search/","_type":"slug","_key":"dba62a80-60d6-48ff-b4e0-331968faeae7"},"releaseDate":"2018-03-28T20:37:28+00:00","shortUrl":"https://takeda.info/2YGLpxV"},"shareLabel":"","brightcoveAccountId":"2299575749001","displayOption":"full","notFoundPageLink":{"canonicalUrl":"https://www.takeda.com/404_2/","theme":"","customCssClass":"","seo":{"targetGroup":0,"indexing":0,"_type":"seoBlock","_key":"a019defa-a47d-47eb-8670-3f0ba4faaacf","openGraphImage":""},"startPublish":"2018-03-28T20:38:59+00:00","urlSegment":"/en-us/404/","_createdAt":"2017-07-31T10:37:07Z","headingAsString":"\u003cdiv\u003ePage not found.\u003c/div\u003e","mainContentArea":[],"_langRefs":null,"partialPageCallToActionText":"Learn more","hideSocialSharingButtons":false,"excludeFromSearch":true,"friendlyUrl":{"current":"/en-us/404/","_type":"slug","_key":"1ed5d70c-175a-438f-a15d-7e6bdb0cb0c6"},"releaseDate":"2018-03-28T20:38:59+00:00","title":"404","linkType":"normal","hideFooter":false,"shortUrl":"https://takeda.info/2YCmBqN","trackingRoot":false,"childSortOrder":"createdDescending","language":"en-US","contentFolderWasParent":false,"_rev":"aUNQU13w4ufRVSXZ653Q1s","visibleInMenu":false,"sortIndex":3300,"hideInThisSection":false,"parentWasSkipped":false,"showNewInLanguages":"","_type":"sectionPage","hideHeader":false,"_id":"0c2c27c2-f5f1-4542-980a-6c3f9962259b__i18n_en-US","optimizelyId":"14831","_base":{"_weak":true,"_ref":"0c2c27c2-f5f1-4542-980a-6c3f9962259b","_type":"reference"},"partialPageThumbnailAlt":"","partialPageHeading":"","hideBreadCrumb":false,"_updatedAt":"2018-03-28T20:38:59Z","parent":{"_type":"reference","_weak":true,"_ref":"719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-US"},"shortcut":{"shortcutType":"Normal","_key":"25bb2992-5a8b-4c89-b654-a21bdef0e4df","_type":"shortcut"}},"newsListingPageLink":{"childSortOrder":"index","mainContentArea":[{"childrenPagesOnNoQuery":false,"hideTypesFilter":false,"hideTopicsFilter":false,"numberOfPages":5,"displayOption":"full","searchExcludePdFs":false,"showingSynonymsLabel":"","numberOfResultsLabel":"","searchExcludeContentMedia":false,"noResultTextAsString":"\u003cdiv\u003eNo results to display\u003c/div\u003e","searchRootPageLink":{"_weak":true,"_ref":"dde5a2ec-2787-4035-842d-c63e5bedf08a","_type":"reference"},"chronologyFilter":"#all,#last12months,2023,2022,2021,2020,2019,2018,2017,2016","showingResultLabel":"","_type":"searchResultBlock","allYearsLabel":"All","layout":"simplegroupbymonth","searchExcludeVideos":false,"isNewsroom":true,"_key":"d6015bbd-8c80-4b6a-846f-db8968627bee","mostRecentLabel":"Last 12 months","descriptionExcerptLength":200,"numberOfResultsPerPage":8,"searchResultSortOrder":1,"searchButtonLabel":"Enter","hideChronologyFilter":false,"allTopicsLabel":"","searchExcludeImages":false,"dateFormat":"","allTypesLabel":"","searchFieldPlaceholder":"Search","searchDefaultTerm":"*","hideNewsListHeader":false,"heading":""}],"releaseDate":"2018-03-28T20:26:06+00:00","_base":{"_weak":true,"_ref":"dde5a2ec-2787-4035-842d-c63e5bedf08a","_type":"reference"},"language":"en-US","parent":{"_weak":true,"_ref":"7bea32ce-d307-498a-820f-a0820b4a4486__i18n_en-US","_type":"reference"},"sortIndex":100,"_type":"contentPage","_id":"dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_en-US","showNewInLanguages":"","hideFooter":false,"hideBreadCrumb":false,"excludeFromSearch":false,"customCssClass":"","contentFolderWasParent":false,"partialPageThumbnailAlt":"","visibleInMenu":true,"shortUrl":"https://bit.ly/30smmku","shortcut":{"_type":"shortcut","shortcutType":"Normal","_key":"a8461b97-de4f-4d6f-ae4c-9015f78e5e43"},"optimizelyId":"9143","partialPageHeading":"","parentWasSkipped":false,"urlSegment":"/en-us/newsroom/news-releases/","trackingRoot":false,"hideInThisSection":false,"friendlyUrl":{"current":"/en-us/newsroom/news-releases/","_type":"slug","_key":"11cc5445-46b6-4296-992b-bdb3404b8a29"},"seo":{"_type":"seoBlock","title":"US News Releases | Takeda","openGraphTitle":"US News Releases | Takeda","targetGroup":0,"_key":"50f0e7c1-5726-49e1-9b74-564fdc76e484","indexing":0,"openGraphDescription":"News releases for Takeda in the United States","openGraphImage":"","descriptionString":"News releases for Takeda in the United States"},"hideSideMenu":false,"_createdAt":"2017-06-16T09:09:12Z","headingAsString":"\u003cdiv\u003eUS News Releases\u003c/div\u003e","hideHeader":false,"_langRefs":null,"hideSocialSharingButtons":false,"taxonomy":[],"title":"US News Releases","_updatedAt":"2024-01-16T13:11:45Z","canonicalUrl":"https://www.takeda.com/newsroom/newsreleases/","startPublish":"2018-03-28T20:26:06+00:00","linkType":"normal","partialPageCallToActionText":"Learn more","_rev":"YVUUdUd2zukYylFwVKiBAQ"},"breadcrumbIncludeStartPage":true,"_type":"siteGlobalContentBlock","brightcovePlayerId":"r1m84eZA","oGimageUrl":{"url":{"resource_type":"image","_type":"cloudinary.asset","type":"upload","version":1675248794,"public_id":"legacy-dotcom/globalassets/corporate/landing-page-takeda-logo","secure_url":"https://assets-dam.takeda.com/image/upload/v1675248794/legacy-dotcom/globalassets/corporate/landing-page-takeda-logo.png","width":644,"height":643,"bytes":4857,"created_at":"2022-09-09T10:43:06Z","_version":1,"format":"png","url":"http://assets-dam.takeda.com/image/upload/v1675248794/legacy-dotcom/globalassets/corporate/landing-page-takeda-logo.png","_key":"f01bbfa7-bde5-48c6-a7b3-54f6356ced47"},"excludeFromSearch":false,"_type":"imageFile","_key":"57c21b23-08ed-434c-bceb-55c67afc9123","blurDataUrl":"data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAKBAMAAAB/HNKOAAAAG1BMVEX////4zc71srT86er98PD+9vbzpqn74+T73+ACeip6AAAAIklEQVQIHWPAAsKNCxgYGBObxQwYmISUkgQYGEJcXBkwAQBwLQOrR0EsTQAAAABJRU5ErkJggg=="},"downloadLabel":"","_key":"407fd2bf-7936-4947-aa66-0909e45e3ecd","searchPanelPlaceholderText":"Search"},{"mailToSubject":"I would like to share this with you.","hideShareViaLinkedin":false,"targetGroup":6,"hideShareViaFacebook":false,"_type":"socialSharingBlock","_key":"13cfad69-6fe1-4c7a-b4a1-41a52bb72548","labelText":"Share:","displayOption":"full","hideShareViaEmail":false,"hideShareViaTwitter":false,"bitlyGenericAccessToken":"b93b10badf2abcefa56f247736ac164b88c731d2","mailToBody":"Greetings,\n\nI found this interesting and I would like to share it with you.\n\n"},{"bodyScript":"\u003c!-- Google Tag Manager (noscript) --\u003e\n\u003cnoscript\u003e\u003ciframe src=\"https://www.googletagmanager.com/ns.html?id=GTM-K75R39\" height=\"0\" width=\"0\" style=\"display:none;visibility:hidden\"\u003e\u003c/iframe\u003e\u003c/noscript\u003e\n\u003c!-- End Google Tag Manager (noscript) --\u003e\n\u003c!-- Google Tag Manager (noscript) --\u003e\n\u003cnoscript\u003e\u003ciframe src=\"https://www.googletagmanager.com/ns.html?id=GTM-5XBTH5B\"\nheight=\"0\" width=\"0\" style=\"display:none;visibility:hidden\"\u003e\u003c/iframe\u003e\u003c/noscript\u003e\n\u003c!-- End Google Tag Manager (noscript) --\u003e","customFields":[{"value":"","isEnabled":true,"_type":"dataFieldViewModel","name":"version","_key":"592e41d3-ef3d-4090-9011-bb93accb6525"},{"name":"website_name","_key":"a8c5e13c-5111-475c-bdf6-0b112eed3a7d","value":"Takeda Corporate com","isEnabled":true,"_type":"dataFieldViewModel"},{"isEnabled":true,"_type":"dataFieldViewModel","name":"cluster","_key":"7a5391aa-d3f7-489a-898b-57875c3fba12","value":"www.takeda.com"}],"_type":"gtmSettingsBlock","headScript":"\u003c!-- Bing Webmaster tool --\u003e\n\u003cmeta name=\"msvalidate.01\" content=\"E15E71DA876B72B5ACE966AC329C32BA\" /\u003e\n\u003c!-- Baidu Webmaster tool --\u003e\u003cmeta name=\"baidu-site-verification\" content=\"PHSoqJntj0\" /\u003e\n\n\u003c!-- Google Tag Manager --\u003e\n\u003cscript\u003e(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':\nnew Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],\nj=d.createElement(s),dl=l!='dataLayer'?'\u0026l='+l:'';j.async=true;j.src=\n'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);\n})(window,document,'script','dataLayer','GTM-K75R39');\u003c/script\u003e\n\u003c!-- End Google Tag Manager --\u003e\n\n\u003c!-- Google Tag Manager --\u003e\n\u003cscript\u003e(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':\nnew Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],\nj=d.createElement(s),dl=l!='dataLayer'?'\u0026l='+l:'';j.async=true;j.src=\n'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);\n})(window,document,'script','dataLayer','GTM-5XBTH5B');\u003c/script\u003e\n\u003c!-- End Google Tag Manager --\u003e\n\n\u003cmeta name=\"google-site-verification\" content=\"DO9v0oYUmeRbWBX5ftlI3Gmo3hMp3iGwd8s80zF6f6w\" /\u003e\n\n\u003c!-- idio Analytics Tracking Code --\u003e\n\u003cscript type=\"text/javascript\"\u003e\n // Set client and delivery\n \n _iaq = [\n ['client', '54a09b6302244fd3b7dd8dd141292d46'],\n ['delivery', 469],\n ['track', 'consume']\n ];\n \n // Include the Idio Analytics JavaScript\n !function(d,s){var ia=d.createElement(s);ia.async=1,s=d.getElementsByTagName(s)[0],ia.src='//s.usea01.idio.episerver.net/ia.js',s.parentNode.insertBefore(ia,s)}(document,'script');\n // Include the Idio PDF Tracking JavaScript\n !function(t,e){var a=t.attachEvent?'on':'';t[a?'attachEvent':'addEventListener'](a+'click',function(t){for(t=t.srcElement||t.target;t\u0026\u0026'a'!==t.tagName\u0026\u0026'A'!==t.tagName\u0026\u0026!t.href;)t=t.parentNode;if(t){var a=t.href,n=e.protocol+'//'+e.host;0===a.indexOf(n)\u0026\u0026/\\.pdf(\\?|#|$)/i.test(a)\u0026\u0026_iaq.push(['track','consume',a])}})}(document,location);\n\u003c/script\u003e\n\u003c!-- / idio Analytics Tracking Code --\u003e\n","_key":"c98c9bc5-d59c-42f2-bfae-1c41e2daf5fb","displayOption":"full","enabled":true,"mappedProperties":[{"_type":"dataFieldViewModel","name":"page_id","_key":"2afb32b0-28c4-4699-8ccf-698881c7d9f7","value":"ContentLink","isEnabled":false},{"value":"Name","isEnabled":true,"_type":"dataFieldViewModel","name":"page_name","_key":"e874286f-efbc-4e28-b2ee-3f50ba40c0f4"},{"_type":"dataFieldViewModel","name":"page_language","_key":"3aed28ae-5b87-43fb-a8f3-b3c9143e37a2","value":"LanguageID","isEnabled":true},{"_type":"dataFieldViewModel","name":"page_type","_key":"184a73ce-702d-4e3a-b99c-bf0bdfb44faa","value":"PageTypeName","isEnabled":false},{"_key":"47d02e7a-8858-4e6a-b3b8-67c02e3f6554","value":"LinkURL","isEnabled":true,"_type":"dataFieldViewModel","name":"page_url"},{"_type":"dataFieldViewModel","name":"section","_key":"da0faa37-2cf8-4765-a5d5-35e7ad2b1e39","value":"PageSection","isEnabled":true},{"isEnabled":true,"_type":"dataFieldViewModel","name":"page_error","_key":"7c3bd589-4fad-4ff9-9d27-7549afe2c39c","value":"PageError"},{"isEnabled":true,"_type":"dataFieldViewModel","name":"target_group","_key":"50a56620-6f05-4832-a3f4-2c6ef33879bb","value":"TargetGroup"},{"_type":"dataFieldViewModel","name":"ip_address","_key":"bdf427d5-dcc0-427f-85fb-283ab590aca4","value":"IPAddress","isEnabled":true}]}],"_rev":"XqAi32IHlx6w0gbR9jH3Ec","_updatedAt":"2024-01-04T17:05:11Z","startPublish":"2018-03-29T03:26:29+00:00","useNotoSansJp":false,"trackingRoot":false,"urlSegment":"/en-us/system/settings/","_type":"siteSettingsPage","seo":{"targetGroup":0,"indexing":0,"_type":"seoBlock","_key":"fd190ac8-d41b-431e-910a-628214f317b4","openGraphImage":""},"_langRefs":null,"_createdAt":"2018-02-19T08:58:48Z","useNotoSansSc":false,"title":"Settings - en-US","useCustomCdnExpiration":true,"imageWarningText":"","cdnExpiration":4,"contentFolderWasParent":true,"visibleInMenu":false,"_id":"f6caa076-f145-407f-b409-1b3e38b0e08a__i18n_en-US","_base":{"_weak":true,"_ref":"f6caa076-f145-407f-b409-1b3e38b0e08a","_type":"reference"},"useNotoSansKr":false,"parentWasSkipped":false,"friendlyUrl":{"_type":"slug","_key":"0a1c0d67-07ad-4a21-a269-9d4f62fe4b42","current":"/en-us/system/settings/"},"canonicalUrl":"https://www.takeda.com/","language":"en-US","useImageWarningMessage":false,"parent":{"_weak":true,"_ref":"719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-US","_type":"reference"},"sortIndex":0,"useNotoSansTc":false,"releaseDate":"2018-03-29T03:26:29+00:00","optimizelyId":"890","imageWarningSizeLimit":1,"hideHeader":false,"layoutSettings":[{"topToolbarLinksCollection":[{"_type":"linkItem","href":"/en-us/newsroom/news-releases/","text":"Newsroom","_key":"9b4b8a03-851d-445b-86dd-32b1130c5fa7"},{"_type":"linkItem","href":"/en-us/careers/?epslanguage=en-US","text":"Careers","_key":"f4097761-3247-40b2-bf0d-3afb13edb286"},{"_type":"linkItem","href":"/investors/","text":"Investors","_key":"e8b39f37-f530-415e-b41a-cae9e7d73feb"},{"_type":"linkItem","href":"/en-us/who-we-are/contact-us","text":"Contact Us","_key":"03676427-9d46-49ec-a5b1-0f50d17c40a3"}],"_key":"7f59fa51-d495-4747-9f24-bfd542fd0e4f","topTaglineMobileLabelLine2":"Brighter Future","seoOrganizationData":{"items":[{"value":"Takeda Pharmaceutical Company Limited","key":"name","_type":"keyValueListItem","_key":"7551bc50-1cbb-42c0-92d0-6016ac5f43b7"},{"key":"url","_type":"keyValueListItem","_key":"18033f1d-0b4d-4fcb-bf52-9c6218d0efa4","value":"http://www.takeda.com"},{"_type":"keyValueListItem","_key":"0131952d-e5b7-4cc2-b1ee-d9b177a0dc03","value":"https://www.linkedin.com/company/5482","key":"sameAs"}],"_type":"seoOrganizationBlock","_key":"752315ba-4028-437a-b2d4-86a03a57d28c"},"topTaglineMobileLabelLine1":"Better Health,","_type":"headerBlock","topToolbarLinksContent":[{"link":"/worldwide/","linkText":"United States","_key":"2055d916-0af9-493b-85f7-ca097f8f84e0","flagUrl":{"_type":"imageFile","_key":"209a535d-8a05-4361-a5d0-6cddd7056e33","url":{"secure_url":"https://assets-dam.takeda.com/image/upload/v1675248795/legacy-dotcom/siteassets/en-us/us.png","format":"png","resource_type":"image","height":650,"_type":"cloudinary.asset","url":"http://assets-dam.takeda.com/image/upload/v1675248795/legacy-dotcom/siteassets/en-us/us.png","_version":1,"created_at":"2022-09-09T10:44:14Z","public_id":"legacy-dotcom/siteassets/en-us/us","bytes":12815,"type":"upload","_key":"49a80d48-6199-47ed-8707-336b58881aac","version":1675248795,"width":1235},"excludeFromSearch":false,"blurDataUrl":"data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAFBAMAAACOSmBbAAAAFVBMVEVYVoLWiZPgp67Qd4KIh6bLdYKGhKQqMms9AAAAIElEQVQI12NgYAg2NmZgYBAUFGRIcVFSUgKxgGxjEAAALXYDT8yJoTAAAAAASUVORK5CYII="},"_type":"countrySelectorLinkBlock"}],"topTaglineDesktopLabel":"Better Health, Brighter Future","enableAccessibilityText":"Enable Accessibility","disableAccessibilityText":"","logoUrl":{"excludeFromSearch":false,"_type":"imageFile","_key":"4df80ab8-6e4e-47bb-b7d0-851860813133","url":{"width":1080,"url":"http://assets-dam.takeda.com/image/upload/v1662720236/legacy-dotcom/globalassets/corporate/takeda_logo.svg","public_id":"legacy-dotcom/globalassets/corporate/takeda_logo","_key":"88831d10-654b-4ba4-bc20-454d6c77f256","version":1662720236,"created_at":"2022-09-09T10:43:56Z","_version":1,"resource_type":"image","type":"upload","secure_url":"https://assets-dam.takeda.com/image/upload/v1662720236/legacy-dotcom/globalassets/corporate/takeda_logo.svg","bytes":3685,"_type":"cloudinary.asset","height":599,"format":"svg"},"blurDataUrl":"data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAGBAMAAAAI3hL1AAAAKlBMVEVHcEz50tP0r7L+9/f4ztDwj5L3x8n3x8jyoKPxmp31t7n0rrD+8vL2vb9BuiRAAAAAC3RSTlMAEUgBHWQ96+jn7CJFrYQAAAAiSURBVAjXY2CAAMY0AQYG5qgzpQYMLL27dzowMAgpKULlAFZoBOAQ1TjWAAAAAElFTkSuQmCC"},"logoTargetUrl":"/en-us/"},{"levelToTake":3,"root":{"_ref":"719d1b8a-9834-4b1f-8b58-1c0063ac3094","_type":"reference","_weak":true},"_type":"menuBlock","_key":"125c629c-0c00-4164-bdb2-572511ea10c0","menu":[{"document":{"friendlyUrl":{"current":"/en-us/who-we-are/","_type":"slug","_key":"251f017c-ace5-40a3-888e-afdc3696b393"},"partialPageHeading":"About Takeda","featuredContent":[{"linkText":"","_key":"e14425f8-b8fd-4881-b187-f13037b180a6","linkCasing":"normal","customCssClass":"","headingColor":"color1","_type":"spotBlock","linkStyling":"normal","displayOption":"quarter","layout":"topimage","backgroundColor":""}],"partialPageCallToActionText":"Learn more","partialPageCallToActionLink":null,"partialPageIntroAsString":"\u003cdiv\u003eHow can we do more for our patients?\u003cbr\u003eEverything at Takeda starts with this question.\u003c/div\u003e","_id":"7d6ac569-14f6-48e3-bb00-eee484816321__i18n_en-US","navigationNameAsString":"","title":"Who We Are"},"_type":"menuItem","_key":"02b4099d-7679-4b5e-81cd-faf96b35eb3b","submenu":[{"submenu":[{"_type":"menuItem","_key":"593151fd-3dcb-4cc3-a752-0caddbfcfebc","submenu":null,"document":{"_id":"6716cb7f-dcea-41c4-948d-a3d51484e782__i18n_en-US","friendlyUrl":{"current":"/en-us/who-we-are/company-information/company-facts/","_type":"slug","_key":"0ceee25e-bf68-4e50-b4b1-73c54002ed22"},"navigationNameAsString":"","title":"Takeda in the U.S."}},{"_key":"92232202-84f7-4bcb-a9bb-4fbf9169d4e9","submenu":null,"document":{"_id":"1597f769-fc03-4176-81a4-60a373d7ee17__i18n_en-US","friendlyUrl":{"current":"/en-us/who-we-are/company-information/worldwide-offices/","_type":"slug","_key":"79625eb2-e176-4bd3-8fde-1abe5f07262a"},"navigationNameAsString":"","title":"Worldwide Offices"},"_type":"menuItem"},{"_key":"50b6d19d-d024-4717-964b-18faa4331d6d","submenu":null,"document":{"_id":"d0621b29-c6ab-4cb6-b501-3d2b12a7d022","friendlyUrl":{"current":"/en-us/shortcut_content_136879/","_type":"slug","_key":"53462866-2fca-4f9f-9c0a-e8eee4f68b18"},"navigationNameAsString":"","title":"Executive Leadership"},"_type":"menuItem"}],"document":{"_id":"ee89c8dd-9e96-4ed2-9ee8-3b9943cd10f9__i18n_en-US","friendlyUrl":{"current":"/en-us/who-we-are/company-information/","_type":"slug","_key":"72746a7c-3f38-412e-95a4-98dac4af614c"},"navigationNameAsString":"","title":"Company Information"},"_type":"menuItem","_key":"1cd860f9-be7a-4166-a7ca-d068542954bf"},{"submenu":[],"document":{"_id":"e6777430-69fc-4cae-a186-21e4b1c33a24__i18n_en-US","friendlyUrl":{"_type":"slug","_key":"d09578b2-387e-4a8b-9d91-da83ee3753cd","current":"/en-us/who-we-are/corporate-philosophy/"},"navigationNameAsString":"","title":"Corporate Philosophy"},"_type":"menuItem","_key":"e44f2392-155b-44f5-b973-6fe3db5ab2c7"},{"submenu":[],"document":{"_id":"9f0afb21-fac1-4104-9c14-b3b04c6ac1a0","friendlyUrl":{"current":"/en-us/who-we-are/takeda-pricing-philosophy/","_type":"slug","_key":"34e1db5d-2ceb-4278-8de8-07026815b0ae"},"navigationNameAsString":"","title":"Takeda Pricing Philosophy"},"_type":"menuItem","_key":"80a79003-1829-4d7b-8346-a6d9e3ecc3ec"},{"submenu":[],"document":{"_id":"9a7fde7c-b336-434b-a197-030cdc4c497e__i18n_en-US","friendlyUrl":{"current":"/en-us/who-we-are/contact-us/","_type":"slug","_key":"85ad15d3-e9dd-4665-a223-017c1e33de11"},"navigationNameAsString":"","title":"Contact Us"},"_type":"menuItem","_key":"89eff99e-7637-48c3-bdca-a815a896dc38"}]},{"document":{"friendlyUrl":{"current":"/en-us/what-we-do/","_type":"slug","_key":"da9f83b4-2282-4ef7-9817-77894f713c8a"},"title":"What We Do","featuredContent":null,"partialPageHeading":"Our Business","partialPageIntroAsString":"\u003cdiv\u003eTakeda continues its transformation into an agile and innovative global pharmaceutical leader, serving the needs of patients and physicians worldwide.\u003c/div\u003e","_id":"b6e8a5c2-9ba2-442c-baf9-79ef84d80249__i18n_en-US","navigationNameAsString":"","partialPageCallToActionText":"Learn more","partialPageCallToActionLink":null},"_type":"menuItem","_key":"b544969e-020b-405c-aa23-823c6cd479c2","submenu":[{"_type":"menuItem","_key":"2222f944-c45e-4f96-a2aa-736ce90fbc5e","submenu":[{"submenu":null,"document":{"_id":"c2a3795b-b4ab-417c-b0dc-debb2f3e14d3__i18n_en-US","friendlyUrl":{"_type":"slug","_key":"a6c3cfd5-19d5-40dd-9cb3-2e69dbbadf56","current":"/en-us/shortcut_content_2191/"},"navigationNameAsString":"","title":"Our Pipeline"},"_type":"menuItem","_key":"679df639-035a-476c-a969-15af6798ad42"}],"document":null},{"_key":"b5d58823-00f1-40b4-90eb-96f24c5020e2","document":{"_id":"25f3b0d0-c33c-46fe-ac07-bd7e13f023c7","friendlyUrl":{"current":"/en-us/what-we-do/areas-of-focus/","_type":"slug"},"navigationNameAsString":"","title":"Areas of Focus"},"_type":"menuItem","submenu":null},{"_type":"menuItem","_key":"595b3d38-7db3-458d-85fb-ae1362962a40","submenu":[],"document":{"_id":"05bc733a-a1ae-48c5-8119-ff001e76ce77","friendlyUrl":{"current":"/en-us/what-we-do/patient-services/","_type":"slug","_key":"3a709ec3-4dd2-4e41-bf1b-0aaf75eec3b7"},"navigationNameAsString":"","title":"Patient Services \u0026 Assistance"}},{"submenu":[],"document":{"_id":"76594f37-3403-4664-a4b2-ea85c966b2a5","friendlyUrl":{"_key":"ca8fa87e-e0b5-48ef-bdbb-6d28ee39903e","current":"/en-us/what-we-do/product-portfolio/","_type":"slug"},"navigationNameAsString":"","title":"U.S. Product List"},"_type":"menuItem","_key":"0e9ef637-0edf-4c30-9a2b-f98d632b2455"},{"submenu":[],"document":{"_id":"74ca6366-ce6b-4e3c-8d71-7eb9a57bb186","friendlyUrl":{"current":"/en-us/what-we-do/independent-medical-education-grants/","_type":"slug","_key":"de187340-5bf9-4279-8291-711874747947"},"navigationNameAsString":"","title":"Independent Medical Education Grants"},"_type":"menuItem","_key":"f9a4f6ab-9cdd-4544-b39c-7b035319e734"}]},{"submenu":[],"document":{"partialPageCallToActionLink":null,"partialPageHeading":"Our Stories","partialPageIntroAsString":"\u003cdiv\u003eA selection of stories related to Innovation, Caring and Heritage\u003c/div\u003e","_id":"14479174-6503-484f-8d86-87d249c418c5__i18n_en-US","title":"Our Stories","partialPageCallToActionText":"Learn more","featuredContent":null,"friendlyUrl":{"current":"/en-us/our-stories/","_type":"slug","_key":"1f019dc3-720b-4dc0-9d80-9d745f0ac348"},"navigationNameAsString":""},"_type":"menuItem","_key":"c486426a-8d68-4b1f-b255-db1853751841"},{"_type":"menuItem","_key":"4f288c1e-fb6b-4401-942d-689c36a1a322","submenu":[{"document":{"_id":"579e516e-4176-478b-911a-7f1d8d47dfbd","friendlyUrl":{"current":"/en-us/corporate-responsibility/patients/","_type":"slug","_key":"55ccf0af-4765-4a55-b1d8-f638f82133a6"},"navigationNameAsString":"","title":"Patients"},"_type":"menuItem","_key":"de78844b-6b80-410e-ad79-288df5efdd43","submenu":[{"_type":"menuItem","_key":"ae1974b3-3d68-4b0e-9948-973a2b860a3b","submenu":null,"document":{"_id":"c2e5db6c-644b-4d2a-a266-14846843ed96","friendlyUrl":{"current":"/en-us/shortcut_content_251810/","_type":"slug","_key":"5b7b3e3d-fa51-4e37-b550-6d87a1b97552"},"navigationNameAsString":"","title":"Patient Services and Assistance"}},{"submenu":null,"document":{"_id":"9d1a0da4-9868-49d7-86b3-b4a4b0997538","friendlyUrl":{"_key":"0e16c049-fc1f-4014-a8d5-6137435bb9d8","current":"/en-us/shortcut_content_251811/","_type":"slug"},"navigationNameAsString":"","title":"Diversity, Equity \u0026 Inclusion in R\u0026D"},"_type":"menuItem","_key":"74e5d759-4ddc-45b2-885e-26f035c1c158"}]},{"document":{"_id":"3a1c4327-b054-4dfb-95ca-0c01a48a3d48","friendlyUrl":{"current":"/en-us/corporate-responsibility/people/","_type":"slug","_key":"27ebdb42-d938-4875-87c6-210d0a9dc039"},"navigationNameAsString":"","title":"People"},"_type":"menuItem","_key":"d6e635b4-0217-42f0-aa8b-66358c3c46fa","submenu":[{"_key":"1335f872-969c-4cf3-8e86-745cf158d8cc","submenu":null,"document":{"_id":"91e09135-9b82-47ac-9422-366d367c8ee8","friendlyUrl":{"current":"/en-us/shortcut_content_251812/","_type":"slug","_key":"5f5ffa99-9be9-4058-92b5-c0796219a3e9"},"navigationNameAsString":"","title":"Diversity, Equity \u0026 Inclusion"},"_type":"menuItem"},{"_type":"menuItem","_key":"41fa1266-d2ef-4d25-b319-f79768ff7937","submenu":null,"document":{"_id":"92fb279f-3932-4f76-9599-a3ed1391c34a","friendlyUrl":{"current":"/en-us/shortcut_content_251813/","_type":"slug","_key":"9fdc714b-0d89-4fba-8e30-2a1a3b7fe029"},"navigationNameAsString":"","title":"Commitment to Community"}},{"document":{"_id":"18fc12bb-b626-4a65-9d2c-861c4e400573","friendlyUrl":{"current":"/en-us/corporate-responsibility/people/#Philantropic-Giving","_type":"slug"},"navigationNameAsString":"","title":"Philanthropic Giving"},"_type":"menuItem","_key":"f9eea0cd-3cb6-41b0-af93-e046670ecb59","submenu":null},{"_type":"menuItem","_key":"ef99e873-a6fe-4094-a80d-f1f9dd1c642a","submenu":null,"document":{"_id":"a4738ea0-4225-46c4-ac53-4079b0bc5fef","friendlyUrl":{"current":"/en-us/shortcut_content_251814/","_type":"slug","_key":"d7ca9a7f-e271-44c0-a66e-c017eae7465c"},"navigationNameAsString":"","title":"Careers"}}]},{"document":{"_id":"bd302486-3dea-4ee4-a092-7d73a1bc7af7","friendlyUrl":{"current":"/en-us/corporate-responsibility/planet/","_type":"slug","_key":"c58c8c58-6570-4e62-a47f-fa1e8e7c7e29"},"navigationNameAsString":"","title":"Planet"},"_type":"menuItem","_key":"98d619ad-5980-41ef-b71a-8f854c8814b5","submenu":[]},{"_key":"eaf93185-e910-45b0-9075-828033a9f374","submenu":[{"submenu":null,"document":{"_id":"a3bf4784-2101-4455-880d-d46117184534","friendlyUrl":{"current":"/en-us/corporate-responsibility/ethics-and-compliance/cpsia/","_type":"slug","_key":"2af680cd-b57b-4d7d-a51e-e27a3f5e39bb"},"navigationNameAsString":"","title":"Statements \u0026 Disclosures"},"_type":"menuItem","_key":"420068a1-c0ca-4de5-b4e1-cdf89e40d7f3"}],"document":{"_id":"fef439d2-b9ac-4f66-97dc-159c826a5db6","friendlyUrl":{"current":"/en-us/corporate-responsibility/ethics-and-compliance/","_type":"slug","_key":"08d6dcc9-e495-45ab-a837-e142bab86d20"},"navigationNameAsString":"","title":"Ethics and Compliance"},"_type":"menuItem"}],"document":{"title":"Corporate Responsibility","partialPageCallToActionLink":null,"navigationNameAsString":"","partialPageCallToActionText":"Learn more","partialPageHeading":"Purpose-led Sustainability","partialPageIntroAsString":"\u003cdiv\u003eSustainability underpins all we do at Takeda to help solve key societal challenges and create value for society.\u003c/div\u003e","featuredContent":null,"_id":"c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_en-US","friendlyUrl":{"_type":"slug","_key":"68d35994-4f5d-4ed3-ab53-59fbb1cb6de3","current":"/en-us/corporate-responsibility/"}}}],"requirePageTemplate":true,"includeRoot":false,"requireVisibleInMenu":true},{"additionalBlocks":[{"_type":"internalLinkDisclaimerBlock","isCancelBeforeConfirm":false,"_key":"804d9dc2-1f3c-4df9-b876-3c176682443a","displayOption":"","cancelButtonText":"CANCEL","disclaimerTextAsString":"\u003csection class=\"disclaimer internal\"\u003e\n\u003cdiv class=\"disclaimer__close js-close-popup-internal\"\u003e\u0026nbsp;\u003c/div\u003e\n\u003cdiv class=\"disclaimer-wrap\"\u003e\n\u003cp class=\"disclaimer__title\"\u003eYou are about to leave \u003ca target=\"_blank\" href=\"http://www.takeda.com/en-us\"\u003ewww.Takeda.com/en-us\u003c/a\u003e and be redirected to another Takeda domain.\u003c/p\u003e\n\u003c/div\u003e\n\u003c/section\u003e","okButtonText":"OK"},{"_type":"richTextBlock","_key":"04c4f08d-d320-4af1-a58e-c3425a21b334","displayOption":"","customCssClass":"","layout":"","backgroundColor":"Transparent","contentAsString":""},{"_type":"htmlBlock","html":"\u003cstyle\u003e\n@media (max-width: 769px){\n.highlightcard-font-18 {\n font-size: 21px !important;\n}\n}\n\u003c/style\u003e","_key":"e2b19bc7-d527-42ba-a981-eb29732f7f65","displayOption":""}],"goToTopText":"TOP","copyrightNoticeAsString":"\u003cdiv\u003eCopyright 2024 Takeda Pharmaceutical Company Limited. All rights reserved.\u003cbr\u003e\u003cbr\u003e\u003ca href=\"https://www.top-employers.com/en/globalcompanyprofiles/takeda-global/\"\u003eCertified Top Employer\u003c/a\u003e\u003c/div\u003e","footerLinks":[{"_type":"linkItem","href":"/en-us/terms-of-use/?epslanguage=en-US","text":"Terms of Use","_key":"8d53be97-f94b-4d56-9820-b6fdd0d3adad","target":"_blank"},{"_key":"bd2d6894-e452-465a-8180-f7ad4ad7eda1","target":"_blank","_type":"linkItem","href":"/link/f14a80e4a53c4fdbaf012a2e57198ee9.aspx?epslanguage=en","text":"Privacy Notice"},{"_type":"linkItem","href":"/en-us/who-we-are/contact-us/","text":"CONTACT US","_key":"ebcd8de8-c046-44a3-aea5-477810e2fc4d","title":"CONTACT US"},{"href":"/en-us/patents/","text":"PATENTS","_key":"6995110a-4d9a-4daa-a068-b181dff3c92f","title":"US Patents","_type":"linkItem"},{"text":"Accessibility Statement","_key":"c7b2ddcf-5bab-448c-b26c-c72ab8cd2f57","title":"Accessibility Statement","target":"_blank","_type":"linkItem","href":"/accessibility-statement/?lang=en"},{"_type":"linkItem","href":"/cookie-policy/","text":"Cookie Policy","_key":"378891bb-33b6-4159-938c-026a3b49bbb4"}],"socialMediaText":"Connect with us:","footerBlocks":[{"_type":"countrySelectorLinkBlock","link":"/worldwide/","linkText":"United States","_key":"9ea9b143-79ca-433c-9d13-2982d21221a1","flagUrl":{"_type":"imageFile","_key":"43aee4ae-971d-4b37-9d3a-655db587be9b","url":{"height":650,"created_at":"2022-09-09T10:44:14Z","url":"http://assets-dam.takeda.com/image/upload/v1675248795/legacy-dotcom/siteassets/en-us/us.png","width":1235,"format":"png","version":1675248795,"resource_type":"image","secure_url":"https://assets-dam.takeda.com/image/upload/v1675248795/legacy-dotcom/siteassets/en-us/us.png","public_id":"legacy-dotcom/siteassets/en-us/us","_key":"148f3768-16c4-4117-93ed-3cbe180b01c3","type":"upload","_version":1,"bytes":12815,"_type":"cloudinary.asset"},"excludeFromSearch":false,"blurDataUrl":"data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAFBAMAAACOSmBbAAAAFVBMVEVYVoLWiZPgp67Qd4KIh6bLdYKGhKQqMms9AAAAIElEQVQI12NgYAg2NmZgYBAUFGRIcVFSUgKxgGxjEAAALXYDT8yJoTAAAAAASUVORK5CYII="}},{"_type":"htmlBlock","html":"\u003cscript\u003e\nvar x = document.querySelectorAll(\".secondary \u003e label\"); \nif (x.length\u003e1) {\nfor (i =1; i \u003c x.length; i++) {\nx[i].style.display = \"none\";\n}\n}\n\u003c/script\u003e","_key":"a16521b8-9171-4ccc-9f31-4e450c062bab","displayOption":""},{"_key":"2c0ddab5-0f16-4215-a9b2-e2c19cb64d31","displayOption":"","customCssClass":"","layout":"","backgroundColor":"Transparent","contentAsString":"\u003cdiv\u003e\n\n\u003c/div\u003e","_type":"richTextBlock"},{"_type":"htmlBlock","html":"\u003cscript\u003e\nvar accessibilityMobileLink = document.getElementsByClassName('accessbility-mobile-link') [0]; \nif ( accessibilityMobileLink) {\n\taccessibilityMobileLink.style.backgroundColor = \"white\";\n}\n\u003c/script\u003e","_key":"72f27c9a-630f-45e8-9644-8e69f5f47490","displayOption":""}],"_key":"4c98b960-595c-4267-a65c-b503b165e721","_type":"footerBlock","pageCodeLabel":"","followUsLinks":[{"url":"https://www.linkedin.com/company/takeda-pharmaceuticals/","network":"Linkedin","targetGroup":"Journalists"},{"network":"Twitter","targetGroup":"Journalists","url":"https://twitter.com/TakedaPharma"}]}],"showNewInLanguages":"","hideFooter":false},"pageData":{"hideSocialSharingButtons":false,"heading":"","partialPageThumbnailAlt":"","partialPageHeading":"","shortUrl":"https://bit.ly/3Ht7l58","contentFolderWasParent":false,"releaseDate":"2021-11-24T13:04:25+00:00","language":"en-US","friendlyUrl":{"_key":"08d6dcc9-e495-45ab-a837-e142bab86d20","current":"/en-us/corporate-responsibility/ethics-and-compliance/","_type":"slug"},"partialPageThumbnail":{"excludeFromSearch":false,"_type":"imageFile","_key":"7fe09229-06a2-4c3f-9939-0f2827a39385","url":{"url":"http://assets-dam.takeda.com/image/upload/v1663763507/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/patients/ethics--compliance_callout.jpg","_type":"cloudinary.asset","resource_type":"image","height":180,"bytes":16833,"format":"jpg","secure_url":"https://assets-dam.takeda.com/image/upload/v1663763507/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/patients/ethics--compliance_callout.jpg","created_at":"2022-09-09T12:02:26Z","public_id":"legacy-dotcom/siteassets/en-us/home/corporate-responsibility/patients/ethics--compliance_callout","_version":1,"_key":"d6a968f8-60f3-418d-af82-019e44fc25ae","version":1663763507,"type":"upload","width":320},"blurDataUrl":"data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAGCAMAAADNLv/0AAAAdVBMVEX28uyms7htdHV0YV2vvMG7yc21w8gGFCwLGjNRS0x/bGjJvbo8SV+opqgrLDgYKEPj4+DOy8kHDx6tq6+Tn6WJucWFsL1FZnq1pKAHH0JKOCyooqOjcFWOkJlOVGqDfomLenfRtqmEZ2BcWWLfzcIaJTnLpJDEx9oNAAAAQklEQVQI1w3BBQKAIAAEsKMb7A7M/z9RN7QdnQxtCBfoPVusnYkU0Doys61DLaHUmKLfXeBQOpkzB1cWqJ7rPW78PmjNA3bE9l1LAAAAAElFTkSuQmCC"},"_createdAt":"2021-11-16T21:22:50Z","hideHeader":false,"_type":"sectionPage","partialPageCallToActionText":"Learn more","childSortOrder":"createdDescending","mainContentArea":[{"_type":"richTextBlock","_key":"1532e8b6-b84f-4505-9f1c-afb583e9b7a3","displayOption":"full","customCssClass":"","layout":"","backgroundColor":"Transparent","contentAsString":"\u003ch2\u003eOur Culture of Ethics and Compliance\u003c/h2\u003e\n\u003cp\u003eTakeda is a global, values-based, R\u0026amp;D-driven biopharmaceutical leader committed to discovering and delivering life-transforming treatments, and committed to patients, our people and the planet. We’re guided by our values of Takeda-ism, which incorporate Integrity, Fairness,\u0026nbsp;Honesty and Perseverance, with Integrity at the core. They’re brought to life through actions based on Patient-Trust-Reputation-Business.\u003c/p\u003e\n\u003cp\u003eA culture of ethics and compliance is born out of this foundation and shapes the decisions we make and the actions that we take as Takeda employees. Please view the \u003ca rel=\"noopener\" target=\"_blank\" href=\"https://www.takeda.com/who-we-are/global-ethics-compliance/\" title=\"Takeda Global Code of Conduct\"\u003eTakeda Global Code of Conduct\u003c/a\u003e for more information.\u003c/p\u003e\n\u003cp\u003eTo report a suspected violation, please call \u003cspan class=\"red-text\"\u003e1-888-TAKEDA-0 (1-888-825-3320)\u003c/span\u003e or make an online report via \u003ca rel=\"noopener\" target=\"_blank\" href=\"https://secure.ethicspoint.com/domain/media/en/gui/28267/index.html\" title=\"EthicsPoint\"\u003eEthicsPoint\u003c/a\u003e.\u003c/p\u003e","content":null},{"displayOption":"full","customCssClass":"","items":[{"_key":"1dbcf3b1-6fa4-42f8-8238-3ac6ebb3cea8","subheading":"","bodyAsString":"\u003cp\u003ePursuant to the Consumer Product Safety Improvement Act (CPSIA), manufacturers of imported or domestically manufactured (U.S.A.) prescription drug products that are subject to a consumer product safety rule, ban, standard or regulation enforced by the U.S. Consumer\u0026nbsp;Product Safety Commission (CPSC) are required to provide General Certificates of Conformity (GCC).\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eTakeda manufactures prescription drug products that are governed under the CPSC regulations. The Takeda GCC certifies that the product (the child-resistant package) complies with the Poison Prevention Packaging Act (PPPA) requirements for special packaging under 16 CFR §\u0026nbsp;1700.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eThe GCCs are maintained to reflect additions of new products and existing product changes. Please see \u003ca rel=\"noopener\" target=\"_blank\" href=\"https://www.cpsc.gov/\" title=\"cpsc.gov\"\u003eCPSC regulations\u003c/a\u003e for further information and see product-specific GCC listings below.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003ctable border=\"0\" style=\"width: 864px; height: 456px;\" class=\"takeda__table--striped\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 210px;\"\u003e\u003cstrong\u003eName\u003c/strong\u003e\u003c/td\u003e\n\u003ctd style=\"width: 240px;\"\u003e\u003cstrong\u003eDosage\u003c/strong\u003e\u003c/td\u003e\n\u003ctd style=\"width: 100px;\"\u003e\u003cstrong\u003eType\u003c/strong\u003e\u003c/td\u003e\n\u003ctd\u003e\u003cstrong\u003ePrescribing Information\u003c/strong\u003e\u003c/td\u003e\n\u003c/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 210px;\"\u003e\u003cstrong\u003e\u003ca href=\"https://assets-dam.takeda.com/raw/upload/v1662724750/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/cpsia/TGCC_Actos_Pioglitzone_30ct_btl_15mg_30mg_45mg.pdf\"\u003eACTOS (pioglitazone)\u003c/a\u003e\u003c/strong\u003e\u003c/td\u003e\n\u003ctd style=\"width: 240px;\"\u003e\n\u003cp\u003e30ct bottle, 15mg tablet\u003cbr\u003e30ct bottle, 30mg tablet\u003cbr\u003e30ct bottle, 45mg tablet\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd style=\"width: 100px;\"\u003eTablet\u003c/td\u003e\n\u003ctd\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"http://general.takedapharm.com/content/file/pi.pdf?filetypecode=actospi\"\u003e\u003cstrong\u003eClick here for Prescribing Information including boxed warning and medication guide\u003c/strong\u003e\u003c/a\u003e\u003c/td\u003e\n\u003c/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 210px;\"\u003e\u003cstrong\u003e\u003ca href=\"https://assets-dam.takeda.com/raw/upload/v1662724751/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/cpsia/TGCC_ActoPlus_MET_60ct_btl_15mg-500mg_15mg-850mg.pdf\"\u003eACTO\u003cem\u003eplus\u003c/em\u003e met (pioglitazone and metformin HCI)\u003c/a\u003e\u003c/strong\u003e\u003c/td\u003e\n\u003ctd style=\"width: 240px;\"\u003e\n\u003cp\u003e60ct bottle, 15mg/500mg tablet\u003cbr\u003e60ct bottle, 15mg/850mg tablet\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd style=\"width: 100px;\"\u003eTablet\u003c/td\u003e\n\u003ctd\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"http://general.takedapharm.com/content/file/pi.pdf?filetypecode=actoplusmetpi\"\u003e\u003cstrong\u003eClick here for Prescribing Information including boxed warning and medication guide\u003c/strong\u003e\u003c/a\u003e\u003c/td\u003e\n\u003c/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 210px;\"\u003e\n\u003cp\u003e\u003ca href=\"https://assets-dam.takeda.com/raw/upload/v1662724752/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/cpsia/TGCC_ActoPlus_MET_XR_30ct_btl_15mg-1000mg_30mg-1000mg.pdf\"\u003eACTO\u003cem\u003eplus\u003c/em\u003e met XR (pioglitazone and metformin HCI) (extended release)\u003c/a\u003e\u003cbr\u003e\u003csmall\u003e(Discontinued)\u003c/small\u003e\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd style=\"width: 240px;\"\u003e\n\u003cp\u003e30ct bottle, 15mg/1000mg tablet\u003cbr\u003e30ct bottle, 30mg/1000mg tablet\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd style=\"width: 100px;\"\u003eTablet\u003c/td\u003e\n\u003ctd\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"http://general.takedapharm.com/content/file/pi.pdf?filetypecode=ACTOPLUSMETXRPI\"\u003e\u003cstrong\u003eClick here for Prescribing Information including boxed warning and medication guide\u003c/strong\u003e\u003c/a\u003e\u003c/td\u003e\n\u003c/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 210px;\"\u003e\u003cstrong\u003e\u003ca href=\"https://assets-dam.takeda.com/raw/upload/v1662724753/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/cpsia/TGCC_Colcrys_30ct_btl_0.6mg.pdf\"\u003eCOLCRYS (colchicine)\u003c/a\u003e\u003c/strong\u003e\u003c/td\u003e\n\u003ctd style=\"width: 240px;\"\u003e\n\u003cp\u003e30ct bottle, 0.6mg tablet\u003cbr\u003e100ct bottle, 0.6mg tablet\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd style=\"width: 100px;\"\u003eTablet\u003c/td\u003e\n\u003ctd\u003e\u003cstrong\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"http://general.takedapharm.com/content/file.aspx?filetypecode=COLCRYSPI\"\u003eClick here for Prescribing Information including medication guide\u003c/a\u003e\u003c/strong\u003e\u003c/td\u003e\n\u003c/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 210px;\"\u003e\u003cstrong\u003e\u003ca href=\"https://assets-dam.takeda.com/raw/upload/v1662724754/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/cpsia/TGCC_Dexilant_5ct_btl_60mg_30ct_btl_30mg_60mg_90ct_btl_30mg_60mg.pdf\"\u003eDEXILANT (dexlansoprazole)\u003c/a\u003e\u003c/strong\u003e\u003c/td\u003e\n\u003ctd style=\"width: 240px;\"\u003e\n\u003cp\u003e5ct bottle, 30mg capsule\u003cbr\u003e5ct bottle, 60mg capsule\u003cbr\u003e30ct bottle, 30mg capsule\u003cbr\u003e30ct bottle, 60mg capsule\u003cbr\u003e90ct bottle, 60mg capsule\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd style=\"width: 100px;\"\u003eCapsule\u003c/td\u003e\n\u003ctd\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"http://general.takedapharm.com/content/file/pi.pdf?filetypecode=DEXILANTPI\"\u003e\u003cstrong\u003e\u003cbr\u003e\u003c/strong\u003e\u003cstrong\u003eClick here for Prescribing Information including medication guide\u003c/strong\u003e\u003c/a\u003e\u003c/p\u003e\n\u003c/td\u003e\n\u003c/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 210px;\"\u003e\u003cstrong\u003e\u003ca href=\"https://assets-dam.takeda.com/raw/upload/v1662724755/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/cpsia/TGCC_DuetAct_30ct_btl_30mg-2mg_30mg-4mg.pdf\"\u003e\u003cem\u003eDue\u003c/em\u003etact (pioglitazone and glimepiride)\u003c/a\u003e\u003c/strong\u003e\u003c/td\u003e\n\u003ctd style=\"width: 240px;\"\u003e\n\u003cp\u003e30ct bottle, 30mg/2mg tablet\u003cbr\u003e30ct bottle, 30mg/4mg tablet\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd style=\"width: 100px;\"\u003eTablet\u003c/td\u003e\n\u003ctd\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"http://general.takedapharm.com/content/file/pi.pdf?filetypecode=duetactpi\"\u003e\u003cstrong\u003eClick here for Prescribing Information including boxed warning and medication guide\u003c/strong\u003e\u003c/a\u003e\u003c/td\u003e\n\u003c/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 210px;\"\u003e\u003cstrong\u003e\u003ca href=\"https://assets-dam.takeda.com/raw/upload/v1662724756/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/cpsia/TGCC_Kazano_60ct_bottle_12.5mg-500mg.pdf\"\u003eKAZANO (alogliptin and metformin HCI)\u003c/a\u003e\u003c/strong\u003e\u003c/td\u003e\n\u003ctd style=\"width: 240px;\"\u003e\n\u003cp\u003e60ct bottle, 12.5mg/500mg tablet\u003cbr\u003e60ct bottle, 12.5mg/1000mg tablet\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd style=\"width: 100px;\"\u003eTablet\u003cbr\u003e\u003cbr\u003e\u003c/td\u003e\n\u003ctd\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"http://general.takedapharm.com/content/file/pi.pdf?FileTypeCode=KAZANOPI\"\u003e\u003cstrong\u003eClick here for Prescribing Information including boxed warning and medication guide\u003c/strong\u003e\u003c/a\u003e\u003c/td\u003e\n\u003c/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 210px;\"\u003e\u003cstrong\u003e\u003ca href=\"https://assets-dam.takeda.com/raw/upload/v1662724757/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/cpsia/TGCC_Nesina_30ct_btl_6.25mg_12.5mg _25mg.pdf\"\u003eNESINA (alogliptin)\u003c/a\u003e\u003c/strong\u003e\u003c/td\u003e\n\u003ctd style=\"width: 240px;\"\u003e\n\u003cp\u003e30ct bottle, 12.5mg tablet\u003cbr\u003e30ct bottle, 25mg tablet\u003cbr\u003e30ct bottle, 6.25mg tablet\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd style=\"width: 100px;\"\u003eTablet\u003c/td\u003e\n\u003ctd\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"http://general.takedapharm.com/content/file/pi.pdf?FileTypeCode=NESINAPI\"\u003e\u003cstrong\u003eClick here for Prescribing Information including medication guide\u003c/strong\u003e\u003c/a\u003e\u003c/td\u003e\n\u003c/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 210px;\"\u003e\u003cstrong\u003e\u003ca href=\"https://assets-dam.takeda.com/raw/upload/v1662724758/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/cpsia/TGCC_Oseni_30ct_btl_12.5mg-15mg_12.5mg-30mg_12.5mg-45mg_25mg-15mg_25mg-30mg_25mg-45mg.pdf\"\u003eOSENI (alogliptin and pioglitazone)\u003c/a\u003e\u003c/strong\u003e\u003c/td\u003e\n\u003ctd style=\"width: 240px;\"\u003e\n\u003cp\u003e30ct bottle, 12.5mg/15mg tablet\u003cbr\u003e30ct bottle, 12.5mg/30mg tablet\u003cbr\u003e30ct bottle, 12.5mg/45mg tablet\u003cbr\u003e30ct bottle, 25mg/15mg tablet\u003cbr\u003e30ct bottle, 25mg/30mg tablet\u003cbr\u003e30ct bottle, 25mg/45mg tablet\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd style=\"width: 100px;\"\u003eTablet\u003c/td\u003e\n\u003ctd\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"http://general.takedapharm.com/content/file/pi.pdf?filetypecode=OSENIPI\"\u003e\u003cstrong\u003eClick here for Prescribing Information including boxed warning and medication guide\u003c/strong\u003e\u003c/a\u003e\u003c/td\u003e\n\u003c/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 210px;\"\u003e\u003cstrong\u003e\u003ca href=\"https://assets-dam.takeda.com/raw/upload/v1662724759/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/cpsia/TGCC_Prevacid_15mg_30ct_30mg_100ct.pdf\"\u003ePREVACID (lansoprazole)\u003c/a\u003e\u003c/strong\u003e\u003c/td\u003e\n\u003ctd style=\"width: 240px;\"\u003e\n\u003cp\u003e30ct bottle, 15mg capsule \u003cbr\u003e100ct bottle, 30mg capsule\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd style=\"width: 100px;\"\u003eCapsule\u003c/td\u003e\n\u003ctd\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"http://general.takedapharm.com/content/file/pi.pdf?filetypecode=PREVACIDPI\"\u003e\u003cstrong\u003eClick here for Prescribing Information including medication guide\u003c/strong\u003e\u003c/a\u003e\u003c/td\u003e\n\u003c/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 210px;\"\u003e\u003cstrong\u003e\u003ca href=\"https://assets-dam.takeda.com/raw/upload/v1662724760/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/cpsia/TGCC_Rozerm_30ct_btl_8mg_100ct_btl_8mg.pdf\"\u003eROZEREM (ramelteon)\u003c/a\u003e\u003c/strong\u003e\u003c/td\u003e\n\u003ctd style=\"width: 240px;\"\u003e\n\u003cp\u003e30ct bottle, 8mg tablet\u003cbr\u003e100ct bottle, 8mg tablet\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd style=\"width: 100px;\"\u003eTablet\u003c/td\u003e\n\u003ctd\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"http://general.takedapharm.com/content/file/pi.pdf?filetypecode=rozerempi\"\u003e\u003cstrong\u003eClick here for Prescribing Information including medication guide\u003c/strong\u003e\u003c/a\u003e\u003c/td\u003e\n\u003c/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 210px;\"\u003e\u003cstrong\u003e\u003ca href=\"https://assets-dam.takeda.com/raw/upload/v1662724760/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/cpsia/TGCC_Trintellix_7ct_btl_5mg_10mg_30ct_btl_5mg_20mg.pdf\"\u003eTRINTELLIX (vortioxetine)\u003c/a\u003e\u003c/strong\u003e\u003c/td\u003e\n\u003ctd style=\"width: 240px;\"\u003e\n\u003cp\u003e7ct bottle, 5mg tablet\u003cbr\u003e7ct bottle, 10mg tablet\u003cbr\u003e30ct bottle, 5mg tablet\u003cbr\u003e30ct bottle, 10mg tablet\u003cbr\u003e30ct bottle, 20mg tablet\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd style=\"width: 100px;\"\u003eTablet\u003c/td\u003e\n\u003ctd\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"http://general.takedapharm.com/content/file/pi.pdf?filetypecode=TRINTELLIXPI\"\u003e\u003cstrong\u003eClick here for Prescribing Information including boxed warning and medication guide\u003c/strong\u003e\u003c/a\u003e\u003c/td\u003e\n\u003c/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 210px;\"\u003e\u003cstrong\u003e\u003ca href=\"https://assets-dam.takeda.com/raw/upload/v1662724761/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/cpsia/TGCC_Uloric_7ct_btl_40mg_80mg_30ct_btl_40mg_80mg.pdf\"\u003eULORIC (febuxostat)\u003c/a\u003e\u003c/strong\u003e\u003c/td\u003e\n\u003ctd style=\"width: 240px;\"\u003e\n\u003cp\u003e7ct bottle, 40mg tablet\u003cbr\u003e7ct bottle, 80mg tablet\u003cbr\u003e30ct bottle, 40mg tablet\u003cbr\u003e30ct bottle, 80mg tablet\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd style=\"width: 100px;\"\u003eTablet\u003c/td\u003e\n\u003ctd\u003e\u003cstrong\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"http://general.takedapharm.com/content/file/pi.pdf?filetypecode=ULORICPI\"\u003eClick here for Prescribing Information including boxed warning and medication guide\u003c/a\u003e\u003c/strong\u003e\u003c/td\u003e\n\u003c/tr\u003e\n\u003c/tbody\u003e\n\u003c/table\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eACTOS®, ACTOPLUS MET® and DUETACT® are registered trademarks of Takeda Pharmaceutical Company Limited.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eCOLCRYS® is a registered trademark of Takeda Pharmaceuticals U.S.A., Inc.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eDEXILANT® and the DEXILANT Logo® are registered trademarks of Takeda Pharmaceuticals U.S.A., Inc.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eKAZANO® is a registered trademark of Takeda Pharmaceutical Company Limited.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eNESINA® is a registered trademark of Takeda Pharmaceutical Company Limited.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eOSENI® is a registered trademark of Takeda Pharmaceutical Company Limited.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003ePREVACID® is a registered trademark of Takeda Pharmaceuticals U. S. A., Inc.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eROZEREM® is a registered trademark of Takeda Pharmaceutical Company Limited.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eTRINTELLIX® is a registered trademark of H. Lundbeck A/S and used under license by Takeda Pharmaceuticals America, Inc.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eULORIC® is a registered trademark of Teijin Kabushiki Kaisha (Teijin Limited), used under license.\u003c/p\u003e\n\u003chr\u003e","heading":"Consumer Product Safety Improvement Act (CPSIA)","showExpanded":false,"_type":"accordionItem"},{"_type":"accordionItem","_key":"eb3ed475-4845-4ba0-a192-8e97cdbd2b4d","subheading":"","bodyAsString":"\u003ch3\u003eEthical Participation in Federal Health Care Programs\u003c/h3\u003e\n\u003cp\u003eTakeda is committed to being a lawful, compliant, and ethical participant in the federal health care programs. Many federal and state laws,\u0026nbsp;regulations, and other legal requirements, including the federal False Claims Act, have been created to prevent and help detect fraud, waste,\u0026nbsp;and abuse in federal health care programs.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eTakeda complies with any such applicable requirements in full, and has developed various policies and procedures for detecting and preventing fraud, waste and abuse. Takeda maintains a Corporate Ethics \u0026amp; Compliance program, which includes a Code of Conduct, policies\u0026nbsp;and procedures for detecting and preventing fraud, waste and abuse, a monitoring program and a Compliance Hotline/Helpline. Please\u0026nbsp;contact Ethics \u0026amp; Compliance for more information at \u003ca href=\"mailto:USBUCompliance@takeda.com\"\u003eUSBUCompliance@takeda.com\u003c/a\u003e.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003chr\u003e","heading":"Federal Disclosures","showExpanded":false},{"heading":"Lobbying \u0026 Political Contributions","showExpanded":false,"_type":"accordionItem","_key":"631fae80-618f-46b3-84c4-97dd949b6596","subheading":"","bodyAsString":"\u003cp\u003eTakeda is a global, values-based, R\u0026amp;D-driven biopharmaceutical leader with a large U.S. presence. We connect to our 240-year-old history\u0026nbsp;and Japanese heritage through everything we do. Our unwavering commitment to putting patients first guides our scientific discovery and\u0026nbsp;helps us as we strive to address unmet medical needs. As Takeda’s U.S. operations are integral to our global business, it’s important for\u0026nbsp;Takeda to have appropriate engagement opportunities with U.S. policymakers and policy influencers.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eThe U.S. government accounts for nearly half of all U.S. health care spending, and its policies, legislation, and regulations impact the entire\u0026nbsp;health care system. In order to ensure that Takeda’s point of view is considered by policymakers in critical debates affecting our products and therapeutic areas, we must provide a regular stream of information over time to educate elected officials on both sides of the aisle.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003ch2\u003eLobbying Activities\u003c/h2\u003e\n\u003cp\u003eElected officials have an impact on public policy issues affecting Takeda and the patients we serve. We believe that public policy engagement is an important and appropriate role for companies when conducted in a legal and transparent manner. In the U.S., there are important\u0026nbsp;federal and state lobbying registration and disclosure laws with which Takeda complies.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eWhere required, Takeda reports lobbying activity at state and federal levels. Takeda files quarterly lobbying reports that capture federal\u0026nbsp;lobbying activity in the Congress and with any federal agencies. Takeda’s reports can be found by searching the \u003ca rel=\"noopener\" target=\"_blank\" href=\"https://lobbyingdisclosure.house.gov/\" title=\"lobbyingdisclosure.house.gov\"\u003eCongressional lobby disclosure website\u003c/a\u003e.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003ch2\u003eTrade Associations\u003c/h2\u003e\n\u003cp\u003eTakeda is a member of several industry and trade groups that represent both the pharmaceutical industry and the business community at\u0026nbsp;large in an effort to bring about consensus on broad policy issues that can impact Takeda’s business objectives and ability to serve patients. Takeda’s participation as a member of these various industry and trade groups comes with the understanding that we may not always agree\u0026nbsp;with the positions of the larger organization and/or other members, and that we are committed to voicing our concerns as appropriate\u0026nbsp;through our colleagues who serve on the boards and committees of these groups. We disclose our \u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1722434769/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/US_Trade_Associations_over_25k.pdf\"\u003ecurrent memberships in the U.S.\u003c/a\u003e where\u0026nbsp;annual dues are more than $25,000.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003ch2\u003ePolitical Contributions\u003c/h2\u003e\n\u003cp\u003eIn the U.S., Takeda is committed to supporting candidates of any party using fair and objective criteria in the selection of candidates −\u0026nbsp;including those who support public policies that contribute to the health needs of our patients, pharmaceutical innovation, and the interests\u0026nbsp;of our company. This support comes from two different sources: Takeda’s Political Action Committee (TakPAC) and from corporate funds\u0026nbsp;where legally allowed.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eTakPAC is a separate, segregated fund registered with the Federal Election Commission and connected to Takeda Pharmaceuticals America,\u0026nbsp;Inc. as a Lobbyist/Registrant PAC. The purpose of TakPAC is to provide monetary contributions and other support to candidates for federal,\u0026nbsp;state, and local offices. Employee participation in TakPAC is completely voluntary, all contribution guidelines are only suggestions, and\u0026nbsp;employees are free to contribute more or less than the guidelines or nothing at all. Takeda will neither favor nor disadvantage any employee by reason of the amount of his or her contribution or decision not to contribute. Employees may refuse to contribute without reprisal.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eTakPAC activity reports are filed monthly with additional reporting requirements during an election year. TakPAC’s reports are available on the \u003cspan style=\"text-decoration: underline;\"\u003e\u003ca href=\"https://www.fec.gov\"\u003eFederal Election Commission’s website\u003c/a\u003e\u003c/span\u003e, and a list of all PAC contributions is included in the TakPAC Annual Report:\u003c/p\u003e\n\u003cul\u003e\n \u003cli\u003e\u003cstrong\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1722434945/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/TAKEDA_2023_Annual_Report_TakPAC.pdf\"\u003e\u003cspan style=\"position: relative;\" class=\"chevron-after\"\u003e\u003cspan style=\"text-decoration: underline;\"\u003e2023 TakPAC ANNUAL REPORT\u003c/span\u003e\u003c/span\u003e\u003c/a\u003e\u003c/strong\u003e\u003c/li\u003e\n \u003cli\u003e\u003cstrong\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1691773715/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/2022_Annual_Report_TakPAC.pdf\"\u003e\u003cspan style=\"position: relative;\" class=\"chevron-after\"\u003e\u003cspan style=\"text-decoration: underline;\"\u003e2022 TakPAC ANNUAL REPORT\u003c/span\u003e\u003c/span\u003e\u003c/a\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/raw/upload/v1675187316/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/2021-takpac-annual-report.pdf\"\u003e\u003cspan style=\"position: relative;\" class=\"chevron-after\"\u003e\u003cspan style=\"text-decoration: underline;\"\u003e2021 TakPAC ANNUAL REPORT\u003c/span\u003e\u003c/span\u003e\u003c/a\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/raw/upload/v1675187316/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/2020-takpac-annual-report.pdf\"\u003e\u003cspan style=\"position: relative;\" class=\"chevron-after\"\u003e\u003cspan style=\"text-decoration: underline;\"\u003e2020 TakPAC ANNUAL REPORT\u003c/span\u003e\u003c/span\u003e\u003c/a\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003cli\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/raw/upload/v1662724969/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/takeda_2019-annual-report_public.pdf\"\u003e\u003cspan style=\"position: relative;\" class=\"chevron-after\"\u003e2019 TakPAC ANNUAL REPORT\u003c/span\u003e\u003c/a\u003e\u003c/strong\u003e\u003c/span\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eIn some states, corporations are allowed to give directly to candidates in accordance with state campaign finance law. Takeda chooses to\u0026nbsp;make contributions in some of these states, and discloses these contributions annually:\u003c/p\u003e\n\u003cul\u003e\n \u003cli\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1722435027/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/2023_State_Corporate_Political_Contributions.pdf\"\u003e\u003cspan style=\"position: relative;\" class=\"chevron-after\"\u003eTAKEDA’S 2023 CORPORATE CONTRIBUTIONS\u003c/span\u003e\u003c/a\u003e\u003c/strong\u003e\u003c/span\u003e\u003c/li\u003e\n \u003cli\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1691773708/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/2022_USPA_Corporate_Contributions.pdf\"\u003e\u003cspan style=\"position: relative;\" class=\"chevron-after\"\u003eTAKEDA’S 2022 CORPORATE CONTRIBUTIONS\u003c/span\u003e\u003c/a\u003e\u003c/strong\u003e\u003c/span\u003e\u003c/li\u003e\n\u003cli\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/raw/upload/v1675187316/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/2021-corporate-contributions.pdf\"\u003e\u003cspan style=\"position: relative;\" class=\"chevron-after\"\u003eTAKEDA’S 2021 CORPORATE CONTRIBUTIONS\u003c/span\u003e\u003c/a\u003e\u003c/strong\u003e\u003c/span\u003e\u003c/li\u003e\n\u003cli\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/raw/upload/v1675187315/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/2020-corporate-contributions.pdf\"\u003e\u003cspan style=\"position: relative;\" class=\"chevron-after\"\u003eTAKEDA’S 2020 CORPORATE CONTRIBUTIONS\u003c/span\u003e\u003c/a\u003e\u003c/strong\u003e\u003c/span\u003e\u003c/li\u003e\n\u003cli\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/raw/upload/v1662724972/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/2019-takeda-us-corporate-contributions.pdf\"\u003e\u003cspan style=\"position: relative;\" class=\"chevron-after\"\u003eTAKEDA’S 2019 CORPORATE CONTRIBUTIONS\u003c/span\u003e\u003c/a\u003e\u003c/strong\u003e\u003c/span\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003chr\u003e"},{"bodyAsString":"\u003ch3\u003eOpen Payments Act\u003c/h3\u003e\n\u003cp\u003eTakeda is committed to improving health for people worldwide through innovation in medicine. We recognize the important contributions of valuable insight, expertise, and feedback that health care professionals (\"HCPs\") provide to us in support of this mission.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eSection 6002 of the Patient Protection and Affordable Care Act, commonly known as the Open Payments Act or the Sunshine Act, requires pharmaceutical manufacturers, including Takeda, to track “transfers of value” provided to actively-licensed U.S. HCPs and Teaching Hospitals (collectively described as “Covered Recipients”) and to submit an annual report detailing such transactions to the Center for Medicare and Medicaid Services by March 31st each year for the prior calendar year.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003ch4\u003eReport Information\u003c/h4\u003e\n\u003cp\u003eIt is helpful to understand that there are two reporting submission templates provided by the Centers for Medicare and Medicaid Services\u0026nbsp;(CMS) for reporting transfers of value under the Open Payments Act: General Payments and Research Payments. Takeda will report transfers of value in these areas based on the type of interaction conducted with Covered Recipients and the statutory definitions. Transfers of value to Covered Recipients that do not meet the Open Payments Act definition of Research will be submitted on the General Payments template\u0026nbsp;with a corresponding payment nature per the statutory requirements.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eFor 2021 spend, Takeda is required to report transfers of value to Covered Recipients provided by, or on behalf of, Takeda, including fees/reimbursable expenses that are individually greater than $11.05 or cumulatively greater than $110.40.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eIt is important to note that Research payments will appear as aligned both with the entity receiving the payment and the principal investigator(s) for the clinical trial.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eSome additional examples of reportable transfers of value are listed below:\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eProfessional Services:\u003c/strong\u003e Including payments for advisory boards, consulting services, or promotional speaking\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eEducational Materials:\u003c/strong\u003e Including certain reference materials such as journal articles and textbooks\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eBusiness Meals:\u003c/strong\u003e Including Takeda-provided or reimbursed meals in conjunction with professional services or recruiting\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eBusiness Travel:\u003c/strong\u003e Including Takeda provided or reimbursed amounts for transportation (e.g., airfare, hotel, taxi)\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003ch4\u003eCollaboration\u003c/h4\u003e\n\u003cp\u003eTakeda values working with Covered Recipients and we believe such collaboration is critical to deliver better health and a brighter future to patients we serve.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003ch4\u003eAdditional Information about Open Payments\u003c/h4\u003e\n\u003cp\u003eTo learn more about the Open Payments Act, please visit the CMS \u003ca rel=\"noopener\" target=\"_blank\" href=\"https://www.cms.gov\" title=\"www.cms.gov\"\u003ewebsite\u003c/a\u003e.\u003c/p\u003e\n\u003ch4\u003e\u0026nbsp;\u003c/h4\u003e\n\u003ch4\u003eQuestions\u003c/h4\u003e\n\u003cp\u003eIf you have any questions concerning this matter, please do not hesitate to contact us at \u003ca href=\"mailto:SunshineActQuestions@takeda.com\"\u003eSunshineActQuestions@takeda.com\u003c/a\u003e.\u003c/p\u003e","heading":"Open Payments Act Disclosures","showExpanded":false,"_type":"accordionItem","_key":"d1c4ddfb-edfb-4fab-bb9b-8e753c1c0ff4","subheading":""},{"bodyAsString":"\u003ch3 id=\"statecompliance\"\u003eState Compliance\u003c/h3\u003e\n\u003cp\u003eCompliance with state law requirements is an important feature of Takeda’s Ethics \u0026amp; Compliance Program. Click the links below for information relating to our state compliance efforts.\u003c/p\u003e\n\u003cp\u003eYou can view our California Annual Comprehensive Compliance Program Declaration by clicking the button below.\u003c/p\u003e\n\u003cp style=\"padding-top:20px;\"\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/state/ca/State_of_California.pdf\"\u003e\u003cbutton style=\"font-size: 18px; color: white; background-color: #34373f; padding: 15px 32px;\"\u003e\u003cspan style=\"position: relative;\" class=\"chevron-after\"\u003eGO NOW\u003c/span\u003e\u003c/button\u003e\u003c/a\u003e\u003c/p\u003e","heading":"California State Commercial Disclosure","showExpanded":false,"_type":"accordionItem","_key":"9ef0e50b-c2bd-4ef1-be7e-2142419d9e87","subheading":""},{"_key":"5cdc7eac-4eff-40dd-9e95-430cd6cea462","subheading":"","bodyAsString":"\u003cdiv style=\"column-count: 4;\"\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299129/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Adderall_XR.pdf\" title=\"CO - Adderall XR\"\u003eAdderall XR\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299130/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Advate.pdf\" title=\"CO Advate\"\u003eAdvate\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299131/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Adynovate.pdf\" title=\"CO - Adynovate\"\u003eAdynovate\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299132/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Adzynma.pdf\" title=\"CO - Adzynma\"\u003eAdzynma\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299133/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Agrylin.pdf\" title=\"CO - Agrylin\"\u003eAgrylin\u003c/a\u003e\u003c/p\u003e\n \u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730921472/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Alunbrig.pdf\" title=\"CO - Alunbrig\"\u003eAlunbrig\u003c/a\u003e\u003c/p\u003e\n \u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299134/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Amitiza.pdf\" title=\"CO - Amitiza\"\u003eAmitiza\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/state/CO_Aralast_NP_Product_Form.pdf\" title=\"CO - Aralast NP\"\u003eAralast NP\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299136/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Carbatrol.pdf\" title=\"CO - Carbatrol\"\u003eCarbatrol\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299137/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Ceprotin.pdf\" title=\"CO - Ceprotin\"\u003eCeprotin\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299139/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Cinryze.pdf\" title=\"CO - Cinryze\"\u003eCinryze\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299140/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Colcrys.pdf\" title=\"CO - Colcrys\"\u003eCOLCRYS\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299141/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Cuvitru.pdf\" title=\"CO - Cuvitru\"\u003eCuvitru\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299142/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Dexilant.pdf\" title=\"CO - Dexilant\"\u003eDEXILANT\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299143/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Elaprase.pdf\" title=\"CO - Elaprase\"\u003eElaprase\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299144/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Entyvio.pdf\" title=\"CO - Entyvio\"\u003eEntyvio\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299146/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Eohilia.pdf\" title=\"CO - Eohilia\"\u003eEohilia\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299147/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Feiba.pdf\" title=\"CO - Feiba\"\u003eFeiba\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299148/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Firazyr.pdf\" title=\"CO - Firazyr\"\u003eFirazyr\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299150/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Flexbumin_25.pdf\" title=\"CO - Flexbumin 25%\"\u003eFlexbumin\u0026nbsp;25%\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299152/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Fosrenol_-_CO.pdf\" title=\"CO - Flexbumin 5%\"\u003eFlexbumin 5%\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299152/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Fosrenol.pdf\" title=\"CO - Fosrenol\"\u003eFosrenol\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730912005/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Fruzaqla.pdf\" title=\"CO - Fruzaqla\"\u003eFruzaqla\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299153/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Gammagard_Liquid.pdf\" title=\"CO - Gammagard\"\u003eGammagard\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299154/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Gammagard_SD.pdf\" title=\"CO - Gammagard SD\"\u003eGammagard SD\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299155/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Gattex.pdf\" title=\"CO - Gattex\"\u003eGattex\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299157/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Glassia.pdf\" title=\"CO - Glassia\"\u003eGlassia\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299159/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Hemofil_M.pdf\" title=\"CO - Hemofil\"\u003eHemofil\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299160/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Hyqvia.pdf\" title=\"CO - Hyqvia\"\u003eHyqvia\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca href=\"https://assets-dam.takeda.com/image/upload/v1730921518/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Iclusig.pdf\" title=\"CO - Inclusig\"\u003eIclusig\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299161/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Intuniv.pdf\" title=\"CO - Intuniv\"\u003eIntuniv\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299163/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Kalbitor.pdf\" title=\"CO - Kalbitor\"\u003eKalbitor\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299165/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Kazano.pdf\" title=\"CO - Kazano\"\u003eKazano\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299166/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Lialda.pdf\" title=\"CO - Lialda\"\u003eLialda\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299167/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Livtencity.pdf\" title=\"CO - Livtencity\"\u003eLivtencity\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299168/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Motegrity.pdf\" title=\"CO - Motegrity\"\u003eMotegrity\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299170/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Mydayis.pdf\" title=\"CO - Mydayis\"\u003eMydayis\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/raw/upload/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/state/CO_Natpara_Product_Form.pdf\" title=\"CO - Natpara\"\u003eNatpara\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299171/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Nesina.pdf\" title=\"CO - Nesina\"\u003eNesina\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca href=\"https://assets-dam.takeda.com/image/upload/v1730921518/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Ninlaro.pdf\" title=\"CO - Ninlaro\"\u003eNinlaro\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca href=\"https://assets-dam.takeda.com/image/upload/v1730299173/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Obizur.pdf\" title=\"CO - Obizur\"\u003eObizur\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299174/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Oseni.pdf\" title=\"CO - Oseni\"\u003eOseni\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299175/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Pentasa.pdf\" title=\"CO - Pentasa\"\u003ePentasa\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299177/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Recombinate.pdf\" title=\"CO - Recombinate\"\u003eRecombinate\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299179/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Rixubis.pdf\" title=\"CO - Rixubis\"\u003eRixubis\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299180/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Rozerem.pdf\" title=\"CO - Rozerem\"\u003eRozerem\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299182/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Takhzyro.pdf\" title=\"CO- Takhzyro\"\u003eTakhzyro\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299183/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Trintellix.pdf\" title=\"CO - Trintellix\"\u003eTrintellix\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299186/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Uloric.pdf\" title=\"uloric\"\u003eUloric\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca href=\"https://assets-dam.takeda.com/image/upload/v1730921519/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Velcade.pdf\" title=\"Velcade Colorado price form\"\u003eVelcade\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299187/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Vonvendi.pdf\" title=\"CO - Vonvendi\"\u003eVonvendi\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299189/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/VPRIV.pdf\" title=\"CO - VPRIV\"\u003eVPRIV\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730299191/LOC/en-us/home/corporate_responsability/ethics_and_compliance/colorado/Vyvanse.pdf\" title=\"CO - Vyvanse\"\u003eVyvanse\u003c/a\u003e\u003c/p\u003e\n\u003c/div\u003e\n\u003chr\u003e","heading":"Colorado Prescriber Price Disclosure Forms","showExpanded":false,"_type":"accordionItem"},{"heading":"Connecticut Prescriber Price Disclosure Forms","_type":"accordionItem","_key":"853a7fc6-4f2d-4cae-99e2-9ef67e4264f0","bodyAsString":"\u003cdiv style=\"column-count: 4;\"\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730307438/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Advate.pdf\" title=\"CT Advate\"\u003eAdvate\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730307440/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Adynovate.pdf\" title=\"CT - Adynovate price form\"\u003eAdynovate\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730307444/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Adzynma.pdf\" title=\"CT - Adzynma price form\"\u003eAdzynma\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca href=\"https://assets-dam.takeda.com/image/upload/v1730921680/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Alunbrig.pdf\" title=\"CT - Alunbrig pricing form\"\u003eAlunbrig\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730307447/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Aralast.pdf\" title=\"CT - Aralast NP price form\"\u003eAralast NP\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730307451/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Ceprotin.pdf\" title=\"CT - Cinryze price form\"\u003eCeprotin\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730307454/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Cinryze.pdf\" title=\"CT - Cinryze price form\"\u003eCinryze\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730307458/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Cuvitru.pdf\" title=\"CT - Cuvitru price form\"\u003eCuvitru\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730307463/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Elaprase.pdf\" title=\"CT - Elaprase price form\"\u003eElaprase\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730307467/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Entyvio.pdf\" title=\"CT - Entyvio price form\"\u003eEntyvio\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730307472/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Eohilia.pdf\" title=\"CT - Eohilia price form\"\u003eEohilia\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730307476/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Feiba.pdf\" title=\"CT - Feiba price form\"\u003eFeiba\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730307480/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Firazyr.pdf\" title=\"CT - Firazyr price form\"\u003eFirazyr\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730307488/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Flexbumin_25.pdf\" title=\"CT - Flexbumin 25% price form\"\u003eFlexbumin\u0026nbsp;25%\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730307484/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Flexbumin_5.pdf\" title=\"CT - Flexbumin 5% price form\"\u003eFlexbumin 5%\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730911971/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Fruzuqla.pdf\" title=\"CT - Fruzaqla price form\"\u003eFruzaqla\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730307492/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Gammagard.pdf\" title=\"CT - Gammagard Liquid price form\"\u003eGammagard Liquid\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730307496/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Gammagard_SD.pdf\" title=\"CT - Gammagard SD price form\"\u003eGammagard SD\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730307501/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Gattex.pdf\" title=\"CT - Gattex price form\"\u003eGattex\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730307506/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Glassia.pdf\" title=\"CT - Glassia price form\"\u003eGlassia\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730307510/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Hemofil_M.pdf\" title=\"CT - Hemofil M price form\"\u003eHemofil M\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730307514/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Hyqvia.pdf\" title=\"CT - Hyqvia price form\"\u003eHyqvia\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca href=\"https://assets-dam.takeda.com/image/upload/v1730922767/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Iclusig.pdf\" title=\"CT - Inclusig price form\"\u003eIclusig\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730307519/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Kalbitor.pdf\" title=\"CT - Kalbitor price form\"\u003eKalbitor\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730307524/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Livtencity.pdf\" title=\"CT - Livtencity price form\"\u003eLivtencity\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca href=\"https://assets-dam.takeda.com/image/upload/v1730921678/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Ninlaro.pdf\" title=\"CT - Ninlaro price form\"\u003eNinlaro\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730307528/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Obizur.pdf\" title=\"CT - Obizur\"\u003eObizur\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730307533/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Recombinate.pdf\" title=\"CT - Recombinate\"\u003eRecombinate\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730307537/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Rixubis.pdf\" title=\"CT - Rixubis price form\"\u003eRixubis\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730307542/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Takhzyro.pdf\" title=\"CT- Takhzyro price form\"\u003eTakhzyro\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730307547/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Trintellix.pdf\" title=\"CT - Trintellix price form\"\u003eTrintellix\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca href=\"https://assets-dam.takeda.com/image/upload/v1730921679/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Velcade.pdf\" title=\"CT - Velcade price form\"\u003eVelcade\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730307552/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Vonvendi.pdf\" title=\"CT - Vonvendi price form\"\u003eVonvendi\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730307557/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/VPRIV.pdf\" title=\"CT - VPRIV price form\"\u003eVPRIV\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730307561/LOC/en-us/home/corporate_responsability/ethics_and_compliance/connecticut/Vyvanse.pdf\" title=\"CT - Vyvanse price form\"\u003eVyvanse\u003c/a\u003e\u003c/p\u003e\n\u003c/div\u003e\n\u003chr\u003e"},{"heading":"Vermont Prescriber Price Disclosure Forms","showExpanded":false,"_type":"accordionItem","_key":"4ec5b489-7042-4384-a3ff-408fdffd2cb0","subheading":"","bodyAsString":"\u003cdiv style=\"column-count: 4;\"\u003e\n\u003cp\u003eADDERALL XR\u003cbr\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730320779/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Adderall_XR_SF.pdf\" title=\"Adderall XR Vermont Prescribers short form\"\u003eShort Form\u003c/a\u003e | \u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730321118/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Adderall_LF.pdf\" title=\"Adderall XR Vermont Prescribers long form\"\u003eLong Form\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003eAGRYLIN\u003cbr\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730320781/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Agrylin_SF.pdf\" title=\"Agrylin Vermont Prescribers short form\"\u003eShort Form\u003c/a\u003e | \u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730321116/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Agrylin_LF.pdf\" title=\"Agrylin Vermont prescribers long form\"\u003eLong Form\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003eALUNBRIG\u003cbr\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730922980/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Alunbrig_SF.pdf\" title=\"Alunbrig Vermont Prescribers short form\"\u003eShort Form\u003c/a\u003e | \u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730922979/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Alunbrig_LF.pdf\" title=\"Alunbrig Vermont Prescribers long form\"\u003eLong Form\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003eAMITIZA\u003cbr\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/state/VT_Amitiza_SF.pdf\" title=\"VT Amitiza short form\"\u003eShort Form\u003c/a\u003e | \u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/state/VT_Amitiza_LF.pdf\" title=\"VT Amitiza long form\"\u003eLong Form\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003eCOLCRYS\u003cbr\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/state/VT_Colcrys_SF.pdf\" title=\"VT Colcrys short form\"\u003eShort Form\u003c/a\u003e\u0026nbsp;|\u0026nbsp;\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/state/VT_Colcrys_LF.pdf\" title=\"VT Colcrys long form\"\u003eLong Form\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003eCARBATROL\u003cbr\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730320786/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Carbatrol_SF.pdf\" title=\"Carbatrol Vermont prescribers short form\"\u003eShort Form\u003c/a\u003e\u0026nbsp;|\u0026nbsp;\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730321122/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Carbatrol_LF.pdf\" title=\"Carbatrol Vermont prescribers long form\"\u003eLong Form\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003eDEXILANT\u003cbr\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730320790/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Dexilant_SF.pdf\" title=\"VT DEXILANT short form\"\u003eShort Form\u003c/a\u003e\u0026nbsp;|\u0026nbsp;\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730321128/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Dexilant_LF.pdf\" title=\"VT DEXILANT long form\"\u003eLong Form\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003eFOSRENOL\u003cbr\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730320793/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Fosrenol_SF.pdf\" title=\"FOSRENOL Vermont Prescribers short form\"\u003eShort Form\u003c/a\u003e\u0026nbsp;|\u0026nbsp;\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730321133/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Fosrenol_LF.pdf\" title=\"FOSRENOL Vermont Prescribers long form\"\u003eLong Form\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003eFRUZAQLA\u003cbr\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730911894/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Fruzaqla_SF.pdf\" title=\"Fruzaqla Vermont Prescribers short form\"\u003eShort Form\u003c/a\u003e\u0026nbsp;|\u0026nbsp;\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730911895/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Fruzaqla_LF.pdf\" title=\"Fruzaqla Vermont Prescribers long form\"\u003eLong Form\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003eICLUSIG\u003cbr\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730922974/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Iclusig_SF.pdf\" title=\"Iclusig Vermont Prescribers short form\"\u003eShort Form\u003c/a\u003e\u0026nbsp;|\u0026nbsp;\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730922980/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Iclusig_LF.pdf\" title=\"Iclusig Vermont Prescribers long form\"\u003eLong Form\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003eINTUNIV\u003cbr\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730320797/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Intuniv_SF.pdf\" title=\"Intuniv Vermont prescribers short form\"\u003eShort Form\u003c/a\u003e\u0026nbsp;|\u0026nbsp;\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730321138/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Intuniv_LF.pdf\" title=\"Intuniv Vermont prescribers long form\"\u003eLong Form\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003eKazano\u003cbr\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/state/VT_Kazano_SF.pdf\" title=\"VT Kazano short form\"\u003eShort Form\u003c/a\u003e\u0026nbsp;|\u0026nbsp;\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/state/VT_Kazano_LF.pdf\" title=\"VT Kazano long form\"\u003eLong Form\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003eLIALDA\u003cbr\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730320800/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Lialda_SF.pdf\" title=\"Lialda Vermont prescribers short form\"\u003eShort Form\u003c/a\u003e\u0026nbsp;|\u0026nbsp;\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730321269/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Lialda_LF.pdf\" title=\"Lialda Vermont prescribers long form\"\u003eLong Form\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003eLIVTENCITY\u003cbr\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730320805/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Livtencity_SF.pdf\" title=\"Livtencity Vermont short form\"\u003eShort Form\u003c/a\u003e | \u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730321142/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Livtencity_LF.pdf\" title=\"Livtencity Vermont long form\"\u003eLong Form\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003eMOTEGRITY\u003cbr\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730320808/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Motegrity_SF.pdf\" title=\"Motegrity-Vermont Prescribers short form\"\u003eShort Form\u003c/a\u003e\u0026nbsp;|\u0026nbsp;\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730321147/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Motegrity_LF.pdf\" title=\"Motegrity-Vermont Prescribers long form\"\u003eLong Form\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003eMydayis\u003cbr\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730320813/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Mydayis_SF.pdf\" title=\"Mydayis Vermont prescribers short form\"\u003eShort Form\u003c/a\u003e\u0026nbsp;|\u0026nbsp;\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730320813/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Mydayis_SF.pdf\" title=\"Mydayis Vermont prescribers long form\"\u003eLong Form\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003eNESINA\u003cbr\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/state/VT_Nesina_SF.pdf\" title=\"VT Nesina short form\"\u003eShort Form\u003c/a\u003e\u0026nbsp;|\u0026nbsp;\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/state/VT_Nesina_LF.pdf\" title=\"VT Nesina long form\"\u003eLong Form\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003eNINLARO\u003cbr\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730922975/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Ninlaro_SF.pdf\" title=\"Ninlaro Vermont Prescribers short form\"\u003eShort Form\u003c/a\u003e\u0026nbsp;|\u0026nbsp;\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730922981/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Ninlaro_LF.pdf\" title=\"Ninlaro Vermont Prescribers long form\"\u003eLong Form\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003eOseni\u003cbr\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/state/VT_Oseni_SF.pdf\" title=\"VT Oseni short form\"\u003eShort Form\u003c/a\u003e\u0026nbsp;|\u0026nbsp;\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/culture-of-compliance/state/VT_Oseni_LF.pdf\" title=\"VT Oseni long form\"\u003eLong Form\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003ePENTASA\u003cbr\u003e\u003ca href=\"https://assets-dam.takeda.com/image/upload/v1730320816/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Pentasa_SF.pdf\" title=\"Pentasa Vermont prescribers short form\"\u003eShort Form\u003c/a\u003e\u0026nbsp;|\u0026nbsp;\u003ca href=\"https://assets-dam.takeda.com/image/upload/v1730321158/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Pentasa_LF.pdf\" title=\"Pentasa Vermont prescribers long form\"\u003eLong Form\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003eROZEREM\u003cbr\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730320822/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Rozerem_SF.pdf\" title=\"VT Rozerem short form\"\u003eShort Form\u003c/a\u003e\u0026nbsp;|\u0026nbsp;\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730321163/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Rozerem_LF.pdf\" title=\"VT Rozerem long form\"\u003eLong Form\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003eTRINTELLIX\u003cbr\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730320826/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Trintellix_SF.pdf\" title=\"VT Trintellix short form\"\u003eShort Form\u003c/a\u003e\u0026nbsp;|\u0026nbsp;\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730321168/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Trintellix_LF.pdf\" title=\"VT Trintellix long form\"\u003eLong Form\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003eULORIC\u003cbr\u003e\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730320831/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Uloric_SF.pdf\" title=\"VT Uloric short form\"\u003eShort Form\u003c/a\u003e\u0026nbsp;|\u0026nbsp;\u003ca rel=\"noopener\" target=\"_blank\" href=\"https://assets-dam.takeda.com/image/upload/v1730321173/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Uloric_LF.pdf\" title=\"VT Uloric long form\"\u003eLong Form\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003eVYVANSE\u003cbr\u003e\u003ca href=\"https://assets-dam.takeda.com/image/upload/v1730320835/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Vyvanse_SF.pdf\" title=\"Vyvanse Vermont prescribers short form\"\u003eShort Form\u003c/a\u003e\u0026nbsp;|\u0026nbsp;\u003ca href=\"https://assets-dam.takeda.com/image/upload/v1730321179/LOC/en-us/home/corporate_responsability/ethics_and_compliance/vermont/Vyvanse_LF.pdf\" title=\"Vyvanse Vermont prescribers long form\"\u003eLong Form\u003c/a\u003e\u003c/p\u003e\n\u003c/div\u003e"}],"_type":"accordionBlock","collapsibleGroup":false,"_key":"1717e1c4-7c8e-483e-b3ee-edd015fde628"},{"_type":"dividerBlock","_key":"8006c358-84f1-411a-839b-db893bdfafda","displayOption":"full"},{"backgroundColor":"color1","layout":"topimage","linkStyling":"bold","_type":"spotBlock","link":"/en-us/corporate-responsibility/patients/","image":{"excludeFromSearch":false,"_type":"imageFile","_key":"2cf793ac-999a-4c25-af0c-335204105a70","url":{"created_at":"2022-09-09T12:02:25Z","url":"http://assets-dam.takeda.com/image/upload/v1665672885/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/people/patient_callout-2.jpg","type":"upload","width":320,"_version":1,"version":1665672885,"resource_type":"image","secure_url":"https://assets-dam.takeda.com/image/upload/v1665672885/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/people/patient_callout-2.jpg","_key":"1eb176b4-05cb-4d13-ad9f-66f882310b7a","height":180,"_type":"cloudinary.asset","bytes":12859,"format":"jpg","public_id":"legacy-dotcom/siteassets/en-us/home/corporate-responsibility/people/patient_callout-2"},"blurDataUrl":"data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAGCAMAAADNLv/0AAAATlBMVEXl1tTSurnn3NfIqaPezMi9p6bq4uDt7Ozr5eXz8fHf0c+KeXN2ZWKXgnlRQUIrISdgUFPs6OHhw763nZyciYm3mZmll46yiIVYQD85Mi17LYQSAAAAPElEQVQIHQ3BhwGAMAwDMKeZdLPh/0dBwvILQGeFByAE7gNuG9+a+BnwSHRmkzbhIaSapHWslvejlKu+HzwKAhwvlKCkAAAAAElFTkSuQmCC"},"headingColor":"color1","linkCasing":"uppercase","displayOption":"onethird","customCssClass":"","linkText":"PATIENTS","_key":"c75f6e4d-7f0a-4bc5-9a61-3b79cc836b90"},{"displayOption":"onethird","_type":"spotBlock","linkText":"People","image":{"_type":"imageFile","_key":"7e88c667-05af-4fec-b46d-ab6a96e905bb","url":{"resource_type":"image","secure_url":"https://assets-dam.takeda.com/image/upload/v1664375418/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/patients/people_callout.jpg","_version":1,"width":320,"_type":"cloudinary.asset","created_at":"2022-09-09T12:02:29Z","_key":"3345f8cc-34fc-47b7-8c00-8998eb3b5b09","format":"jpg","height":180,"url":"http://assets-dam.takeda.com/image/upload/v1664375418/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/patients/people_callout.jpg","bytes":10265,"public_id":"legacy-dotcom/siteassets/en-us/home/corporate-responsibility/patients/people_callout","version":1664375418,"type":"upload"},"excludeFromSearch":false,"blurDataUrl":"data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAGCAMAAADNLv/0AAAAY1BMVEWsramqtLeopZ6vqaN5h5CzvsGysq+lt782HhkrFhCvxs8uKza3yc9ERlRDIyaowMuGlJ+RgHLMu655g4p3a2YjHCOrn5dmXF+niXt7aVxHOz+QlZmJWkacsrxJSFOifWp5Uj5TB6A3AAAAQUlEQVQI1wXBhQHAIBAEsMN53OpC95+yCTgYM4/sgyC0Ui6X+RGgEYK77mGBtTKT+/la8HpIWaJPFq2JfYt+SfQDWdAC+Sn3zbAAAAAASUVORK5CYII="},"layout":"topimage","linkStyling":"bold","_key":"f766724c-2a51-44de-9d3d-4b7d94de4b3f","customCssClass":"","headingColor":"color1","link":"/en-us/corporate-responsibility/people/","backgroundColor":"color1","linkCasing":"uppercase"},{"_key":"9fc8f996-2bd8-45c2-9325-057123400640","layout":"topimage","linkCasing":"uppercase","displayOption":"onethird","link":"/en-us/corporate-responsibility/planet/","backgroundColor":"color1","headingColor":"color1","linkText":"Planet","customCssClass":"","_type":"spotBlock","image":{"excludeFromSearch":false,"_type":"imageFile","_key":"67178ee5-8bf6-440c-b86a-daaa4f06a38b","url":{"url":"http://assets-dam.takeda.com/image/upload/v1665672888/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/planet-thumb.jpg","format":"jpg","resource_type":"image","created_at":"2022-09-09T12:02:27Z","bytes":140420,"_version":1,"width":547,"_type":"cloudinary.asset","_key":"09713332-094e-47de-a93c-702e2f71169b","height":364,"type":"upload","version":1665672888,"secure_url":"https://assets-dam.takeda.com/image/upload/v1665672888/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/planet-thumb.jpg","public_id":"legacy-dotcom/siteassets/en-us/home/corporate-responsibility/planet-thumb"},"blurDataUrl":"data:image/webp;base64,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"},"linkStyling":"bold"}],"linkType":"normal","_rev":"LymlyBQtzd2m0v8si6UCQN","hideInThisSection":false,"optimizelyId":"251574","title":"Ethics and Compliance","trackingRoot":false,"urlSegment":"/en-us/corporate-responsibility/ethics-and-compliance/","startPublish":"2021-11-24T13:04:25+00:00","visibleInMenu":true,"hideFooter":false,"customCssClass":"","excludeFromSearch":false,"canonicals":[{"friendlyUrl":{"current":"/en-us/corporate-responsibility/ethics-and-compliance/","_type":"slug","_key":"08d6dcc9-e495-45ab-a837-e142bab86d20"},"language":"en-US"}],"_base":{"_weak":true,"_ref":"fef439d2-b9ac-4f66-97dc-159c826a5db6","_type":"reference"},"mainHeroArea":[{"_key":"133ad5a6-3db2-463f-b497-b6b4fc5d989b","displayOption":"full","customCssClass":"","backgroundImageUrl":{"_key":"0d3ff7e4-6539-4e94-a330-d2dcce852cbe","url":{"url":"http://assets-dam.takeda.com/image/upload/v1662724948/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/ethics--compliance_banner.jpg","public_id":"legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/ethics--compliance_banner","created_at":"2022-09-09T12:02:28Z","format":"jpg","_key":"5c3bc31b-6dd1-4144-aeb4-ffa3b32cafc5","width":1280,"resource_type":"image","version":1662724948,"height":300,"_type":"cloudinary.asset","_version":1,"type":"upload","secure_url":"https://assets-dam.takeda.com/image/upload/v1662724948/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/ethics--compliance_banner.jpg","bytes":68418},"excludeFromSearch":false,"_type":"imageFile","blurDataUrl":"data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAACBAMAAACTT1DjAAAALVBMVEW6x8xkW1qjo6cQIDq0srRzZV9lQzB8Zl5xnK2unphnip5NQEOnub+6iXFWWGvGeRJ9AAAAFElEQVQI12PoChPXYWAw3iun6QAAEGQCmxwXDl0AAAAASUVORK5CYII="},"backgroundImageAlignment":0,"spotContentAlignment":1,"spotContentAsString":"\u003cdiv\u003eLiving our values every day\u003c/div\u003e","_type":"heroBannerBlock","backgroundMobileImageUrl":{"excludeFromSearch":false,"_type":"imageFile","_key":"acf0b8c1-ba8b-4c77-be06-62f32fc17f6f","url":{"resource_type":"image","_version":1,"height":180,"secure_url":"https://assets-dam.takeda.com/image/upload/v1663763507/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/patients/ethics--compliance_callout.jpg","public_id":"legacy-dotcom/siteassets/en-us/home/corporate-responsibility/patients/ethics--compliance_callout","version":1663763507,"type":"upload","bytes":16833,"width":320,"_key":"1a53b9e2-50ee-4c9c-906a-d11215a19203","_type":"cloudinary.asset","format":"jpg","created_at":"2022-09-09T12:02:26Z","url":"http://assets-dam.takeda.com/image/upload/v1663763507/legacy-dotcom/siteassets/en-us/home/corporate-responsibility/patients/ethics--compliance_callout.jpg"},"blurDataUrl":"data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAGCAMAAADNLv/0AAAAdVBMVEX28uyms7htdHV0YV2vvMG7yc21w8gGFCwLGjNRS0x/bGjJvbo8SV+opqgrLDgYKEPj4+DOy8kHDx6tq6+Tn6WJucWFsL1FZnq1pKAHH0JKOCyooqOjcFWOkJlOVGqDfomLenfRtqmEZ2BcWWLfzcIaJTnLpJDEx9oNAAAAQklEQVQI1w3BBQKAIAAEsKMb7A7M/z9RN7QdnQxtCBfoPVusnYkU0Doys61DLaHUmKLfXeBQOpkzB1cWqJ7rPW78PmjNA3bE9l1LAAAAAElFTkSuQmCC"},"callToActionLinkText":""}],"parent":{"_ref":"c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_en-US","_type":"reference","_weak":true},"parentWasSkipped":false,"canonicalUrl":"https://www.takeda.com/en-us/corporate-responsibility/ethics-and-compliance/","theme":"","hideBreadCrumb":false,"_id":"fef439d2-b9ac-4f66-97dc-159c826a5db6","showNewInLanguages":"","partialPageIntroAsString":"\u003cdiv\u003eTakeda believes that, in addition to complying with all applicable laws and regulations, it is\u0026nbsp;essential for all Takeda employees to conduct business in line with the highest ethical and\u0026nbsp;moral standards.\u003c/div\u003e","sortIndex":16200,"_langRefs":null,"_updatedAt":"2024-11-06T20:54:58Z","seo":{"descriptionString":"Takeda believes that, in addition to complying with all applicable laws and regulations, it is essential for all Takeda employees to conduct business in line with the highest ethical and moral standards.","targetGroup":0,"_type":"seoBlock","_key":"22b83052-e04f-45cf-b87d-0ca9cf05835a","title":"Ethics and Compliance","openGraphTitle":"Ethics and Compliance","indexing":0,"openGraphDescription":"Takeda believes that, in addition to complying with all applicable laws and regulations, it is essential for all Takeda employees to conduct business in line with the highest ethical and moral standards.","openGraphImage":"https://www.takeda.com/4ac76f/siteassets/en-us/home/corporate-responsibility/ethics-and-compliance/ethics--compliance_mobile_banner.jpg"},"shortcut":{"_type":"shortcut","shortcutType":"Normal","_key":"0d261e61-fdd4-4346-8f4e-8973fdcecd19"},"slug":{"_key":"08d6dcc9-e495-45ab-a837-e142bab86d20","current":"/en-us/corporate-responsibility/ethics-and-compliance/","_type":"slug"},"breadcrumbItems":[{"_type":"sectionPage","title":"HOME","href":"/en-us/","parentBase":{"_ref":null},"parentTranslationMetadataIds":null,"_id":"719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-US"},{"_id":"c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_en-US","_type":"sectionPage","title":"Corporate Responsibility","href":"/en-us/corporate-responsibility/","parentBase":{"_ref":["719d1b8a-9834-4b1f-8b58-1c0063ac3094","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_bg-BG","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_bs-Latn-BA","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_cs-CZ","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_da-DK","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_de-AT","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_de-CH","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_de-DE","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_el-GR","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-AU","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-BE","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-CA","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-GB","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-GI","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-HK","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-IE","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-IN","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-US","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_es-AR","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_es-CO","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_es-EC","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_es-ES","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_es-MX","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_es-PE","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_et-EE","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_fi-FI","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_fr-CA","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_fr-CH","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_fr-FR","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_he-IL","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_hr-HR","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_hu-HU","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_id-ID","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_it-IT","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_ja","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_ja-JP","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_kk-KZ","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_ko-KR","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_lt-LT","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_lv-LV","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_nl-NL","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_nn-NO","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_pl-PL","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_pt-BR","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_pt-PT","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_ro-RO","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_ru-KZ","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_ru-RU","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_sk-SK","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_sl-SI","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_sr-Latn-RS","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_sv-SE","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_th-TH","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_tr-TR","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_uk-UA","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_uz-Cyrl-UZ","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_zh-CN","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_zh-HK","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_zh-TW","drafts.719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-GI","drafts.719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_he-IL","drafts.719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_nn-NO","drafts.719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_ru-MD","drafts.719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_tr-TR"]},"parentTranslationMetadataIds":["719d1b8a-9834-4b1f-8b58-1c0063ac3094","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_bg-BG","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_bs-Latn-BA","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_cs-CZ","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_da-DK","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_de-AT","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_de-CH","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_de-DE","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_el-GR","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-AU","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-BE","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-CA","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-GB","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-GI","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-HK","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-IE","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-IN","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-US","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_es-AR","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_es-CO","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_es-EC","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_es-ES","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_es-MX","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_es-PE","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_et-EE","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_fi-FI","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_fr-CA","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_fr-CH","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_fr-FR","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_he-IL","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_hr-HR","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_hu-HU","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_id-ID","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_it-IT","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_ja","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_ja-JP","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_kk-KZ","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_ko-KR","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_lt-LT","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_lv-LV","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_nl-NL","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_nn-NO","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_pl-PL","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_pt-BR","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_pt-PT","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_ro-RO","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_ru-KZ","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_ru-RU","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_sk-SK","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_sl-SI","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_sr-Latn-RS","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_sv-SE","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_th-TH","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_tr-TR","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_uk-UA","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_uz-Cyrl-UZ","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_zh-CN","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_zh-HK","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_zh-TW","drafts.719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-GI","drafts.719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_he-IL","drafts.719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_nn-NO","drafts.719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_ru-MD","drafts.719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_tr-TR"]},{"_id":"fef439d2-b9ac-4f66-97dc-159c826a5db6","_type":"sectionPage","title":"Ethics and Compliance","href":"/en-us/corporate-responsibility/ethics-and-compliance/","parentBase":{"_ref":["c97319bc-d412-46c9-8d68-8fb5a8560bad","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_bg-BG","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_bs-Latn-BA","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_cs-CZ","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_de-AT","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_de-CH","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_de-DE","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_el-GR","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_en-AU","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_en-BE","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_en-CA","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_en-GB","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_en-GI","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_en-HK","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_en-IE","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_en-IN","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_en-US","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_es-AR","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_es-CO","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_es-EC","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_es-ES","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_es-MX","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_es-PE","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_et-EE","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_fi-FI","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_fr-CA","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_fr-CH","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_fr-FR","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_he-IL","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_hr-HR","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_hu-HU","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_id-ID","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_it-IT","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_ja","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_kk-KZ","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_ko-KR","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_lt-LT","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_lv-LV","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_nl-NL","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_nn-NO","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_pl-PL","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_pt-BR","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_pt-PT","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_ro-RO","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_ru-KZ","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_sk-SK","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_sl-SI","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_sr-Latn-RS","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_th-TH","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_tr-TR","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_uk-UA","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_uz-Cyrl-UZ","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_zh-HK","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_zh-TW","drafts.c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_es-ES","drafts.c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_ru-MD"]},"parentTranslationMetadataIds":["c97319bc-d412-46c9-8d68-8fb5a8560bad","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_bg-BG","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_bs-Latn-BA","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_cs-CZ","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_de-AT","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_de-CH","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_de-DE","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_el-GR","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_en-AU","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_en-BE","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_en-CA","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_en-GB","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_en-GI","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_en-HK","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_en-IE","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_en-IN","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_en-US","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_es-AR","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_es-CO","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_es-EC","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_es-ES","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_es-MX","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_es-PE","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_et-EE","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_fi-FI","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_fr-CA","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_fr-CH","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_fr-FR","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_he-IL","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_hr-HR","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_hu-HU","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_id-ID","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_it-IT","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_ja","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_kk-KZ","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_ko-KR","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_lt-LT","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_lv-LV","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_nl-NL","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_nn-NO","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_pl-PL","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_pt-BR","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_pt-PT","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_ro-RO","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_ru-KZ","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_sk-SK","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_sl-SI","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_sr-Latn-RS","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_th-TH","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_tr-TR","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_uk-UA","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_uz-Cyrl-UZ","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_zh-HK","c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_zh-TW","drafts.c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_es-ES","drafts.c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_ru-MD"],"active":true}]},"globalSiteSettings":{"oneTrustScriptAttributes":{"autoBlockSrc":"https://cdn.cookielaw.org/consent/3625bb82-8e0e-4be8-80d3-257e4f469168/OtAutoBlock.js","src":"https://cdn.cookielaw.org/scripttemplates/otSDKStub.js","_type":"oneTrustScriptAttributes","id":"3625bb82-8e0e-4be8-80d3-257e4f469168"},"_createdAt":"2023-01-19T12:09:34Z","oneTrustScriptAttributesCN":{"autoBlockSrc":"https://cdn.cookielaw.org/consent/cc1a26ec-1a2e-4023-9f59-c5ce6fa4a2e0/OtAutoBlock.js","src":"https://cdn.cookielaw.org/scripttemplates/otSDKStub.js","_type":"oneTrustScriptAttributes","id":"cc1a26ec-1a2e-4023-9f59-c5ce6fa4a2e0"},"_type":"globalSiteSettingsPage","_updatedAt":"2024-07-09T11:03:40Z","logo":{"_type":"image","asset":{"_ref":"image-934f4f2c06a8d0f9dd6de5e05696143e1b186758-512x512-png","_type":"reference"}},"locales":[{"_updatedAt":"2024-07-09T11:03:39Z","displayName":"Ukrainian - Ukraine","shortUrl":"https://bit.ly/3IL8ZRl","_rev":"08sdc3VS02r1AeJ6JPNuNN","localeCode":"uk-UA","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoAGhg","friendlyUrl":{"current":"/uk-ua/"},"nativeName":"українська","_type":"Locale","languageCode":"uk","regionCode":"UA","_createdAt":"2024-07-09T11:03:36Z"},{"displayName":"Lithuanian - Lithuania","shortUrl":"https://bit.ly/3IKDmre","_rev":"08sdc3VS02r1AeJ6JPNuRt","_type":"Locale","languageCode":"lt","_updatedAt":"2024-07-09T11:03:40Z","nativeName":"lietuvių","regionCode":"LT","localeCode":"lt-LT","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoAFNs","friendlyUrl":{"current":"/lt-lt/"}},{"shortUrl":"https://bit.ly/3IK5niP","_type":"Locale","localeCode":"en-BE","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoACuU","friendlyUrl":{"current":"/en-be/"},"nativeName":"English","displayName":"English - Belgium","_rev":"08sdc3VS02r1AeJ6JPNuWP","languageCode":"en","regionCode":"BE","_createdAt":"2024-07-09T11:03:36Z","_updatedAt":"2024-07-09T11:03:42Z"},{"displayName":"English - United States","_rev":"hOy10qbiXBGAt5MTQoAOmk","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"friendlyUrl":{"current":"/en-us/"},"nativeName":"English","_type":"Locale","languageCode":"en","regionCode":"US","localeCode":"en-US","_id":"hOy10qbiXBGAt5MTQoADZO","_updatedAt":"2024-07-09T11:03:43Z","shortUrl":"https://bit.ly/3Prjbm4"},{"languageCode":"es","regionCode":"MX","localeCode":"es-MX","isEnabled":true,"nativeName":"español","displayName":"Spanish Castilian - Mexico","shortUrl":"https://bit.ly/43pfTp9","_rev":"08sdc3VS02r1AeJ6JPNuav","friendlyUrl":{"current":"/es-mx/"},"_updatedAt":"2024-07-09T11:03:44Z","_type":"Locale","_createdAt":"2024-07-09T11:03:36Z","_id":"hOy10qbiXBGAt5MTQoADyx"},{"languageCode":"kk","localeCode":"kk-KZ","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoAFDe","friendlyUrl":{"current":"/kk-kz/"},"shortUrl":"https://bit.ly/4aFWgvx","displayName":"Kazakh - Kazakhstan","_rev":"08sdc3VS02r1AeJ6JPNufR","_type":"Locale","regionCode":"KZ","_createdAt":"2024-07-09T11:03:36Z","_updatedAt":"2024-07-09T11:03:45Z","nativeName":"қазақ тілі"},{"regionCode":"GR","localeCode":"el-GR","_id":"hOy10qbiXBGAt5MTQoACkG","_updatedAt":"2024-07-09T11:03:47Z","shortUrl":"https://bit.ly/3v9P9MM","_rev":"hOy10qbiXBGAt5MTQoAP7C","_type":"Locale","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"friendlyUrl":{"current":"/el-gr/"},"nativeName":"Ελληνικά","displayName":"Modern Greek (1453-) - Greece","languageCode":"el"},{"localeCode":"sv-SE","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoAGSL","friendlyUrl":{"current":"/sv-se/"},"_updatedAt":"2024-07-09T11:03:48Z","nativeName":"svenska","displayName":"Swedish - Sweden","_rev":"hOy10qbiXBGAt5MTQoAPHQ","regionCode":"SE","_createdAt":"2024-07-09T11:03:36Z","shortUrl":"https://bit.ly/3PvuVDS","_type":"Locale","languageCode":"sv"},{"nativeName":"Deutsch","displayName":"German - Austria","shortUrl":"https://bit.ly/3IIgKrv","_rev":"hOy10qbiXBGAt5MTQoAPRe","_type":"Locale","languageCode":"de","localeCode":"de-AT","_createdAt":"2024-07-09T11:03:36Z","_id":"hOy10qbiXBGAt5MTQoACUv","_updatedAt":"2024-07-09T11:03:49Z","regionCode":"AT","isEnabled":true,"friendlyUrl":{"current":"/de-at/"}},{"nativeName":"ўзбекча","shortUrl":"https://bit.ly/3Vt8J1g","_rev":"hOy10qbiXBGAt5MTQoAPbs","localeCode":"uz-Cyrl-UZ","_createdAt":"2024-07-09T11:03:36Z","_id":"hOy10qbiXBGAt5MTQoAGmn","_updatedAt":"2024-07-09T11:03:50Z","displayName":"Uzbek","_type":"Locale","languageCode":"uz","regionCode":"Cyrl","isEnabled":true,"friendlyUrl":{"current":"/uz-uz/"}},{"nativeName":"English","displayName":"English","shortUrl":"https://bit.ly/3VudcRi","_rev":"hOy10qbiXBGAt5MTQoAPm6","_type":"Locale","friendlyUrl":{"current":"/en/"},"_updatedAt":"2024-07-09T11:03:51Z","localeCode":"en","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoAC5M","languageCode":"en"},{"displayName":"English - Canada","_rev":"08sdc3VS02r1AeJ6JPNumD","regionCode":"CA","localeCode":"en-CA","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoACzb","_updatedAt":"2024-07-09T11:03:52Z","nativeName":"English","_type":"Locale","languageCode":"en","_createdAt":"2024-07-09T11:03:36Z","friendlyUrl":{"current":"/en-ca/"},"shortUrl":"https://bit.ly/3vkDDhs"},{"languageCode":"et","regionCode":"EE","localeCode":"et-EE","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"displayName":"Estonian - Estonia","shortUrl":"https://bit.ly/3Ptha8E","_type":"Locale","_id":"hOy10qbiXBGAt5MTQoAEEI","_updatedAt":"2024-07-09T11:03:53Z","nativeName":"eesti","_rev":"hOy10qbiXBGAt5MTQoAQBf","friendlyUrl":{"current":"/et-ee/"}},{"regionCode":"HU","localeCode":"hu-HU","_createdAt":"2024-07-09T11:03:36Z","_rev":"iwSJAlC9N7TuVxGxCvbCH2","displayName":"Hungarian - Hungary","shortUrl":"https://bit.ly/3vl6FgZ","_type":"Locale","languageCode":"hu","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoAEo5","friendlyUrl":{"current":"/hu-hu/"},"nativeName":"magyar","_updatedAt":"2024-07-09T11:03:54Z"},{"_updatedAt":"2024-07-09T11:03:56Z","displayName":"French - Switzerland","shortUrl":"https://bit.ly/3TJVLdX","_rev":"hOy10qbiXBGAt5MTQoAQLt","_type":"Locale","languageCode":"fr","_id":"hOy10qbiXBGAt5MTQoAETd","friendlyUrl":{"current":"/fr-ch/"},"nativeName":"français","regionCode":"CH","localeCode":"fr-CH","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true},{"friendlyUrl":{"current":"/he-il/"},"_updatedAt":"2024-07-09T11:03:57Z","nativeName":"עברית","displayName":"Hebrew - Israel","shortUrl":"https://bit.ly/3INh0W8","_type":"Locale","languageCode":"he","_id":"hOy10qbiXBGAt5MTQoAEdr","_rev":"hOy10qbiXBGAt5MTQoAQbE","regionCode":"IL","localeCode":"he-IL","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true},{"localeCode":"sr-Latn-RS","_createdAt":"2024-07-09T11:03:36Z","_updatedAt":"2024-07-09T11:03:58Z","nativeName":"srpski","languageCode":"sr","regionCode":"Latn","_type":"Locale","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoAGNE","friendlyUrl":{"current":"/sr-rs/"},"displayName":"Serbian","shortUrl":"https://bit.ly/3TM6CnZ","_rev":"hOy10qbiXBGAt5MTQoAQlS"},{"_type":"Locale","_updatedAt":"2024-07-09T11:03:59Z","nativeName":"English","displayName":"English - Ireland","shortUrl":"https://bit.ly/4anUoXM","localeCode":"en-IE","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoADK3","friendlyUrl":{"current":"/en-ie/"},"_rev":"08sdc3VS02r1AeJ6JPNuqj","languageCode":"en","regionCode":"IE"},{"_updatedAt":"2024-07-09T11:04:00Z","nativeName":"中文(繁體)","shortUrl":"https://bit.ly/3vl6Fxv","_type":"Locale","languageCode":"zh","localeCode":"zh-HK","friendlyUrl":{"current":"/zh-hk/"},"displayName":"Chinese - Hong Kong","_rev":"hOy10qbiXBGAt5MTQoAQvg","regionCode":"HK","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoAGx1"},{"shortUrl":"https://bit.ly/3IMtbm1","_rev":"iwSJAlC9N7TuVxGxCvbCQG","_type":"Locale","regionCode":"IN","localeCode":"en-IN","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"displayName":"English - India","friendlyUrl":{"current":"/en-in/"},"_id":"hOy10qbiXBGAt5MTQoADPA","languageCode":"en","_updatedAt":"2024-07-09T11:04:01Z","nativeName":"English"},{"_rev":"08sdc3VS02r1AeJ6JPNuvF","localeCode":"en-AU","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"friendlyUrl":{"current":"/en-au/"},"nativeName":"English","displayName":"English - Australia","shortUrl":"https://bit.ly/3TIdQcu","_id":"hOy10qbiXBGAt5MTQoACpN","_updatedAt":"2024-07-09T11:04:02Z","_type":"Locale","languageCode":"en","regionCode":"AU"},{"friendlyUrl":{"current":"/ko-kr/"},"shortUrl":"https://bit.ly/43oV0dH","_rev":"iwSJAlC9N7TuVxGxCvbCe6","_type":"Locale","languageCode":"ko","regionCode":"KR","localeCode":"ko-KR","_id":"hOy10qbiXBGAt5MTQoAFIl","nativeName":"한국어","displayName":"Korean - Republic of Korea","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"_updatedAt":"2024-07-09T11:04:03Z"},{"isEnabled":true,"friendlyUrl":{"current":"/ja-jp/"},"nativeName":"日本語","localeCode":"ja-JP","_rev":"08sdc3VS02r1AeJ6JPNv6X","_type":"Locale","languageCode":"ja","regionCode":"JP","_createdAt":"2024-07-09T11:03:36Z","_id":"hOy10qbiXBGAt5MTQoAF8X","displayName":"Japanese - Japan","shortUrl":"https://bit.ly/3vcE6T1","_updatedAt":"2024-07-09T11:04:04Z"},{"friendlyUrl":{"current":"/hr-hr/"},"shortUrl":"https://bit.ly/4akhJK6","_rev":"hOy10qbiXBGAt5MTQoAR5u","languageCode":"hr","regionCode":"HR","localeCode":"hr-HR","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoAEiy","nativeName":"hrvatski","displayName":"Croatian - Croatia","_type":"Locale","_createdAt":"2024-07-09T11:03:36Z","_updatedAt":"2024-07-09T11:04:05Z"},{"_updatedAt":"2024-07-09T11:04:07Z","nativeName":"español","displayName":"Spanish Castilian - Venezuela","_type":"Locale","_createdAt":"2024-07-09T11:03:36Z","friendlyUrl":{"current":"/es-ve/"},"isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoAE9B","shortUrl":"https://bit.ly/43qi77s","_rev":"iwSJAlC9N7TuVxGxCvbCrw","languageCode":"es","regionCode":"VE","localeCode":"es-VE"},{"nativeName":"slovenčina","displayName":"Slovak - Slovakia","languageCode":"sk","localeCode":"sk-SK","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"_updatedAt":"2024-07-09T11:04:08Z","shortUrl":"https://bit.ly/3PsaMyA","_rev":"08sdc3VS02r1AeJ6JPNvFZ","_type":"Locale","regionCode":"SK","_id":"hOy10qbiXBGAt5MTQoAGD0","friendlyUrl":{"current":"/sk-sk/"}},{"nativeName":"Indonesia","shortUrl":"https://bit.ly/3TM6BQX","localeCode":"id-ID","_id":"hOy10qbiXBGAt5MTQoAEtC","_updatedAt":"2024-07-09T11:04:09Z","displayName":"Indonesian - Indonesia","_rev":"iwSJAlC9N7TuVxGxCvbD1A","_type":"Locale","languageCode":"id","regionCode":"ID","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"friendlyUrl":{"current":"/id-id/"}},{"nativeName":"polski","shortUrl":"https://bit.ly/4amjl63","languageCode":"pl","regionCode":"PL","localeCode":"pl-PL","friendlyUrl":{"current":"/pl-pl/"},"displayName":"Polish - Poland","_rev":"08sdc3VS02r1AeJ6JPNvOb","_type":"Locale","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoAFiK","_updatedAt":"2024-07-09T11:04:11Z"},{"languageCode":"en","regionCode":"VN","displayName":"English - Viet Nam","_createdAt":"2024-07-09T11:03:36Z","_type":"Locale","_id":"hOy10qbiXBGAt5MTQoAD9p","_updatedAt":"2024-07-09T11:04:12Z","localeCode":"en-VN","shortUrl":"https://bit.ly/43uqNK3","isEnabled":true,"_rev":"08sdc3VS02r1AeJ6JPOkrF","friendlyUrl":{"current":"/en-vi/"}},{"_id":"hOy10qbiXBGAt5MTQoADtq","_updatedAt":"2024-07-09T11:04:15Z","_rev":"08sdc3VS02r1AeJ6JPOsOf","_type":"Locale","isEnabled":true,"languageCode":"es","regionCode":"ES","localeCode":"es-ES","_createdAt":"2024-07-09T11:03:36Z","friendlyUrl":{"current":"/es-es/"},"nativeName":"español","displayName":"Spanish Castilian - Spain","shortUrl":"https://bit.ly/3IMGbYJ"},{"_rev":"08sdc3VS02r1AeJ6JPOsXh","_type":"Locale","languageCode":"en","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"_updatedAt":"2024-07-09T11:04:18Z","nativeName":"English","shortUrl":"https://bit.ly/3VKEMKf","regionCode":"HK","localeCode":"en-HK","_id":"hOy10qbiXBGAt5MTQoADEw","friendlyUrl":{"current":"/en-hk/"},"displayName":"English - Hong Kong"},{"localeCode":"bg-BG","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoACAT","_updatedAt":"2024-07-09T11:04:21Z","shortUrl":"https://bit.ly/43qluLU","languageCode":"bg","_rev":"iwSJAlC9N7TuVxGxCveMh6","_type":"Locale","regionCode":"BG","_createdAt":"2024-07-09T11:03:36Z","friendlyUrl":{"current":"/bg-bg/"},"nativeName":"български","displayName":"Bulgarian - Bulgaria"},{"_type":"Locale","_id":"hOy10qbiXBGAt5MTQoAFxf","friendlyUrl":{"current":"/ro-ro/"},"nativeName":"română","displayName":"Romanian Moldavian Moldovan - Romania","shortUrl":"https://bit.ly/3TqAmoW","localeCode":"ro-RO","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"_updatedAt":"2024-07-09T11:04:23Z","_rev":"iwSJAlC9N7TuVxGxCveMqK","languageCode":"ro","regionCode":"RO"},{"_rev":"08sdc3VS02r1AeJ6JPOseT","regionCode":"KZ","localeCode":"ru-KZ","_id":"hOy10qbiXBGAt5MTQoAG2m","nativeName":"русский","displayName":"Russian - Kazakhstan","languageCode":"ru","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"friendlyUrl":{"current":"/ru-kz/"},"_updatedAt":"2024-07-09T11:04:24Z","shortUrl":"https://bit.ly/4antPC9","_type":"Locale"},{"isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoAEJP","friendlyUrl":{"current":"/fi-fi/"},"_updatedAt":"2024-07-09T11:04:26Z","languageCode":"fi","regionCode":"FI","shortUrl":"https://bit.ly/3INSd4o","_rev":"iwSJAlC9N7TuVxGxCveN4A","_type":"Locale","localeCode":"fi-FI","_createdAt":"2024-07-09T11:03:36Z","nativeName":"suomi","displayName":"Finnish - Finland"},{"languageCode":"zh","regionCode":"CN","localeCode":"zh-CN","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"_updatedAt":"2024-07-09T11:04:28Z","nativeName":"中文(简体) 旧版","displayName":"Chinese - China","shortUrl":"https://bit.ly/3vvE3S9","_rev":"08sdc3VS02r1AeJ6JPOslF","_type":"Locale","_id":"hOy10qbiXBGAt5MTQoAGru","friendlyUrl":{"current":"/zh-cn/"}},{"_id":"hOy10qbiXBGAt5MTQoACKh","friendlyUrl":{"current":"/cs-cz/"},"_updatedAt":"2024-07-09T11:04:30Z","displayName":"Czech - Czechia Czech Republic","languageCode":"cs","localeCode":"cs-CZ","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"nativeName":"čeština","shortUrl":"https://bit.ly/3IRuxM8","_rev":"08sdc3VS02r1AeJ6JPOswX","_type":"Locale","regionCode":"CZ"},{"shortUrl":"https://bit.ly/3IIgOrf","languageCode":"fr","localeCode":"fr-FR","isEnabled":true,"displayName":"French - France","_rev":"iwSJAlC9N7TuVxGxCveNVq","_type":"Locale","regionCode":"FR","_createdAt":"2024-07-09T11:03:36Z","_id":"hOy10qbiXBGAt5MTQoAEYk","friendlyUrl":{"current":"/fr-fr/"},"_updatedAt":"2024-07-09T11:04:31Z","nativeName":"français"},{"localeCode":"da-DK","_id":"hOy10qbiXBGAt5MTQoACPo","_updatedAt":"2024-07-09T11:04:33Z","nativeName":"dansk","_type":"Locale","regionCode":"DK","languageCode":"da","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"friendlyUrl":{"current":"/da-dk/"},"displayName":"Danish - Denmark","shortUrl":"https://bit.ly/3TuPeT8","_rev":"08sdc3VS02r1AeJ6JPOt13"},{"nativeName":"français","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoAEOW","_updatedAt":"2024-07-09T11:04:34Z","localeCode":"fr-CA","_createdAt":"2024-07-09T11:03:36Z","displayName":"French - Canada","shortUrl":"https://bit.ly/3Px8ZrY","_rev":"hOy10qbiXBGAt5MTQoCvdU","_type":"Locale","languageCode":"fr","regionCode":"CA","friendlyUrl":{"current":"/fr-ca/"}},{"languageCode":"nn","localeCode":"nn-NO","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoAFdD","friendlyUrl":{"current":"/nn-no/"},"nativeName":"nynorsk","displayName":"Norwegian Nynorsk - Norway","shortUrl":"https://bit.ly/3TIdRx4","_rev":"iwSJAlC9N7TuVxGxCveSry","_type":"Locale","regionCode":"NO","_updatedAt":"2024-07-09T11:04:36Z"},{"displayName":"Portuguese - Portugal","regionCode":"PT","friendlyUrl":{"current":"/pt-pt/"},"_updatedAt":"2024-07-09T11:04:38Z","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"nativeName":"português","shortUrl":"https://bit.ly/3INixeP","_rev":"08sdc3VS02r1AeJ6JPOt7p","_type":"Locale","languageCode":"pt","localeCode":"pt-PT","_id":"hOy10qbiXBGAt5MTQoAFsY"},{"displayName":"Spanish Castilian - Argentina","shortUrl":"https://bit.ly/3vkDBpQ","_rev":"08sdc3VS02r1AeJ6JPOtCL","localeCode":"es-AR","isEnabled":true,"nativeName":"español","languageCode":"es","regionCode":"AR","_createdAt":"2024-07-09T11:03:36Z","_id":"hOy10qbiXBGAt5MTQoADeV","friendlyUrl":{"current":"/es-ar/"},"_updatedAt":"2024-07-09T11:04:39Z","_type":"Locale"},{"_id":"hOy10qbiXBGAt5MTQoACf9","shortUrl":"https://bit.ly/3IK5xXt","regionCode":"DE","localeCode":"de-DE","isEnabled":true,"languageCode":"de","_createdAt":"2024-07-09T11:03:36Z","friendlyUrl":{"current":"/de-de/"},"_updatedAt":"2024-07-09T11:04:41Z","nativeName":"Deutsch","displayName":"German - Germany","_rev":"08sdc3VS02r1AeJ6JPOtPt","_type":"Locale"},{"shortUrl":"https://bit.ly/3IRuvUw","_rev":"iwSJAlC9N7TuVxGxCveTlK","_type":"Locale","regionCode":"CO","isEnabled":true,"friendlyUrl":{"current":"/es-co/"},"_updatedAt":"2024-07-09T11:04:43Z","nativeName":"español","displayName":"Spanish Castilian - Colombia","languageCode":"es","localeCode":"es-CO","_createdAt":"2024-07-09T11:03:36Z","_id":"hOy10qbiXBGAt5MTQoADjc"},{"friendlyUrl":{"current":"/nl-nl/"},"nativeName":"Nederlands","_rev":"08sdc3VS02r1AeJ6JPOtUP","localeCode":"nl-NL","isEnabled":true,"regionCode":"NL","_createdAt":"2024-07-09T11:03:36Z","_id":"hOy10qbiXBGAt5MTQoAFY6","_updatedAt":"2024-07-09T11:04:44Z","displayName":"Dutch Flemish - Netherlands","shortUrl":"https://bit.ly/4aid2Aq","_type":"Locale","languageCode":"nl"},{"_rev":"08sdc3VS02r1AeJ6JPOtbB","_type":"Locale","languageCode":"en","regionCode":"MY","isEnabled":true,"_updatedAt":"2024-07-09T11:04:47Z","nativeName":"English","displayName":"English - Malaysia","shortUrl":"https://bit.ly/3VsUKbr","localeCode":"en-MY","_createdAt":"2024-07-09T11:03:36Z","_id":"hOy10qbiXBGAt5MTQoADUH","friendlyUrl":{"current":"/en-my/"}},{"_createdAt":"2024-07-09T11:03:36Z","displayName":"Turkish - Turkey","_type":"Locale","languageCode":"tr","localeCode":"tr-TR","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoAGcZ","friendlyUrl":{"current":"/tr-tr/"},"_updatedAt":"2024-07-09T11:04:48Z","nativeName":"Türkçe","shortUrl":"https://bit.ly/3INTZSO","_rev":"iwSJAlC9N7TuVxGxCveU3m","regionCode":"TR"},{"friendlyUrl":{"current":"/jp/"},"nativeName":"日本語","localeCode":"ja","displayName":"Japanese","isEnabled":true,"_rev":"08sdc3VS02r1AeJ6JPOtkD","_type":"Locale","_id":"hOy10qbiXBGAt5MTQoAF3Q","languageCode":"ja","_updatedAt":"2024-07-09T11:04:50Z","shortUrl":"https://bit.ly/43qii2C","_createdAt":"2024-07-09T11:03:36Z"},{"shortUrl":"https://bit.ly/3wYAdBo","_type":"Locale","languageCode":"es","regionCode":"EC","localeCode":"es-EC","_updatedAt":"2024-07-09T11:04:52Z","displayName":"Spanish Castilian - Ecuador","_rev":"hOy10qbiXBGAt5MTQoCwIO","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoADoj","friendlyUrl":{"current":"/es-ec/"},"nativeName":"español"},{"regionCode":"IT","_createdAt":"2024-07-09T11:03:36Z","friendlyUrl":{"current":"/it-it/"},"_updatedAt":"2024-07-09T11:04:54Z","nativeName":"italiano","_rev":"08sdc3VS02r1AeJ6JPOuI5","languageCode":"it","localeCode":"it-IT","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoAEyJ","displayName":"Italian - Italy","shortUrl":"https://bit.ly/3TLXpLd","_type":"Locale"},{"_rev":"08sdc3VS02r1AeJ6JPOuMb","_type":"Locale","languageCode":"en","regionCode":"GB","_updatedAt":"2024-07-09T11:04:56Z","displayName":"English - United Kingdom","shortUrl":"https://bit.ly/3IPgtD7","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoAD4i","friendlyUrl":{"current":"/en-gb/"},"nativeName":"English","localeCode":"en-GB"},{"displayName":"Latvian - Latvia","shortUrl":"https://bit.ly/4akyDID","_rev":"08sdc3VS02r1AeJ6JPOuR7","localeCode":"lv-LV","isEnabled":true,"friendlyUrl":{"current":"/lv-lv/"},"nativeName":"latviešu","_type":"Locale","languageCode":"lv","regionCode":"LV","_createdAt":"2024-07-09T11:03:36Z","_id":"hOy10qbiXBGAt5MTQoAFSz","_updatedAt":"2024-07-09T11:04:58Z"},{"isEnabled":true,"_updatedAt":"2024-07-09T11:05:00Z","displayName":"Spanish Castilian - Peru","shortUrl":"https://bit.ly/43tj13h","languageCode":"es","regionCode":"PE","localeCode":"es-PE","friendlyUrl":{"current":"/es-pe/"},"nativeName":"español","_rev":"08sdc3VS02r1AeJ6JPOuVd","_type":"Locale","_createdAt":"2024-07-09T11:03:36Z","_id":"hOy10qbiXBGAt5MTQoAE44"},{"friendlyUrl":{"current":"/ru-ru/"},"nativeName":"русский","displayName":"Russian - Russian Federation","_type":"Locale","regionCode":"RU","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoAG7t","shortUrl":"https://bit.ly/3vkDDOu","_rev":"08sdc3VS02r1AeJ6JPOuef","languageCode":"ru","localeCode":"ru-RU","_createdAt":"2024-07-09T11:03:36Z","_updatedAt":"2024-07-09T11:05:02Z"},{"_type":"Locale","localeCode":"pt-BR","_createdAt":"2024-07-09T11:03:36Z","_id":"hOy10qbiXBGAt5MTQoAFnR","friendlyUrl":{"current":"/pt-br/"},"_rev":"iwSJAlC9N7TuVxGxCvfC6c","displayName":"Portuguese - Brazil","shortUrl":"https://bit.ly/3UF9Msp","languageCode":"pt","regionCode":"BR","isEnabled":true,"_updatedAt":"2024-07-09T11:05:04Z","nativeName":"português"},{"_id":"hOy10qbiXBGAt5MTQoACFa","shortUrl":"https://bit.ly/3VuXPYC","languageCode":"bs","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"regionCode":"Latn","localeCode":"bs-Latn-BA","friendlyUrl":{"current":"/bs-ba/"},"_updatedAt":"2024-07-09T11:05:05Z","nativeName":"bosanski","displayName":"Bosnian","_rev":"08sdc3VS02r1AeJ6JPP8vp","_type":"Locale"},{"_id":"hOy10qbiXBGAt5MTQoAGI7","friendlyUrl":{"current":"/sl-si/"},"displayName":"Slovenian - Slovenia","_type":"Locale","regionCode":"SI","_createdAt":"2024-07-09T11:03:36Z","localeCode":"sl-SI","isEnabled":true,"_updatedAt":"2024-07-09T11:05:07Z","nativeName":"slovenščina","shortUrl":"https://bit.ly/3IMteyd","_rev":"08sdc3VS02r1AeJ6JPPNrd","languageCode":"sl"},{"_rev":"iwSJAlC9N7TuVxGxCvgAN4","languageCode":"de","regionCode":"CH","friendlyUrl":{"current":"/de-ch/"},"_id":"hOy10qbiXBGAt5MTQoACa2","nativeName":"Deutsch","displayName":"German - Switzerland","shortUrl":"https://bit.ly/3IRuy2E","_type":"Locale","localeCode":"de-CH","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"_updatedAt":"2024-07-09T11:05:08Z"},{"_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoAGXS","friendlyUrl":{"current":"/th-th/"},"nativeName":"ไทย","shortUrl":"https://bit.ly/3IOv8hY","_rev":"hOy10qbiXBGAt5MTQoEBtd","regionCode":"TH","_updatedAt":"2024-07-09T11:05:10Z","displayName":"Thai - Thailand","_type":"Locale","languageCode":"th","localeCode":"th-TH"},{"nativeName":"中文(繁體) 舊版","_type":"Locale","localeCode":"zh-TW","isEnabled":true,"friendlyUrl":{"current":"/zh-tw/"},"displayName":"Chinese - Taiwan, Province of China","shortUrl":"https://bit.ly/43qqNuM","_rev":"iwSJAlC9N7TuVxGxCvgeZu","languageCode":"zh","regionCode":"TW","_createdAt":"2024-07-09T11:03:36Z","_id":"hOy10qbiXBGAt5MTQoAH28","_updatedAt":"2024-07-09T11:05:12Z"}],"_rev":"iwSJAlC9N7TuVxGxCvb6zW","scripts":[{"id":"matomo-script","_key":"b71b3c2c6d22","strategy":"beforeInteractive","async":false,"defer":false,"referrerPolicy":"","src":"data:text/javascript,%20%20var%20_mtm%20%3D%20window._mtm%20%3D%20window._mtm%20%7C%7C%20%5B%5D%3B%0A%20%20_mtm.push%28%7B%27mtm.startTime%27%3A%20%28new%20Date%28%29.getTime%28%29%29%2C%20%27event%27%3A%20%27mtm.Start%27%7D%29%3B%0A%20%20%28function%28%29%20%7B%0A%20%20%20%20var%20d%3Ddocument%2C%20g%3Dd.createElement%28%27script%27%29%2C%20s%3Dd.getElementsByTagName%28%27script%27%29%5B0%5D%3B%0A%20%20%20%20g.async%3Dtrue%3B%20g.src%3D%27https%3A%2F%2Fcdn.matomo.cloud%2Ftakeda.matomo.cloud%2Fcontainer_rTZNKGIx.js%27%3B%20s.parentNode.insertBefore%28g%2Cs%29%3B%0A%20%20%7D%29%28%29%3B","_type":"scriptTag"}],"title":"Global Site Settings","redirectManager":null,"externalLinkDisclaimerBlock":{"_type":"externalLinkDisclaimerBlock","displayOption":""},"_id":"000f3268-1464-4f3e-a14f-524ab5ecca53"},"withStackbit":false,"redesignLocales":[{"isEnabled":true,"localeCode":"en","displayName":"Global English","friendlyUrl":{"current":"en","_type":"slug"}},{"isEnabled":true,"localeCode":"ja","displayName":"Global Japanese","friendlyUrl":{"_type":"slug","current":"jp"}},{"isEnabled":true,"localeCode":"en-PH","displayName":"Philippines","friendlyUrl":{"current":"/en-ph","_type":"slug"}},{"isEnabled":true,"localeCode":"ar-SA","displayName":"Saudi Arabia","friendlyUrl":{"current":"ar-sa","_type":"slug"}},{"isEnabled":true,"localeCode":"en-SG","displayName":"Singapore","friendlyUrl":{"current":"/en-sg","_type":"slug"}},{"isEnabled":true,"localeCode":"es-ES","displayName":"España","friendlyUrl":{"current":"/es-es","_type":"slug"}},{"isEnabled":true,"localeCode":"es-CL","displayName":"Chile","friendlyUrl":{"current":"es-cl","_type":"slug"}},{"isEnabled":true,"localeCode":"en-CL","displayName":"Chile","friendlyUrl":{"current":"en-cl","_type":"slug"}},{"isEnabled":true,"localeCode":"en-AU","displayName":"Australia","friendlyUrl":{"current":"/en-au","_type":"slug"}},{"isEnabled":true,"localeCode":"en-NZ","displayName":"New Zealand","friendlyUrl":{"current":"/en-nz","_type":"slug"}},{"isEnabled":true,"localeCode":"da-DK","displayName":"Denmark","friendlyUrl":{"current":"/da-dk","_type":"slug"}},{"isEnabled":true,"localeCode":"sv-SE","displayName":"Sweden","friendlyUrl":{"current":"/sv-se/","_type":"slug"}},{"isEnabled":true,"localeCode":"kk-KZ","displayName":"Kazakhstan","friendlyUrl":{"current":"kk-kz","_type":"slug"}},{"isEnabled":true,"localeCode":"id-ID","displayName":"Indonesia","friendlyUrl":{"current":"id-id","_type":"slug"}},{"isEnabled":true,"localeCode":"en-SA","displayName":"Saudi Arabia","friendlyUrl":{"current":"en-sa","_type":"slug"}},{"isEnabled":true,"localeCode":"hr-HR","displayName":"Croatia","friendlyUrl":{"current":"/hr-hr","_type":"slug"}},{"isEnabled":true,"localeCode":"en-MY","displayName":"Malaysia","friendlyUrl":{"current":"/en-my","_type":"slug"}},{"isEnabled":true,"localeCode":"pt-PT","displayName":"Portugal","friendlyUrl":{"current":"/pt-pt","_type":"slug"}},{"isEnabled":true,"localeCode":"ru-KZ","displayName":"Kazakhstan","friendlyUrl":{"current":"ru-kz","_type":"slug"}},{"isEnabled":true,"localeCode":"es-AR","displayName":"Argentina","friendlyUrl":{"current":"/es-ar/","_type":"slug"}},{"isEnabled":true,"localeCode":"bg-BG","displayName":"Bulgaria","friendlyUrl":{"current":"/bg-bg/","_type":"slug"}},{"isEnabled":true,"localeCode":"sr-RS","displayName":"Serbia","friendlyUrl":{"current":"/sr-rs","_type":"slug"}},{"isEnabled":true,"localeCode":"en-ZA","displayName":"South Africa","friendlyUrl":{"current":"/en-za","_type":"slug"}},{"isEnabled":true,"localeCode":"pl-PL","displayName":"Poland","friendlyUrl":{"current":"/pl-pl/","_type":"slug"}},{"isEnabled":true,"localeCode":"ro-RO","displayName":"Romania","friendlyUrl":{"current":"ro-ro","_type":"slug"}},{"isEnabled":true,"localeCode":"ms-MY","displayName":"Malaysia","friendlyUrl":{"current":"/ms-my","_type":"slug"}}],"defaultLocale":{"isEnabled":true,"localeCode":"en","displayName":"Global English","friendlyUrl":{"current":"en","_type":"slug"}}},"__N_SSG":true},"page":"/[[...slug]]","query":{"slug":["corporate-responsibility","ethics-and-compliance"]},"buildId":"B-wrCqxaVyylFXttWiqv_","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[20777,3743,26189,12062,62516,46089,67597,62691,18042,29391,21878],"gsp":true,"locale":"en-us","locales":["en","uk-ua","lt-lt","en-be","en-us","es-mx","kk-kz","el-gr","sv-se","de-at","uz-uz","en-ca","et-ee","hu-hu","fr-ch","he-il","sr-rs","en-ie","zh-hk","en-in","en-au","ko-kr","ja-jp","hr-hr","es-ve","sk-sk","id-id","pl-pl","en-vi","es-es","en-hk","bg-bg","ro-ro","ru-kz","fi-fi","zh-cn","cs-cz","fr-fr","da-dk","fr-ca","nn-no","pt-pt","es-ar","de-de","es-co","nl-nl","en-my","tr-tr","jp","es-ec","it-it","en-gb","lv-lv","es-pe","ru-ru","pt-br","bs-ba","sl-si","de-ch","th-th","zh-tw"],"defaultLocale":"en","domainLocales":[{"domain":"www.takeda.com.cn","defaultLocale":"zh-cn"}],"scriptLoader":[]}</script></body></html>